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INTRODUCTION
Cardiovascular diseases comprise the most important cause of morbidity and 
mortality worldwide.1 They are common in developing and developed nations and 
afflict both men and women. Most notably, atherosclerosis, leading to ischemic 
heart disease, ventricular remodeling and heart failure, accounts for the major 
share of cardiovascular diseases. The increasing life expectancy of the popula-
tion contributes to the increased burden. In addition, advances in diagnosis 
and treatment of various cardiovascular diseases have improved the survival of 
patients with residual myocardial dysfunction, thereby increasing prevalence of 
manifest heart failure. Most available treatment strategies alleviate symptoms 
but do not cure, let alone prevent, ischemic heart disease. Major challenges for 
cardiovascular research in the ensuing years will be to develop strategies for 
early recognition of individuals at risk of ischemic heart disease and its compli-
cations so that early prevention and treatment measures may be initiated.
The structure of the heart
The heart consists of cardiomyocytes and non-myocytes. The cardiomyocytes 
account for approximately 70% of the volume of the myocardium, but constitute 
only about 33% of the cell population.2 The non-myocytes consist of several dif-
ferent cell types like fibroblasts, endothelial cells and vascular smooth muscle 
cells and are found in the cardiac interstitium.   
The extracellular matrix of the heart
The structural backbone of the heart is provided by the extracellular matrix 
comprising various proteins, such as collagens. Type I, III and VI collagen are 
present in and around the coronary arteries and within the interstitium; type IV 
collagen is present in the basement membrane surrounding the cardiomyocytes 
and other cells, such as endothelial cells and pericytes. Collagen is produced 
by (myo-)fibroblasts as soluble pro-collagen, which crosslinks extracellularly to 
mature collagen. In a normal adult, interstitial collagen makes up to 1–2% of 
the volume of the heart.3 Under pathological conditions, such as after myocardial 
infarction (MI), in addition to the replacement fibrosis (infarct wound healing), 
there is excessive deposition of interstitial collagen in the infarct border and the 
remote myocardium. The increased interstitial fibrosis may constitute up to 10% 
of the volume of the heart.4 
The wound healing process after myocardial infarction
Myocardial infarction usually results from coronary atherosclerosis with super-
imposed coronary thrombosis, which leads to myocardial necrosis involving the 
full (transmural) or partial ventricular wall thickness subtended by the affected 
coronary artery.5 
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The wound healing after myocardial infarction mimics the wound healing pro-
cesses observed in other tissues, such as the skin. However, cardiac wound 
healing has some distinctive features. The adult cardiomyocytes are terminally 
differentiated cells that have lost, at least to a great extent, the capacity to 
divide and regenerate.6 Therefore, adequate cardiac wound healing is mainly 
determined by the factors that control the formation of granulation tissue. Fur-
thermore, there is the rhythmic contraction of the non-infarcted myocardium, 
which imposes a cyclic stretch on the healing wound. In addition, the architec-
tural changes in the infarct are tightly controlled in order to maintain cardiac 
function after infarction.  
The process of cardiac wound healing after myocardial infarction can be divided 
into four overlapping phases, which are schematically represented in Figure 1.1. 
Phase 1 is characterized by the death of cardiomyocytes, either by apoptosis, 
necrosis or both. Various intracellular macromolecules are released into the blood-
stream, for example creatine kinase (CK), CK isoenzymes and cardiac-specific 
troponins.5 Elevated circulating levels of these cardiomyocyte biomarkers can be 
measured as indicators of the severity of myocardial damage. 
Phase 2 of the healing process embodies an early inflammatory response.  Since 
the majority of the apoptotic cells after infarction cannot be phagocytosed by 
neighboring cells, secondary necrosis occurs from 12 hours to 4 days after in-
farction,7 stimulating the influx of inflammatory cells. One of the first features of 
the inflammatory response is activation of the complement system, and release 
of several cytokines, such as interleukins-6 and -8.8-10 Within 6–8 hours after the 
onset of myocardial infarction neutrophilic granulocytes (PMN) migrate into the 
infarcted area, reaching their peak number within 24–48 hours after infarction. 
The granulocytes help to remove the dead cardiomyocytes. Granulocyte infil-
tration is followed by the influx of other inflammatory cells, like lymphocytes, 
plasma cells and macrophages at 3-7 days post-MI.3 
Phase 3 of the cardiac wound healing process constitutes the formation of gran-
ulation tissue. Simultaneously with the activation of collagen synthesis, col-
lagen degradation is activated. In the first week after myocardial infarction, 
specific matrix metalloproteinases (MMP) are activated, that cleave interstitial 
collagens.11, 12 Increased collagenolytic activity can result in loss of structural 
support, distortion of tissue architecture, reduction of cardiac stiffness, wall 
thinning and even rupture of the myocardium. Two to three days after infarction, 
new extracellular matrix proteins are being deposited, first in the infarct border 
zone and later in the infarct center. The granulation tissue increases the tensile 
strength of the infarct and prevents cardiac rupture. During this phase, fibrin is 
deposited followed by other extracellular matrix proteins, e.g. fibronectin and 
tenascin.13, 14 Within approximately one week after infarction, myofibroblasts 
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The top row shows a normal heart, a transverse heart section, and associated normal heart histology. 
Acute myocardial infarction occurs when there is occlusion of one of the coronary arteries (occlusion 
of the left anterior descending coronary artery is represented by a black dot over the artery). The first 
phase of the wound healing process (12-18 hours post-infarction) is characterized by eosinophilia and 
nuclear pyknosis (second row, far right panel). Between days 1 and 4 post infarction the nuclei may 
disappear and polymorphonuclear leukocytes infiltrate into the infarcted area with removal of necrotic 
fibers (third row, phase 2). At this time, when the infarct wall is weakest, the myocardium may rup-
ture, often leading to sudden death. In the hearts that do not rupture, there is matrix remodeling and 
granulation tissue formation that by 3 weeks includes removal of necrotic debris, mononuclear cell infil-
tration, increased numbers of fibroblasts and capillaries, and an increase in collagen deposition (fourth 
row, phase 3). After three months, the infarcted region thins and is replaced by scar tissue (bottom 
row, phase 4). The remaining viable myocardium may remodel and become dysfunctional, leading 
to heart failure. Scale bar length is indicated in micrometers. Figure adapted from: E. Creemers and 
J. Cleutjens. For full color illustration, see page 152.
Figure 1.1   The different phases of wound healing post-myocardial infarction
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surround the infarcted area, producing interstitial collagens. The peak of type 
III collagen production is followed by a lower and slower developing peak of 
type I collagen. Complete collagen cross-linking takes another couple of weeks 
to occur. Collagen turnover in a normal adult non-infarcted heart may take ap-
proximately 4 months to complete, but may be much faster in the early phase 
of cardiac wound healing in the infarcted zone.15 
Granulation tissue is also characterized by the presence of many blood ves-
sels, starting to appear within a few days after infarction. The new blood ves-
sels are derived from pre-existent blood vessels (angiogenesis) or from en-
dothelial progenitor cells that migrate from the border zone into the infarct 
(neovascularization).3 A 2–3 week old granulation tissue in an infarcted region 
is characterized as a cell-rich tissue, containing (partly) cross-linked interstitial 
collagens, macrophages, blood vessels, and (myo) fibroblasts. 
Phase 4 of cardiac wound healing is characterized by the formation of scar tis-
sue. During this phase, cells disappear from the wound and collagen becomes 
almost completely cross-linked. The cardiac scar tissue has a permanent nature 
because of the lack of cardiomyocyte regeneration. A well healed myocardial 
infarct consists of a strong replacement scar and little interstitial fibrosis in the 
non-infarcted areas. However, the loss of functional myocardium creates addi-
tional biomechanical stress on the remaining viable heart muscle. This can lead 
to adverse myocardial remodeling leading to dilatation of the heart, thinning of 
the walls of the ventricles and eventually heart failure.16 The above mentioned 
time line of post-infarction wound healing is generalized for humans, and is ob-
served to be significantly accelerated in smaller animals, like rats and mice.3 
Changes in the non-infarcted myocardium after myocardial infarction
As mentioned above, structural changes after infarction are not limited to the 
infarcted area, but also extend into the non-infarcted myocardium. Although 
the changes in the non-infarcted region are not as outspoken as in the infarct 
area, they contribute significantly to the ventricular remodeling. Changes in the 
non-infarcted myocardium include hypertrophy of the cardiomyocytes, growth 
of the capillary network, and an increase in interstitial collagen. Myocardial hy-
pertrophy starts within several days after infarction and cardiomyocyte volume 
may increase by 110% in humans.17 Capillary endothelial cells proliferate, but 
usually not enough to fully compensate for the extent of cardiomyocyte hy-
pertrophy; this results in an increase of oxygen diffusion distance and hence 
relative ischemia. Besides heart muscle and endothelial cells, changes in the 
interstitial collagen content are apparent in the non-infarcted ventricle. As men-
tioned above, interstitial collagens double within 1 week after infarction.4 Similar 
to the infarct zone, type III collagen deposition precedes type I collagen. The 
increase in interstitial collagen deposition may be beneficial to the heart in that 
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it helps to prevent dilatation. Increased amounts of interstitial collagens will, 
on the other hand, increase the stiffness of the heart and result in a reduced 
cardiac function.18 
Major complications of infarct healing
The process of myocardial infarct healing is very complex and can lead to sev-
eral complications. In this thesis we will focus on two common complications of 
myocardial infarction, associated with the healing process. The first complica-
tion is myocardial infarct rupture which occurs early, usually within a week after 
MI. The second complication is heart failure post-MI, a complication that typi-
cally occurs in a later stage (months to years) after MI. 
1. Infarct Rupture
Myocardial infarct rupture is a usually lethal complication of acute myocardial 
infarction for which no adequate treatment is available. The overall incidence 
of infarct rupture is approximately 2-7%; however, infarct rupture accounts 
for 15% of the in-hospital mortality post-MI.19 The acute presentation of myo-
cardial infarct rupture of the ventricular free wall results from the subsequent 
tamponade that develops. Symptoms are severe, persistent chest pain, hy-
potension, restlessness and agitation, pulsus paradoxus, cardiogenic shock and 
eventually electro-mechanical dissociation.20 Infarct rupture is associated with 
increasing age, transmural infarction, the first episode of myocardial infarction 
and the absence of a history of ischemic heart disease.19 Almost 80% of free wall 
ruptures occur within the first week after the onset of myocardial infarction.21 
This period corresponds well with healing phase 2, in which there are dead 
cardiomyocytes in the infarct area without adequate replacement fibrosis.3 
Research in animal models demonstrated that inhibition of plasminogen activa-
tion22, 23 or targeted deletion of MMP-224 or MMP-923 reduced the influx of inflam-
matory cells in the infarct area and reduced the incidence of infarct rupture. 
Sheikh et al.25 have demonstrated an important role for cellular adhesion pro-
teins in the development of rupture. They described that aE-catenin condition-
al knockout mice showed an increased incidence of cardiac rupture post-MI.25 
However, the molecular mechanisms involved in infarct rupture in humans have 
not been described so far.
2. Heart Failure
A more frequent complication of myocardial infarction associated with adverse 
remodeling is heart failure. Heart failure is the condition in which the heart is 
unable to maintain sufficient cardiac output to meet the metabolic and oxygen 
demands of the peripheral tissue.26 One of the most important causes of heart 
failure is myocardial infarction. Due to the improved survival post-MI, more 
and more people are at risk to develop heart failure. Within six years of the 
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clinical event of acute myocardial infarction, 22% of male and 46% of female 
patients develop heart failure.27  The loss of ventricular muscle during the epi-
sode of acute ischemic heart disease, and the complex architectural alterations 
involving both the infarcted and non-infarcted myocardium contribute to the 
evolution of heart failure. Dilatation and infarct expansion are the most promi-
nent changes in the infarct region,28 and can lead to both systolic (decreased 
contraction) and diastolic (decreased relaxation) dysfunction.29 The ventricular 
dilatation may initially serve as a compensatory mechanism to maintain stroke 
volume after the loss of contractile tissue. However, this precarious balance can 
be exceeded in which increased cavity volume with insufficient compensatory 
hypertrophy results in loading conditions promoting further enlargement and 
dysfunction. Patients showing extensive infarct expansion after myocardial in-
farction are more likely to develop heart failure.30  Recently a role for myofibro-
blasts was proposed in the prevention of dilatation post-MI. Myofibroblasts have 
contractile properties and can persist in human infarcts for decades post-MI13 
and may prevent infarct expansion (see chapter 2).
Molecular imaging
Since heart failure is a progressive and invalidating disease for which no cure is 
available, it is of utmost importance to detect patients at risk of heart failure as 
early as possible before the clinical symptoms become manifest. That way, high 
risk patients can be treated aggressively in order to prevent the development 
of heart failure. The current imaging modalities, such as echocardiography and 
cardiovascular magnetic resonance imaging provide excellent information on 
left ventricular chamber dimensions and function post-MI (see Figure 1.2). How-
ever, these changes represent delayed, and often irreversible, consequences of 
remodeling. Furthermore, these techniques do not provide biological or molecu-
lar information on the development of heart failure or processes involved in the 
progression of heart failure. 
Molecular imaging is broadly defined as the in vivo assessment of biological pro-
cesses at the cellular and molecular level.31 Recent insight in molecular mecha-
nisms of disease on the one hand and imaging technologies on the other hand, 
have merged to allow monitoring of disease processes at their most fundamen-
tal levels, i.e. the molecular pathways involved. The impact of molecular imag-
ing on ischemic heart disease can be envisioned in several ways. First, patients 
at risk for complications after MI may be identified before they develop symp-
toms. Furthermore, emerging molecular imaging tools can provide markers of 
therapy success or failure before clinical effects become manifest. Imaging will 
also provide important information on the optimal timing and dosing of drugs. 
So whereas conventional diagnostic imaging detects the outcome of disease 
processes, molecular imaging provides an opportunity to monitor the develop-
ment of these processes in an early stage. 
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Molecular imaging detects early changes on a molecular level, at a pre-symptomatic stage. Detect-
ing molecular changes at an early stage can help in patient stratification and prevention of disease 
progression by earlier and more aggressive treatment. Moreover, molecular imaging may be a tool 
to study the effect of treatment. Conventional imaging detects anatomical changes, usually when the 
patient already has symptoms of the disease.
Figure 1.2   Molecular imaging versus conventional, anatomical imaging
Outline of this thesis
As described in the previous paragraphs, the wound healing after myocardial 
infarction is a very complex process and if this does not occur properly, it can 
lead to several complications such as ventricular rupture in the early stage or 
adverse cardiac remodeling and heart failure in later stages post-MI. 
The first hypothesis of the present thesis is that cell adhesion molecules, es-
pecially aE-catenin, and upregulation of MMP’s are involved in the process of 
infarct rupture in humans. Second, we hypothesized that molecular imaging is 
a tool to study the process of heart failure and the effects of heart failure treat-
ment post-MI.    
Therefore, the aims of this thesis were twofold: 
1. To study molecular mechanisms of myocardial infarct rupture post-MI,
 focusing on adhesion molecules and matrix metalloproteinases.
2. To study adverse myocardial remodeling and heart failure post-MI, 
 using a molecular imaging tool.
We started with a study in a mouse model of myocardial infarction (Chapter 3), 
in which we studied infarct healing post-MI in 5 different strains frequently used 
in cardiovascular research. We studied incidence of rupture and heart failure and 
mechanisms contributing to these complications. Since it is known from litera-
ture that members of the matrix metalloproteinase family play an important role 
Pre-symptomatic 
state
Beginning of
symptoms
Anatomical
changes
SymptomsEarly detection
Physiological
changes
Molecular imaging Conventional imaging
Predict disease     stop disease progression
Molecular
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Molecular Imaging of Myocardial Remodeling:
Targeting the Myofibroblasts
submitted
in development of cardiac rupture post-MI in mouse models, we studied the role 
of these MMP’s in post mortem heart samples of patients who died of cardiac 
rupture post-MI in chapter 4. Furthermore, we studied the role of the cellular 
adhesion proteins in cardiomyocytes and their role in cardiac rupture post-MI 
in chapter 5, and described a possible molecular mechanism that can lead to 
infarct rupture post-MI in humans.
Molecular imaging was used to visualize cardiac remodeling post-MI in an early 
stage in chapter 6. Furthermore, in chapter 7 we investigated whether this 
molecular imaging probe for heart failure can detect the efficacy of pharmaco-
logical intervention after myocardial infarction, thereby creating the possibility 
of following up on treatment and offering individualized therapy. In chapter 8, 
the findings of the experimental chapters are discussed and put into a broader 
context. 
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ABSTRACT 
The adverse cardiac remodeling after acute myocardial infarction (MI) is an in-
exorable process that continues to occur even after the initial injury has abated 
and leads to development of heart failure (HF).  Since 22% of men and 46% of 
women develop heart failure within 6 years after their first episode of MI, the 
importance of a better understanding of the process of remodeling after MI can 
hardly be overemphasized.  For development of an effective preventive strategy 
it will be necessary to identify a subset of MI patients who are at higher risk for 
development of HF. It is expected that novel biomarkers and/or morphological 
and molecular imaging tools will offer this discriminatory prognostic informa-
tion. 
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Adverse cardiac remodeling refers to geometric changes and inexorable func-
tional deterioration, typically after acute myocardial infarction (MI).32, 33 During 
the earlier healing phase, there is an efficient removal of necrotic debris and col-
lagen is deposited; the replacement fibrosis initially supports ventricular func-
tion. This process involves a complex interplay among different cell types, in-
cluding inflammatory cells, endothelial cells of newly forming blood vessels and 
fibroblast-like cells. With the passage of time, numerous changes also occur in 
myocytic and interstitial compartments in the unaffected remote myocardial re-
gions. There is substantial myocyte hypertrophy and significant interstitial fibro-
sis that eventually contribute to functional compromise. The process of wound 
healing and adverse remodeling after MI has been studied predominantly in 
rodent models, wherein a coronary artery is surgically ligated for induction of 
MI. The development of transgenic and knockout mouse models has allowed 
the study of the effect of individual genes and pathogenetic cascades on the 
remodeling process. 
Targeted imaging of various components of the infarct healing and remodeling 
process, in both injured and remote areas, should allow identification of sus-
ceptible post-MI patients before clinically manifest heart failure (HF). Such an 
imaging strategy may also provide important information on the efficacy and 
adequacy of therapeutic intervention. One of the prominent cell types in the 
healing infarct, useful for imaging purposes, is the myofibroblast. This cell type 
combines characteristics of fibroblasts (ECM production) with smooth muscle 
cells (contractile properties), and appears to play a crucial role in infarct healing 
and scar contraction. We will discuss the role of the myofibroblast in infarct 
healing, define molecular targets on myofibroblasts, and discuss the feasibility 
of molecular imaging of these cells for early detection and treatment of patients 
at risk for developing heart failure post-MI.
Origin, proliferation and characteristics of myocardial myofibroblasts
The wound healing process and fibroblast-like cells  
The wound healing after MI involves a complex cascade of events. Cardiomyo-
cyte death during acute injury invokes recruitment of inflammatory cells at the 
infarct border, which remove the necrotic cell debris by phagocytosis; and gran-
ulation tissue formation begins around the fourth day after MI, depending on 
the species. The granulation tissue consists of inflammatory cells, newly formed 
blood vessels for restoration of blood supply and fibroblast-like cells which de-
posit collagen. Eventually, this granulation tissue matures into a scar which is 
devoid of inflammatory cells but rich in extracellular matrix and fibroblast-like 
cells.3 Tacitly, the scar tissue in the infarct has been perceived as a passive 
replacement for the lost cardiomyocytes with little biological activity. However, 
the scar tissue is now being increasingly recognized as an active playground 
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wherein ongoing activity of fibroblast-like cells maintain a process of collagen 
turnover and scar tissue contraction.3, 34 The persistence of fibroblast-like cells 
in the infarct area is a prerequisite to ensure maintenance of the extracellular 
matrix in the scar, which is subjected to mechanical stress, and wear and tear 
in the beating heart.  Since the fibroblasts-like cells remain for a long time in 
the myocardial scar tissue and their quantitative extent is proportional to the 
collagen deposition, such cells and their characteristics should comprise worthy 
targets for molecular imaging for the early detection of adverse remodeling.
Origin of myofibroblasts
The most intriguing fibroblasts-like cells in the granulation tissue are myofibro-
blasts, which may be derived from multiple sources (Figure 2.1).35 In addition 
to pre-existing local fibroblasts which can differentiate into myofibroblasts, epi-
thelial and endothelial cells may evolve into myofibroblasts by the process of 
epithelial-mesenchymal transition (EMT)36 and endothelial-mesenchymal tran-
sition (EndMT).37 Further, circulating fibroblast-like cells may be derived from 
bone marrow stem cells; these blood-borne mesenchymal stem cell progenitors 
have a fibroblast/myofibroblasts-like phenotype and are called fibrocytes.38 It 
is believed that myofibroblasts of different origins participate with the resident 
mesenchymal cells in the reparative process, although the relative contribution 
of each of these populations remains to be established. There is a growing inter-
est in dissecting the role of the various myofibroblast subpopulations in tissue 
regeneration and fibroproliferative diseases.35 
Myofibroblast differentiation after MI 
Under normal circumstances, the resident cardiac fibroblasts have no contractile 
microfilaments or stress fibers, and exhibit few or no actin-associated cell-to-cell 
and cell-to-matrix contacts and have minimal extracellular matrix production.39 
In aftermath of MI, fibroblasts are activated to differentiate as myofibroblasts, 
which converge into the damaged region and accelerate extracellular matrix 
protein synthesis, such as collagen, fibronectin and laminin40 to replace necrotic 
cardiomyocytes by a scar.
An important stimulus for the phenotypic transition of fibroblast to myofibroblast 
is the change in the mechanical microenvironment. In intact tissue, fibroblasts are 
generally stress shielded within the framework of the cross linked extracellular 
matrix (ECM). When the architectural integrity is lost in the injured region, 
fibroblasts exposed to mechanical stress transform into proto-myofibroblasts.41 
The proto-myofibroblasts are characterized by the presence of stress fibers 
containing cytoplasmic b- and g-actins. Subsequent exposure to transforming 
growth factor b1 (TGF-b1), and ED-A splice variant of fibronectin result in the 
evolution of proto-myofibroblasts into differentiated myofibroblasts.42, 43 This 
fully differentiated cell type is characterized by the expression of alpha smooth 
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Fibrocyte
Myofibroblasts may be derived from different cell types. Besides the residential fibroblasts, they 
can also evolve from smooth muscle cells (SMC), epithelial and endothelial cells and blood-borne 
mesenchymal stem cell progenitors (called fibrocytes). Upon specific stimuli these cells can transform 
into proto-myofibroblasts, which in turn can differentiate into myofibroblasts in response to TGF-b1, 
ED-A fibronectin and mechanical stretch. 
Figure 2.1   Origin of cardiac myofibroblasts
muscle actin (ASMA) and other smooth muscle differentiation markers.44-46 
Indeed, mice lacking the ED-A exon of fibronectin have been shown to display 
abnormal skin wound healing.47
The reconstructed ECM enables the repaired tissue to take over the mechanical 
load again and myofibroblasts disappear by apoptosis. Stress release is a potent 
promoter of myofibroblasts apoptosis in vivo.48 Therefore, interrupting the 
mechanical feedback loop of myofibroblasts contraction and gradually increasing 
ECM tension may constitute a strategy to prevent excessive collagen deposition 
in the heart.
Fibroblast SMC Epithelium Endothelium
Mechanical 
tension
EMT EndMT
Protomyofibroblast
Differentiated Myofibroblast
TGF-b1
ED-A fibronectin
Mechanical tension
Contractile properties of myofibroblasts 
During the skin wound healing, myofibroblasts align perpendicular to the wound 
rim and their contractile properties bring wound margins closer, a phenomenon 
which is know as wound contraction and which minimizes the scar size.49 The re-
duction in size is stabilized by extracellular matrix deposition and subsequently 
the myofibroblasts disappear from the scar area.44 This explains why a scar is 
generally considered to be an ECM-rich acellular entity. However, unlike wound 
healing in the skin,50 myofibroblasts persist for up to 20 years even in healed 
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human infarcts13 proposing a continued role for myofibroblasts for the stability 
of the infarct area which is under repetitive stress in a beating heart. Not only 
are the myofibroblasts persistent in the infarct scar, they continue to produce 
type I and III fibrillar collagen long after the scar tissue has replaced the ne-
crotic myocytes indicative of their role in the stability of the scar.  
The nature of contraction generated by the myofibroblasts is fundamentally 
distinct from that generated by the cardiomyocytes. Whereas myofibroblasts 
typically generate a sustained contraction resembling smooth muscle cells (such 
as in vasculature), cardiomyocytes contract and relax cyclically. Cardiomyo-
cytes contract upon a stimulus from the cardiac conduction system, whereas 
the sustained contraction of myofibroblasts is modulated by circulating factors 
and neurohormones, like angiotensin II.39 Given the high electrical resistance 
of the connective tissue in the infarct area,51 smooth muscle-like cells, such 
as the myofibroblasts, are better suited for tonic contraction than cardiomyo-
cytes; myofibroblast contraction is also more favorable energetically in relatively 
poorly-perfused scarred tissue. 
 
ECM deposition, scar formation and adverse myocardial remodeling
Collagen deposition, replacement and interstitial fibrosis 
It is well established that well-healed infarcts contain large amounts of ECM, 
which may occupy up to 80% of the infarct area.3 On the other hand, colla-
gen deposition in uninfarcted remote myocardial region occurs predominantly in 
the interstitium and contributes to ventricular stiffness and dysfunction. Various 
neurohumoral substances such as angiotensin II and transforming growth factor 
beta-1 (TGF-b1), which are preferentially overexpressed within the cardiomyo-
cytes in the infarct border, traverse the common interstitial space and enhance 
collagen synthesis at sites distant from the MI. The fibrosis that develops over 
time in regions remote to the infarct represents the majority of connective tis-
sue found in ischemic cardiomyopathy, and contributes to adverse structural 
remodeling in the failing human heart.52 It seems reasonable to presume that an 
optimally healed infarcted heart comprises a strong ECM-rich replacement scar, 
but minimal remote fibrosis. Summarily, whereas resident interstitial fibroblasts 
are responsible for minimal normal collagen deposition in healthy myocardium, 
phenotypically transformed myofibroblasts are central to fibrogenesis at sites of 
remodeling after MI. 
Molecular targets in myofibroblasts amenable to imaging
The myofibroblast as a target for molecular imaging of infarct healing 
From the foregoing discussion, one can surmise that assessment of the extent 
of myofibroblast presence and collagen deposition would be a useful tool for 
identification of patients likely to develop heart failure after MI. In these pa-
Thesis vd Borne V2.indd   22 20-2-2009   14:59:29
CHAPTER 2 | Imaging myofibroblasts 
| page 23 
tients, one would expect either a low amount of myofibroblasts in the infarct 
area (predicting poor ECM maintenance and excessive scar dilatation) or exces-
sive amounts of fibroblasts in the uninjured parts of the heart (indicative for 
fibrosis of the non-infarcted myocardium). For development of useful imaging 
techniques within this context, it would be desirable to define moieties that are 
exclusively expressed by myofibroblasts. Although myofibroblasts express sev-
eral markers, both intracellular and extracellular, unfortunately none of these 
targets are sufficiently exclusive to be highly specific for myofibroblasts.53  
Worthy markers for identification of myofibroblasts  
Myofibroblasts share the expression of ASMA with smooth muscle cells, which 
is an early differentiation marker of vascular smooth muscle cells (SMC) (see 
Figure 2.2). Unlike SMC however, myofibroblasts express relatively low amounts 
of smooth muscle myosin heavy chain and do not express smoothelin, a late 
differentiation marker.48 Expression of various (trans) membrane moieties on 
myofibroblasts may, however, comprise better targets. The migration and differ-
entiation of myofibroblasts are partially determined by expression of frizzled-2, 
a tissue polarity gene with a seven transmembrane structure.54 Frizzled-2 is 
upregulated in the myofibroblasts during their migration into the infarct area. 
Frizzled-2 receptors are located on the plasma membrane and should be easily 
accessible, provided that specific ligands would be available (see Figure 2.2). 
The myofibroblasts expresses several targets that might be of interest for molecular imaging. 
Angiotensin receptor, Frizzled-2 receptor and TGF-b receptors are reasonable candidates and easily 
accessible to targeting tracer molecules because of their extracellular localization. avb3 integrins are 
expressed in the supermature focal adhesions and may constitute yet another candidate. However, 
specificity and efficacy of these targets needs to be determined because these targets are presented 
on numerous other cell types. For full color illustration, see page 153. 
Figure 2.2   Potential targets for myofibroblast imaging
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Myofibroblasts also express renin, angiotensin converting enzyme (ACE) and 
angiotensin receptors.51 Because renin and ACE are excreted, they are not very 
suitable as targets for molecular imaging. Angiotensin II perpetuates collagen 
synthesis by induction of TGF-b1 expression which is abrogated by angiotensin 
II type 1 receptor (AT1) antagonists. An ongoing expression of angiotensin II 
and AT1 receptors and active TGF-b1 and TGF-b1 receptors is observed in the 
infarcted rodent heart months after MI and underscores persistent metabolic ac-
tivity of activated myofibroblasts.51 Angiotensin II, produced locally by activated 
macrophages, cardiomyocytes and myofibroblasts exerts its effect by directly 
inducing NADPH oxidase activity in myofibroblasts stimulating TGFb1 produc-
tion, and triggering fibroblast proliferation and differentiation into collagen se-
creting myofibroblasts. Because of the persistent expression of AT1 receptors on 
myofibroblasts, they can serve as suitable targets for molecular imaging. 
TGFb1 augments production of interstitial collagens, fibronectin and proteogly-
cans by cardiac myofibroblasts (see Figure 2.2). It also stimulates its own pro-
duction in myofibroblasts, thereby establishing an autocrine cycle of myofibro-
blastic differentiation and activation.35 Studies have shown that overexpression 
of TGFb1 in transgenic mice can lead to cardiac hypertrophy, characterized by 
both interstitial fibrosis and hypertrophic growth of cardiac myocytes.55 There-
fore, TGF-β1 receptors could be a potential target for molecular imaging. The 
components of the RAS system and TGF-b1 signaling, although expressed at 
high levels on myofibroblasts, are not specific for these cells as they can be 
found on other cells as well. 
Analysis of myofibroblasts in fibrotic and granulation tissue reveals extensive 
cell-matrix contacts called fibronexi; such fibronexi are not observed in fibro-
blasts isolated from normal connective tissue. Cultured myofibroblasts develop 
specialized focal adhesions (FA) that have been termed ‘supermature FA’ to 
account for their significantly longer appearance compared with classical FA 
of ASMA-negative fibroblasts. In addition, supermature FA exhibit a specific 
molecular composition by coexpressing high levels of vinculin, paxillin, tensin 
and the integrins avb3 and a5b156 (see Figure 2.2).  avb3 integrin expression 
in myocardium is generally rare in adults, but it is seen on endothelial cells 
during angiogenesis in response to angiogenic growth factors such as bFGF, and 
is fundamental for endothelial cell proliferation, adhesion and survival. Since 
neoangiogenesis and myofibroblastic proliferation occur together in post-MI re-
modeling, integrin targeting may be a reasonable approach for molecular imag-
ing.
In addition to relatively exclusive (trans) membrane markers, it may also be 
prudent to target the company myofibroblasts keep. In the infarct area, for 
instance, the presence of myofibroblasts leads to collagen deposition and colla-
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gen crosslinking is mediated by lysyl oxidase family enzymes.57 Lysyl oxidase is 
upregulated during the first weeks of infarct healing, remains elevated up to 90 
days after MI,57 its expression is responsive to connective tissue growth factor 
(CTGF) and TGF-b,58 and could probably be used as a surrogate marker for the 
extent of myofibroblast proliferation. 
Imaging of upregulation of receptors for growth factors on myofibro-
blasts
As discussed above, myocardial upregulation of the RAS system contributes 
prominently to ventricular remodeling. Myocardial angiotensin II (AT) type 1 
receptor overexpression is associated with interstitial fibrosis59 and AT type 1 
receptor deficient transgenic mice exhibit minimal structural remodeling after 
MI.60 Angiotensin receptor blockers in myocardial infarction prevent and restrict 
ventricular remodeling, and reduce morbidity and mortality after MI regardless 
of LV functional deterioration.61-65  It is therefore conceivable that a novel diag-
In vivo microscopic imaging shows a 3-week old myocardial infarction in a mouse model for myocardial 
infarction. After administration of green fluorescent angiotensin peptide analog (APA) increased uptake 
in the infarct area is observed (A). Sections show no uptake of APA in the remote zone (B) and clear up-
take in non-myocytic cells in the infarct region (C). The angiotensin receptor positive cells (D, green), 
also stained positive for ASMA (E, red) showing colocalization (F, yellow) indicating that AT receptors 
are present on myofibroblasts. For full color illustration, see page 154.
Figure 2.3   Optical imaging of angiotensin receptors
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nostic strategy targeted at detecting the extent of myocardial AT receptor ex-
pression would allow identification of patients at risk of developing HF, and allow 
optimization of pharmacologic therapy in HF patients. For this purpose, employ-
ing molecular imaging techniques, an angiotensin peptide analogue (APA) was 
labeled with a fluorescent tracer, which targeted both angiotensin type 1 and 
2 receptors with high affinity (Ki= 3 pM).66 Intravital fluorescence imaging was 
performed to determine the myocardial upregulation of AT receptors in a murine 
MI model. To more specifically target type 1 receptors, radionuclide imaging 
with Tc-99m-labeled losartan, an AT type 1 receptor blocker, was performed us-
ing microSPECT/microCT. For this purpose, AT receptor imaging was performed 
in a large number of mice at various time points after permanent coronary ar-
tery ligation as well as in controls using a fluoresceinated or radiolabeled target-
ing probe, followed by pathological characterization using confocal and ex vivo 
2-photon microscopy.  No or little tracer uptake was observed in control animals 
or in infarct region up to the first day. Distinct uptake occurred in the infarct area 
at 1 to 12 weeks after MI, with maximum uptake at 3 weeks; uptake markedly 
resolved at 12 weeks after MI. Pre-mortem echocardiographic characterization 
confirmed left ventricular remodeling and pathologic characterization revealed 
localization of the tracer with collagen producing myofibroblasts, and co-local-
ization with alpha smooth muscle actin (Figure 2.3).  99mTc-labeled losartan up-
take in the infarct region was 2.5-fold higher than the control animals.66 This 
study has demonstrated the feasibility of in vivo imaging through targeting of 
myocardial angiotensin receptors. It is eminently important for the development 
of a strategy for prevention of HF, to recognize the subjects that are prone to 
develop HF from those with no apparent structural LV abnormality (stage A) 
and asymptomatic post-MI patients (stage B).67 Although angiotensin receptor 
upregulation in kidney has been observed earlier by a carbon-11 labeled AT1 an-
tagonist,68 the hypothesis of the role of targeting neurohumoral upregulation for 
ventricular remodeling was initially proposed by imaging of ACE with F-18 fluo-
ro-benzoyl lisinopril,69 by incubating short-axis myocardial slices explanted from 
cardiac allograft recipients with end-stage ischemic cardiomyopathy. There was 
specific binding of radiotracer to ACE which, expressed as luminescence/mm2, 
was highest in infarct border zone, followed by infarct and remote segments and 
the uptake reduced to half after the segments pre-incubated with cold lisinopril. 
The targeting studies presented here, demonstrated that ACE (and probably AT 
II, also) upregulation may induce proliferation of myofibroblasts, which have 
increased angiotensin receptor density and contribute to collagen deposition.66 
However, it remains to be seen whether imaging targeted to AT receptors and/or 
ACE will result in clinically robust imaging strategy.
Imaging of surface moieties on myofibroblasts in the infarct area
Besides upregulation of angiotensin receptors, integrin moieties are overex-
pressed on myofibroblasts, which enhance promoter activity of collagen genes 
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and reduce metalloproteinase genes, an effect reversible by abrogation of 
autocrine TGF-b signaling.70 The RGD probes that bind to integrins such as avb3 
have been used to identify myofibroblastic proliferation in post-infarct animal 
models71 as well as in clinical studies.72 It has been proposed that the uptake 
of RGD probe indirectly represents the rate of fibrogenesis or collagen deposi-
tion. The first animal study demonstrating myofibroblasts by integrin targeting 
used Cy5.5-RGD imaging peptide (CRIP) labeled with technetium-99m (Tc) in a 
murine model of ventricular dysfunction after MI. The fluorescent moiety of the 
targeting peptide was exploited for immunoelectron microscopic characteriza-
tion of the probe localization. Similar to ATII receptor imaging, MI was induced 
in Swiss-Webster mice by coronary artery occlusion and imaging performed 2, 
4, and 12 weeks after MI.  MicroSPECT-microCT imaging was performed after 
intravenous administration of Tc-99m labeled CRIP (Figure 2.4); scrambled CRIP 
was used for comparison to demonstrate specificity of the targeting agent. A 
subset of animals received either captopril or captopril combined with losartan 
up to 4 weeks after MI to evaluate the impact of neurohumoral antagonists 
on myofibroblasts population and collagen deposition, and hence their role in 
modifying myocardial remodeling.  Maximum CRIP uptake was observed in the 
infarct area; quantitative uptake, expressed as percent injected dose per gram 
(%ID/g) was highest at 2 weeks, 6-fold higher than the myocardium of un-
manipulated mice. The CRIP uptake resolved by 50% in the infarct zone at 3 
months and almost entirely disappeared at one year. However, the uptake was 
higher at 12 weeks in the peri-infarct zone and remote areas.  The uptake was 
histologically traced to myofibroblasts by fluorescent microscopic localization 
of CRIP and concurrent staining with ASMA. Ultrastructural analysis by immu-
nogold labeled anti-Cy antibody, confirmed CRIP uptake in myofibroblasts. In 
vitro experiments revealed CRIP binding to activated avb3/5 with an affinity of 
1-3nM, but did not bind to integrins working as collagen receptors (e.g. a1b1 or 
In vivo imaging with radiolabeled CRIP showed intense uptake in the infarct area two weeks post MI. 
The uptake decreased over time. The cardiac localization is confirmed in CT fusion image and ex vivo 
images. For full color illustration, see page 154.
Figure 2.4   In and Ex vivo images of radiolabeled CRIP imaging
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a5b1) or platelet receptor (e.g. aIIb3). Histologic characterization of the infarcts 
revealed maximum myofibroblasts infiltration (expressing ASMA) at 2 weeks 
post MI, which decreased over time. Picrosirius red polarization microscopy re-
vealed that although the total collagen content of the infarct region remained 
similar over time, the thin, newly formed, yellow-green collagen fibers were 
reduced and correlated directly with the radiotracer uptake. Compared to the 
infarct zone, collagen deposition was substantially less in the remote myocardi-
um, but overall collagen content and yellow-green thin collagen fibers increased 
substantially in the remote region with passage of time; there was again a direct 
correlation between tracer uptake and the thin collagen fiber deposition in the 
remote myocardium. In addition, there was a directly proportional relationship 
between radiotracer uptake and ASMA-positive myofibroblasts. Correlation be-
tween radiotracer uptake and ASMA as well as thin collagen fiber areas suggests 
that the neocollagen production is decreased in the infarct zone and increased 
in remote zone over time.71 
Treatment with captopril alone reduced the CRIP uptake by 50% and combina-
tion therapy with losartan further reduced the uptake by 75%. Pharmacological 
intervention decreased collagen deposition by about 15% in the infarct and si-
multaneously induced maturation of collagen deposition as represented by sub-
stantial increase in proportion of red-orange collagen fibers. On the other hand, 
there was a 50% reduction in collagen deposition in the remote myocardium by 
combination therapy.71
An RGD imaging peptide (RIP) directed against integrin expression, which is 
similar to CRIP but not fluorophore-labeled, has been used in a clinical study to 
assess the feasibility and safety of noninvasive imaging of interstitial alterations 
after myocardial infarction (MI).72 RIP-based early integrin imaging, in patients 
with their first episode of myocardial infarction, was compared to the extent 
of fibrotic scar formation verified by late gadolinium enhanced cardiovascular 
magnetic resonance (CMR) imaging one year after MI. This preliminary imag-
ing study was performed in 10 patients (ages 39-72 years, 6 male) at 3 and 
8 weeks after MI. Technetium-99m labeled RIP was injected intravenously and 
SPECT images were acquired 2 hours later. Myocardial perfusion imaging was 
performed within one week after MI for delineation of infarct size prior to dis-
charge. One year later all patients underwent CMR for the assessment of scar 
size. Image fusion and analysis software allowed comparison of both early RIP 
uptake and subsequent scar formation, and comparison of myocardial perfusion 
and RIP uptake. The RIP uptake was observed in 7 of the 10 patients at both 3 
and 8 weeks. Although the RIP uptake corresponded to areas of perfusion de-
fects, it almost always extended beyond the infarct zone. In all positive cases, 
RIP uptake co-localized with the extent of the scar demonstrated by MR imaging 
one year later (Figure 2.5).  This study provided a proof of concept that imaging 
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The MIBI scan (first row) shows apical perfusion defects in the short axis (SA), vertical axis (VA) and 
horizontal axis (HA) at baseline. RIP imaging at 3 and 8 weeks post MI (row 2 and 3) show uptake 
corresponding to the infarct area and borderzone delineated by the MIBI scan. The cardiac MR one 
year post-MI shows scar formation corresponding to RIP uptake (row 4). For full color illustration, see 
page 155.
MIBI at baseline, RIP imaging at 3 and 8 week post-MI and cardiac 
MRI 1 year post-MI
of myofibroblasts is a feasible proposal. We do expect that such and similar 
strategies would allow risk stratification in the aftermath of MI and may also al-
low optimization of pharmacological intervention.
The good and the bad of myofibroblasts and collagen deposition after 
myocardial infarction 
Myofibroblast in the infarct region replace the lost cardiomyocytes which are not 
able to regenerate, and help produce a strong scar tissue. They also possess 
contractile properties and are associated with a smaller scar area which helps 
to prevent infarct expansion and ventricular dilatation. On the other hand, the 
inexorable production of collagen from the myofibroblasts in the remote area 
contributes to adverse ventricular remodeling and unfavorable outcomes. Un-
like in skin and other organs, myofibroblasts persist for a long time in the heart 
with net balance in favor of remodeling.  It is of paramount importance that we 
SA VA HA
MIBI Baseline
RIP 3 weeks
RIP 8 weeks
MRI 12 months
Figure 2.5
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woundhealing post-MI
submitted
understand the process of myofibroblast proliferation better and modulate the 
process to subdue the disadvantages without compromising the advantages. 
As such, there has been a growing interest in dissecting the role of the various 
myofibroblasts subpopulations in tissue regeneration and fibroproliferative dis-
eases. Could myofibroblasts from different locations behave differently and may 
pharmacological intervention influence the healing characteristics favorably? 
We have observed the favorable impact of captopril-losartan therapy on infarct 
healing, that contributes to maturation of collagen tissue in the infarct zone but 
preferentially reduces the extent of collagen deposition in the remote myocar-
dium. This allows for a balanced influence on ventricular mechanics, and vindi-
cates clinical outcomes in patients appropriately treated by RAS antagonists.   
Conclusions
Myofibroblast presence happens to be a prominent phenomenon in myocardial 
healing after myocardial infarction. Myofibroblasts produce collagen which is 
expected to stabilize the lost tissue, prevent infarct expansion and ventricular 
dysfunction after deposition in the myocardial void. However, concurrent pro-
liferation of fibroblasts in the non-injured myocardial regions results in adverse 
ventricular remodeling and evolution of heart failure over time. An ability to im-
age myofibroblasts before the onset of clinically manifest HF should allow iden-
tification of patients likely to develop heart failure and institution of aggressive 
preventive strategies. Although there are no obvious candidates for molecular 
imaging of myofibroblasts, as they at least partially share antigenic properties 
with other surrounding cellular population (such as fibroblasts and smooth mus-
cle cells), overexpression of integrin moieties and upregulation of receptors for 
growth factors comprise potential targets for imaging.  Successful use of RGD-
based imaging in both experimental and clinical settings may offer encouraging 
avenues for individualization of heart failure prevention and management. The 
study of the impact of pharmacological intervention on the processes of infarct 
healing and remodeling, as evaluated by RGD imaging, may also allow better 
explanation of their favorable clinical role. 
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ABSTRACT
Aim:  To study the effect of the genetic background on the wound healing pro-
cess after myocardial infarction (MI) in mice. 
Methods: In five different mouse strains (BalbC, C57Bl6, FVB, 129S6 and 
Swiss) MI was induced. At 3, 14, and 28 days after MI cardiac dimensions were 
monitored by echocardiography and histology, whereas cardiac function was 
determined by direct intraventricular pressure measurements (dP/dt). Further-
more, matrix metalloproteinases (MMP) were measured by zymography, and 
mRNA expression by QPCR. 
Results: Infarct rupture, which typically occurred at 3-6 days post-MI, was 
most frequent in 129S6 mice (62%), followed by C57Bl6 (36%), FVB (29%), 
Swiss (23%) and BalbC (5%). The high incidence of infarct rupture in 129S6 
mice was associated with high systolic blood pressures and increased influx of 
inflammatory cells. Cardiac dilatation was most marked in Swiss mice and least 
prominent in 129S6 mice. The degree of dilatation was associated with a re-
duced ejection fraction and decreased dP/dt values at 14 and 28 days post-MI. 
At day 14 and 28 post-MI, secondary thinning of the infarct area was marked 
in BalbC, FVB and Swiss, but absent in C57Bl6 and 129S6. In the latter two 
groups, this was paralleled by the highest number of myofibroblasts at day 14 
post-MI. 
Conclusion: The outcome of infarct healing in mice strongly depends on ge-
netic background. Based on our results we suggest that for studies on infarct 
rupture, 129S6 is the background of choice, whereas BalbC and Swiss mice are 
the preferred models to study infarct thinning post-MI. 
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INTRODUCTION
The process of cardiac wound healing after myocardial infarction (MI) is complex 
and, if not occurring optimally, may result in severe complications such as infarct 
rupture73 and infarct thinning leading to heart failure.30 To better understand the 
process of infarct healing, rodent models of MI have extensively been studied. 
These studies have yielded invaluable information on the molecular mechanisms 
involved in infarct healing. The availability of genetically altered mice, allowing 
the study of the effect of individual genes on infarct healing, has intensified this 
research even further.
When constructing a transgenic or knockout mouse, the choice of the genetic 
background can have a significant effect on the observed phenotype.74 This 
implies that the selection of the mouse strain can be of vital importance for the 
outcomes of the study. Although strain effects have been reported in different 
cardiovascular studies on hemostasis and thrombosis75 and stroke,76 surprisingly 
little is known about the effects of the genetic background on the wound healing 
process after MI.  To our knowledge, only a single study on differences in the 
frequency of infarct rupture after MI in three different mouse strains has been 
published.77  In this study the incidences of infarct rupture were 3, 27 and 59% 
in male FVB/N, C57Bl/6J and 129sv mice, respectively, illustrating the major 
impact of the genetic background on cardiac pathology.77
The aim of the present study was to perform a systematic comparison of the 
wound healing post-MI in five different mouse strains that are commonly used 
in cardiovascular research. We hypothesized that the genetic background of the 
mice has a profound effect on either early (infarct rupture) or late (infarct thin-
ning and heart failure) complications of MI. The results of the present study al-
low us to formulate recommendations regarding the choice of the genetic back-
ground in studies on specific aspects of the wound healing process post-MI.  
MATERIALS AND METHODS
Experimental protocol
The design and number of animals that were included in the study are given in 
Figure 3.1 and Table 3.1, respectively. In total, 354 mice of five strains were 
included (BalbC n=64, C57Bl6 n=73, FVB n=73, 129S6 n=80 and Swiss n=64). 
All mice underwent baseline echocardiography at their entry into the study, 
before the surgical intervention. Of these 354 mice, 40 mice were subjected to 
sham surgery. In the sham animals echocardiographic measurements were re-
peated on days 3, 14 and 28 after sham surgery and direct intraventricular he-
modynamic pressure measurements (see below) were performed 28 days after 
sham surgery immediately before sacrifice.  All remaining (n=314) mice were 
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Figure 3.1   Flow chart of the experimental protocols
subjected to coronary artery ligation on day 0 to produce MI as described below. 
Of these, 37 mice died during the surgical intervention or within 24 hours after 
MI. Within 10 days after MI 21 mice died of acute heart failure, diagnosed by 
pulmonary edema, and 55 mice died of infarct rupture, diagnosed by hemato-
thorax. The surviving mice were divided into 3 groups and sacrificed on post-MI 
day 3 (n=39), 14 (n=40) or 28 (n=38). Terminal echocardiographic and hemo-
dynamic measurements were performed on the day of sacrifice (Figure 3.1). 
Fifty-six mice were excluded because of no or small MI (<15%) or incomplete 
measurements. The area at ischemic risk was assessed in 28 animals from five 
strains.
Animals
Male mice, 10-12 weeks old were obtained from the following suppliers; FVB/
NJ, Balb/cJ and C57Bl/6J mice from Jackson Labs (Bar Harbor, Maine, USA), 
129S6/SvEv mice from Taconic (Germantown, NY, USA) and outbred Swiss mice 
from Charles River (Wilmington, MA, USA). All experimental procedures were 
approved by the Animal Care and Use Committee of Maastricht University and 
Of each mouse strain, mice were divided into 4 groups. All MI mice were subjected to baseline 
echocardiography, MI surgery and echo and hemodynamic measurements at the experimental time 
point. As a control, sham operated mice of every strain were used. They underwent echocardiography 
before MI and at day 3, 14 and 28. Hemodynamic measurements were executed at day 28. For full 
color illustration, see page 156.
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Table 3.1    Number of animals used in the study
were in accordance with the Guide for the Care and Use of Laboratory Animals, 
published by the US National Institutes of Health (NIH Publication No. 85-23, 
revised 1996). 
Experimental myocardial infarction
Myocardial infarction was induced as previously described.78 In short, mice were 
anesthetized with xylazine (2.5 mg/kg s.c.) and ketamine (50 mg/kg i.m.), and 
maintained on isoflurane (1.5-2.5%). Mice were laid on their back and the tra-
chea was intubated with a stainless steel tube connected to a respirator (Hugo 
Sachs Electronic rodent ventilator type 845, March-Hugstetten, Germany) set at 
a stroke volume of 250mL at a rate of 210 strokes/min. Body temperature was 
monitored with a rectal probe and maintained at 37 oC using a heating pad and 
lamp. After opening the chest through the left 4th intercostal space, a ligature 
(6-0 prolene) was tied around the main left coronary artery. Chest and skin were 
closed in layers using 5-0 silk sutures. Animals recovered overnight in an incu-
bator (30 oC). Sham surgery was performed identically, except that the ligature 
around the coronary artery was not tied. 
All interventions and measurements were performed by the same technician to 
minimize variation in infarct size and measurement procedures. 
Evaluation of ischemic area at risk 
To evaluate if differences in coronary architecture may influence the outcome 
of the study, the area of the left ventricle that was at risk after left coronary 
artery ligation was compared in 5 BalbC, 7 C57Bl6, 6 FVB, 5 129S6 and 5 Swiss 
mice. Directly after the MI procedure, the abdomen was opened and 250 ml of 
2.5% trypan blue was injected through the inferior vena cava to delineate the 
non-ischemic tissue and to quantify the area at risk (AAR). Hearts were excised, 
briefly washed in isotonic saline, frozen at -20 oC and cut into 2 mm thick sec-
tions in a transverse orientation. Well-perfused parts of the myocardium stained 
blue whereas the AAR remained unstained. Using a computerized morphometry 
system (Qwin version 3.2.0, Leica, Cambridge, UK), the AAR was calculated and 
expressed as percentage of the left ventricular area.
           
           
           
           
           
           
           
           
* excluded due to no or small (<15%) infarction
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Echocardiography
Echocardiographic measurements were performed under light (1-2%) isoflurane 
anesthesia. One recording was taken prior to surgical procedures (base-
line) and final recordings were made at 3, 14 or 28 days after MI surgery 
(Figure 3.1). Serial measurements were performed on days 0, 3, 14 and 28 in 
the sham-operated control animals. Transthoracic echocardiography was per-
formed using a Hewlett-Packard 15-MHz linear array transducer (15-6L) inter-
faced with a Sonos 5500 echocardiography system (Phillips, Eindhoven, The 
Netherlands). Two-dimensional B-Mode images were captured at a rate of 90-
120 Hz from the parasternal long-axis views and from the mid-papillary short 
axis view of the left ventricle. Data were obtained from at least 3 different 
images taken in end-diastole and end-systole using EnConcert software (Agilent 
Technologies, Andover, MA, USA).  Infarct size, LV cavity dimensions and ven-
tricular function were assessed. 
Evaluation of left ventricular contractility (dP/dt)
The LV contractility was determined on post-MI day 3, 14 or 28 in the 3 experi-
mental groups and on day 28 in the sham MI group. Mice were anesthetized with 
urethane (2.5 mg/g body weight i.p., Sigma-Aldrich, St Louis, MO, USA). Body 
temperature and respiration were controlled as described above. A high-fidel-
ity catheter tip micromanometer (Mikro-tip, 1.4F, SPR-671; Millar Instruments, 
Houston, Tx, USA) was inserted through the right carotid artery into the left 
ventricular cavity. Ventricular pressure was measured and sampled at a rate of 2 
kHz. Maximal positive and negative pressure development (+dP/dt, -dP/dt) and 
heart rate were determined on a beat to beat basis and one-second averages 
were stored on disk. dP/dt values were determined at baseline and during maxi-
mal stimulation with dobutamine (Sigma). For this purpose, the maximal effect 
of dobutamine was determined during an i.v. ramp-infusion of dobutamine us-
ing a micro injection pump (model 200 series, KdScientific, Boston, MA, USA). 
The infusion rate of dobutamine was increased every 2 minutes by 0.5 ng/g/min 
until the final rate of 5 ng/g/min. 
Tissue preparation
At the end of the experiment, hearts and lungs were excised and weighed. Hearts 
were divided longitudinally; one halve was incubated in 4% paraformaldehyde 
for 24 hours, processed and embedded in paraffin for immunohistochemical 
stainings. The other halve was subdivided in right ventricle, left ventricle, infarct 
and septum and snap-frozen in liquid nitrogen until further used for protein and 
RNA isolation.  
Histology and Immunohistochemistry
Sections of 4 mm were cut from the paraffin embedded heart halves and stained 
with the AZAN technique. Infarct size (percentage of the left ventricular area) as 
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well as infarct and septum thickness were measured using a computerized mor-
phometry system (Qwin, Leica).  For Sirius Red staining, sections were treated 
with 0.2% aqueous phosphomolybdic acid for 5 min and subsequently incubated 
for 60 min with 0.1% Sirius Red F3BA (C.I. 35780, Polysciences, Northhampton, 
UK) in saturated picric acid and washed for 2 min with 0.01 N HCl.  Sections 
were then rinsed in 70% alcohol for 30 seconds, dehydrated and mounted with 
cover-slip. The relative collagen areas in the infarct and septum were quanti-
fied as percentage of total tissue surface using the Qwin morphometry system. 
Alpha smooth muscle actin (ASMA) was used to identify myofibroblasts in the 
infarct area. For this purpose, after deparaffination, rehydration and blocking of 
endogenous peroxidase, sections were incubated for 2 hours at room tempera-
ture using anti-alpha smooth muscle actin (ASMA monoclonal antibody, Sigma, 
dilution 1:2000). After washing in PBS, sections were incubated with secondary 
antibody (rabbit anti mouse HRP 1:500, DakoCytomation, Glostrup, Denmark) 
for 1 hour at room temperature. Sections were briefly counterstained with hae-
matoxylin. Myofibroblast areas were determined using the Qwin morphometry 
system and were expressed as myofibroblast area/total tissue area (%). In 
addition, haematoxylin and eosin-stained sections were used to identify inflam-
matory cells by cytological characteristics and counted in four randomly chosen 
fields (90.000 µm2 per field) of the border zone of day 3 post-MI infarct samples 
in all five strains.
Zymography
Proteins were isolated from the infarct area of the day 3 group for all strains 
as previously described.22 Latent and active MMP activity was detected using 
zymography, as previously described.11 Briefly, gelatin (final concentration of 
0.66 mg/ml) was added to a 10% standard Laemmli79 acrylamide polymeriza-
tion mixture.  Ten µg of non-denatured protein was loaded per lane.80 A protein 
standard with proven MMP-2 and -9 activity was loaded on each gel as a control. 
Following electrophoresis, gels were rinsed two times 15 minutes in 2.5% Triton 
X-100 and incubated overnight at 37 oC in substrate buffer (50 mmol/L Tris HCl 
pH 8.5, 5 mmol/L CaCl2, and 0.02% NaN3).  After incubation, gels were stained 
with 0.1% Coomassie Blue R 250 (BioRad, Hercules, CA, USA) in acetic acid:
methanol:water (1:4:5) and destained in the same solvent. The zones of pro-
teolytic activity were visualized as clear bands against a dark background. The 
gels were digitized and analyzed with image analysis software (Qwin, Leica). 
The integrated optical density of the individual bands was determined and nor-
malized against the value of a standard sample that was run on every gel. 
Real time PCR
Real time PCR was performed as previously described.81 In short, septal tissue 
was homogenized with a PRO200 tissue homogenizer (PRO Scientific, Monroe, 
CT, USA) and RNA was isolated using the RNeasy Fibrous Tissue mini kit (Qiagen, 
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Maryland, USA) according to the manufacturer’s instructions. RNA was further 
purified by DNase digestion using the DNA-Free RNA kitTM (Zymo Research, 
Orange, CA, USA) to remove any residual genomic DNA. First strand cDNA was 
synthesized by adding 100 ng of DNase-treated total RNA to Ready-To-Go You 
Prime First-Strand Beads (Amersham Biosciences Europe, Freiburg, Germany). 
Random hexamers were used as primers. The reactions were incubated for 10 
minutes at 65 °C, 1 hour at 37 °C and 2 minutes at 95 °C. The resulting cDNA 
was either used immediately as template for real-time PCR or stored at −20 °C. 
Real-time PCR primers were designed, using Primer Express software (version 
1.5; Applied Biosystems, Foster City, CA, USA). The designed primers were used 
to quantify the expression of mRNA levels of atrial natriuretic factor (ANF) and 
brain natriuretic peptide (BNP). The expression was determined by measuring 
the binding of the fluorescent dye SYBR Green I, using SYBRGreen PCR Master 
Mix kit (Eurogentec, Seraing, Belgium). Real-time PCR was performed in a MyIQ 
system (Biorad). Cardiac gene expression was normalized to the housekeeping 
gene Cyclophilin. All samples were run in duplicates. Data analyses were per-
formed using the MyIQ System software (Biorad, USA). The following primers 
were used for real time PCR: 
ANF:  forward: ‘CATCATGGGCTCCTTCTCCAT’
  reverse: ‘TGTACACAGGATTTGGTCCAATATG’
BNP:  forward: ‘AGGACCAAGGCCTCACAAAA’
  reverse: ‘TTGAGATATGTGTCACCTTGGAATTT’
cyclophilin: forward: ‘TTCCTCCTTTCACAGAATTATTCCA’
  reverse: ‘CCACCAGTGCCATTATGG’
Statistical analysis
All data are presented as mean±SEM. Survival was analyzed by a Kaplan Meier 
curve with a log-rank test for differences between groups. Statistical analysis 
was performed using ANOVA with Bonferroni posthoc t-tests to identify between 
strain differences or time-dependent changes. Specifically, in sham-MI mice, the 
echocardiographic data were compared between strains using a 2-way ANOVA 
with strain as a between factor and time (days after MI) as a within factor. 
For the between strain comparison of the echocardiographic data after MI, the 
same procedure was applied with time as between factor. The hemodynamic 
(+dP/dt) data were compared using a 3-way ANOVA with strain and time as 
between factors and the response to dobutamine (baseline and maximal values) 
as within factor. In the figures the p-values of the various Bonferonni post-hoc 
comparisons are given. A P-value of <0.05 was considered to indicate statistical 
significance. 
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RESULTS
A total of 354 mice were used for this study. Thirty-seven mice died during or 
shortly (<24 h) after surgery because of complications of anesthesia, arrhyth-
mia or bleeding and were not included in the analysis. In the first week post-MI 
fifty-five mice died of cardiac rupture, as diagnosed by hematothorax. Twenty-
one mice died of heart failure, diagnosed by a more than 270% increase in LW/
BW ratio and clear fluid in the thoracic cavity,  and fifty-six mice were excluded 
from the study due to small infarct size (<15%) or incomplete measurements. 
Twenty-eight mice were used to determine the area at risk and 157 mice were 
included in the experimental protocol (Table 3.1).
Area at risk
The mean left ventricular AAR values were not different between mouse strains. 
The following AARs were observed: BalbC 46±4%, C57Bl6 50±5%, FVB 48±6%, 
129S6 48±2% and Swiss 48±4% (p=0.97). This indicates similar infarct sizes in 
all mouse strains at the time of surgery.  
Survival of the different mouse strains
After induction of MI, only 33% of the 129S6 mice were alive at 28 days post-
MI, as compared to 85% of the BalbC mice (Figure 3.2A). Kaplan Meier analysis 
demonstrated significant differences in mortality between the five mouse strains 
(p=0.004). All mice died of either infarct rupture or acute heart failure. Infarct 
rupture, diagnosed by massive blood loss in the thoracic cavity, occurred in 62% 
of the 129S6 mice, 36% in C57Bl6, 29% in FVB, 23% in Swiss and in 5% of the 
BalbC mice (Figure 3.2B). The timing of infarct rupture differed between the 
groups. 129S6 mice typically ruptured between day 3 and 4 post-MI, C57Bl6 
mice ruptured on day 4 and 5 and FVB mice ruptured on day 5 and 6. Early 
lethal heart failure (between day 2-7 post-MI), occurred mainly in the FVB mice 
(28%) whereas in the other strains this complication occurred in less than 10% 
of the cases (Figure 3.2B). 
Post-mortem characteristics of the five different mouse strains
In Table 2 the post-mortem characteristics of the different mouse strains at the 
different time points are summarized. At baseline there was a variation in body 
weight between the five strains and this variation was maintained over time (see 
sham groups). The Swiss mice weighed significantly more than the other mouse 
strains; all strains gained weight during the study. 
Heart weight normalized for body weight increased in all mouse strains after 
MI surgery compared to sham operated animals. The 129S6 mice had the 
highest heart weight to body weight ratio. Lung weight normalized for body 
weight (LW/BW) also tended to increase in all strains after MI surgery. Over 
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Figure 3.2  Survival and causes of death between 5 different mouse strains
A: Kaplan Meier curve analysis of 5 different mouse strains showed significant differences in survival 
(p=0.004). BalbC mice showed the highest survival, 85% of these mice were still alive at day 28 post-
MI. The BalbC mice were followed by Swiss (69%), C57Bl6 (56%) FVB (37%) whereas only 33% of 
the 129S6 mice were still alive at 28 days post-MI. B: The causes of death in the post-MI mice were 
infarct rupture and early heart failure in the first week post-MI. Of the 129S6 mice, 62% died of infarct 
rupture, as compared to only 5% of the BalbC mice. Death due to acute heart failure in the first week 
post-MI mainly occurred in the FVB mice (28%). For full color illustration, see page 156.
time, post-MI LW/BW increased significantly in BalbC and Swiss mice, but not 
in the other strains, suggesting the development of pulmonary edema in these 
two strains.
 
Cardiac dimensions by echocardiography
Echocardiographic analysis showed similar baseline characteristics in all five 
strains. In sham operated mice, echocardiographic parameters were not sig-
nificantly different between strains and remained similar over the 28 day time 
course of the study. In the sham groups the end systolic volume (ESV) ranged 
from 0.02-0.05 cm3, the end diastolic volume (EDV) from 0.05-0.09 cm3, the 
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Table 3.2    Post mortem characteristics of the 5 different mouse strains
ejection fraction (EF) from 39-57% and the fractional shortening (FS) ranged 
from 25-31%. The range of values observed in the sham group is indicated by 
grey areas in Figure 3.3.  After MI, differences between strains became more 
pronounced: all strains showed an increase in both ESV and EDV after MI (Fig-
ure 3.3A-B), but the ESV and EDV were significantly greater in Swiss mice than 
in other strains. There was a decrease in EF and FS after MI in all mouse strains, 
with the lowest values in Swiss and BalbC mice and the best preserved values 
in FVB mice (Figure 3.3C-D). 
Cardiac function 
Left ventricular function was evaluated at day 3, 14 and 28 post-MI, as well as 
in sham operated mice at day 28 (Figure 3.4). Direct intraventricular measure-
ments were made at baseline conditions and during maximal stimulation with 
dobutamine. Baseline and dobutamine-stimulated systolic blood pressures were 
highest in 129S6 mice, in both the sham and MI groups (Figure 3.4A-B). Lowest 
systolic blood pressures were observed in Swiss mice at all time points after 
MI. C57Bl6 mice had significantly higher systolic blood pressures than FVB and 
Swiss mice. Diastolic blood pressures were not different between mouse strains, 
neither in sham nor at any point of time post-MI (data not shown). Mean heart 
rates varied from 492 to 584 beats/min with the highest heart rate in C57Bl6 
mice and the lowest heart rate in BalbC mice (data not shown).
Maximal ventricular contractility (+dP/dt) was reduced post-MI in all mouse 
strains except in 129S6 (Figure 3.4C). Dobutamine stimulation increased the 
+dP/dt values in all mouse strains (Figure 3.4D). The +dP/dt was highest in 
129S6 mice and differed significantly from BalbC, FVB and Swiss mice. The 
lowest +dP/dt was observed in Swiss mice, which was significantly different 
from all other strains. In BalbC and Swiss mice LV +dP/dt was higher at 3 and 
       


        
        
        
        
        
        
        
        
        
        
        
        
        


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Figure 3.3   Echocardiographic measurements
Echocardiographic measurements were performed in sham operated and in post-MI mice. The values 
measured at baseline in the sham operated mice remained similar over time and are represented by 
the grey rectangle. Post-MI, end systolic volume (ESV) and end diastolic volume (EDV) increased in all 
mouse strains, with the highest increase in Swiss mice (Fig. 3.3 A,B). The ejection fraction (EF) and 
fractional shortening (FS) decreased after MI surgery in all mouse strains with the highest decrease in 
Swiss and BalbC mice. BalbC (green), C57Bl6 (black), FVB (yellow), 129S6 (red), Swiss (blue). For full 
color illustration, see page 157.
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14 days post-MI than at day 28 post-MI, suggesting that cardiac performance 
is deteriorating. Furthermore, the strain differences regarding the +dP/dt val-
ues were maintained when normalized for systolic blood pressure (data not 
shown). 
The strongest maximal ventricular relaxation (-dP/dt) at baseline was observed 
in 129S6 mice and the weakest in Swiss mice (Figure 3.4E). The relaxation val-
ues increased after maximum dobutamine stimulation in all strains with again 
the best relaxation in 129S6 mice and the lowest in Swiss mice (Figure 3.4F). 
The combined data show that cardiac function after MI was best preserved in 
129S6 and C57Bl6 mice, whereas BalbC, FVB and Swiss mice showed more de-
terioration of cardiac function.
Morphometry, ASMA and collagen content
Infarct size, as measured in AZAN-stained sections, was not different between 
the five mouse strains and values were also comparable over time (see Table 
3.3). In the sham groups there were no strain-dependent differences in sep-
tal and anterior wall thickness. The thickness of the infarcted left ventricular 
anterior wall decreased after MI in all five mouse strains compared to the left 
ventricular anterior wall in sham operated mice. Over time the thickness of the 
infarct decreased further in BalbC, Swiss and FVB mice. In contrast, the thick-
ness of the infarcted wall remained relatively constant over time in C56Bl6 and 
129S6 mice. Septum wall thickness did not change in BalbC mice post-MI, while 
in the other strains septum wall thickness increased with the most prominent 
increase in C57Bl6 and FVB mice (Table 3.3). 
Table 3.3    Histological and Immunohistochemical characterisation
       
        
        
        
        
        
µ        
        
        
µ        
        
        
        
        
        
        
        
        
        



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Myofibroblasts were stained using an anti-ASMA antibody and the percentage 
of the infarct area that was populated by myofibroblasts was quantified. At day 
14 post-MI the area covered by myofibroblasts was significantly larger in 129S6 
mice than in Swiss mice (p<0.05) (Table 3.3).The percentage of the infarct area 
populated by myofibroblasts decreased in all mouse strains between day 14 and 
28 post-MI. 
The total collagen content in the anterior left ventricular wall differed between 
sham operated mice. BalbC mice had significantly more collagen in the anterior 
wall than FVB mice (p<0.05). After MI, total collagen content of the left ante-
rior wall increased significantly in all five mouse strains. The magnitude of this 
increase was not different between strains. Also in the septum, remote from 
the infarcted area, the collagen content increased over time after MI in all five 
mouse strains. At day 14 post-MI BalbC mice had significantly more collagen in 
the septum than C57Bl6, FVB and Swiss mice (p<0.05) (Table 3.3). 
Inflammatory cell influx and MMP-activity at day 3 post-myocardial 
infarction
Inflammatory cells were counted at the infarct borderzone 3 days post-MI. A: Quantitative analysis 
showed a significant difference in influx of inflammatory cells between the 5 mouse strains (p=0.0074). 
129S6 mice had a significant higher number of inflammatory cells in the infarct area compared to FVB 
and Swiss mice. (*: p<0.05) and Swiss (#: p<0.01) mice. A field is defined as 90.000 mm2. B: Gelatin 
zymography demonstrating the activity of matrix metalloproteinases (MMP)-2 and -9 in myocardial 
infarct tissue obtained from 3 day old infarcts. Quantification of the latent forms of MMP-2 and MMP-9, 
expressed in intensity units (IOD), showed slightly higher latent-MMP-9 levels in 129S6 mice; how-
ever this did not reach statistical significance. Active MMP-levels were difficult to detect in these tissue 
samples. For full color illustrations, see page 159.
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Figure 3.6    Quantitative PCR characterization of ANF and BNP
A: the ANF/cyclophiline ratio was significantly increased in Swiss mice compared to BalbC, C57Bl6, 
129S6 (*:p<0.001) and FVB mice (#:p<0.01). B: BNP/cyclophilin ratio was lowest in 129S6 mice and 
was significantly different from BalbC (†: p<0.01) and Swiss mice (‡p<005). 
Inflammatory cells in the infarct area
The number of inflammatory cells in the border zone of day 3 post-MI infarcts 
differed significantly between all five mouse strains (p=0.0074). The most 
prominent influx of inflammatory cells was observed in the 129S6 mice, which 
was significantly greater than in FVB mice (p<0.05) and Swiss mice (p<0.01) 
(Figure 3.5A). 
MMP analysis
At day 3 post-MI the amount of latent MMP-2 was comparable in all strains 
(p=0.9424, Figure 5B). Latent MMP-9 levels were slightly elevated in 129S6 
mice although this did not reach statistical significance (p=0.477). Active MMP-2 
and MMP-9 levels were undetectable in day 3 post-MI samples. 
Expression of ANF and BNP
ANF expression, normalized for the housekeeping gene cyclophilin, was signifi-
cantly increased in Swiss mice compared to BalbC, C57Bl6, 129S6 (all p<0.001) 
and FVB mice (p<0.01). BNP expression, corrected for cyclophilin, was lowest in 
129S6 mice and was significantly different from BalbC (p<0.01) and Swiss mice 
(p<0.05) (Figure 3.6).
DISCUSSION
The present study provides a unique insight into the effect of the genetic back-
ground on post-MI wound healing in five different mouse strains. The major 
observations in the present study were marked differences in the frequency of 
infarct rupture and in the magnitude of thinning of the infarct area. The latter 
was inversely related to the preservation of cardiac function.
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In this study we observed a high frequency of infarct rupture in 129S6 mice. 
This is in accordance with findings of other studies, in which the incidence of 
infarct rupture in male 129Sv mice ranged from 59-82%.77, 82 In one of these 
studies infarct rupture was associated with a higher density of regional inflam-
matory cells at the border zone of the infarct area and an increased MMP-9 
expression.82 MMP-9 is known to play an important role in the development of 
infarct rupture, both in mice and humans.23, 73 In the present study, we did ob-
serve a significant increase in the number of inflammatory cells in the border 
zone of the infarct of 129S6 mice. Although there was a tendency towards in-
creased MMP-9 levels in 129S6 mice at 3 days post-MI, the levels did not differ 
significantly from the other strains. This may be explained by the time window 
in which the experiments were done. We sacrificed animals at day 3 post-MI, so 
before the onset of infarct rupture. This implies that MMP-9 responsible for rup-
ture of the infarct area has just started to be produced. We did not observe any 
differences in MMP-2 activity between the five mouse strains at day 3 post-MI. 
Others have described a role for MMP-2; targeted deletion of MMP-2 has been 
shown to reduce the incidence of infarct rupture.24, 83 In these studies, MMP-2 
upregulation occurred at day 4-7 post-MI, which is beyond our time point of 
sacrifice.82, 84 Moreover, in human infarct rupture MMP-2 does not seem to play a 
role, as was observed for mice in the present study.73 Furthermore, 129S6 mice 
also showed a significantly higher systolic blood pressure compared to the other 
mouse strains. In humans, high blood pressure is a risk factor for development 
of infarct rupture.19 The elevated blood pressure in 129S6 mice is therefore 
likely to contribute to the increased frequency of infarct rupture observed in 
these mice.  
Taken together, our observations indicate that 129S6 mice have an augmented 
inflammatory response compared to other mouse strains. The increased influx of 
inflammatory cells, combined with possible increase in MMP-9, may have weak-
ened the extracellular matrix more in 129S6 than in other strains. Combined 
with the high systolic blood pressure, this may contribute to the high incidence 
of infarct rupture in 129S6 mice. It has been suggested that infarct rupture in 
humans may occur due to hypertension and increased local left ventricular wall 
stress; administration of beta-blockers and/or angiotensin converting enzyme 
inhibitors might prevent rupture.19 
In the present study, cardiac function of mice from five different strains was 
followed up to 4 weeks after MI. Swiss and BalbC mice had the worst cardiac 
function after MI. They showed high systolic and end diastolic volumes and 
marked reductions in ejection fraction and fractional shortening. This was asso-
ciated with significant infarct thinning without compensatory hypertrophy of the 
septum. The elevated BNP levels and lung weight/body weight ratios at 28 days 
post-MI suggest that these mice were progressing into heart failure. Remark-
ably, however, Swiss and BalbC mice were the mice with the highest survival 
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rates in our study. This raises an interesting parallel with the current pharma-
cotherapy of heart failure in which administration of a beta-blocker and/or ACE 
inhibitor, drugs that depress cardiac function, reduce the morbidity in heart 
failure patients85 and increase the time of survival.63, 86 
Secondary thinning of the infarct area between day 14 and 28 was marked in 
BalbC, FVB and Swiss, but absent in C57Bl6 and 129S6. This was paralleled 
by the highest number of myofibroblasts at 14 days after MI in the latter two 
groups. The role of myofibroblasts has been well established in wound healing in 
the skin, where the myofibroblasts align perpendicular to the wound rim.49 The 
contractile properties of the myofibroblasts bring the wound margins in closer 
proximity, a phenomenon which is known as wound contraction and which re-
duces the scar size.49 The reduction in size is stabilized by extracellular matrix 
deposition and subsequently the myofibroblasts disappear from the scar area.44 
However, unlike wound healing in the skin,50 myofibroblasts persist for up to 20 
years in well-healed human infarcts13 suggesting a sustained role for myofibro-
blasts in the maintenance of the infarct area and prevention of secondary dilata-
tion in the beating heart  which is under repetitive stress. 
The present study shows profound effects of the genetic background on the 
wound healing process post-MI in mice. This raises the question whether the 
genetic background of mice used in a study is optimal to investigate the effect 
of a specific genetic modification or whether some effects remain unnoticed due 
to the use of a specific genetic background.74, 87 Furthermore, when planning a 
study, either to test the effect of genetic modification or e.g. a pharmacological 
intervention on infarct healing, guidelines would be helpful to chose the optimal 
mouse strain. The present study provides novel insights into the effect of the 
genetic background on infarct healing that can help researchers to determine 
which mouse strain is most suitable to study a certain aspect of infarct healing 
(Table 3.4). 
To study strategies to prevent infarct rupture, 129S6 and –to a lesser extent- • 
C57Bl6 are the models of choice. These mice show a high frequency of in-
farct rupture with characteristics that resemble infarct rupture in humans. 
Therefore these mouse strains should be the first choice in studies aiming 
at testing genetic or pharmacological interventions to reduce the incidence 
of infarct rupture.
To study heart failure post-MI, BalbC and Swiss are the preferred models. • 
These strains clearly show reduced cardiac performance, combined with in-
creases in BNP levels and increases in lung weight, resembling the symp-
toms observed in human heart failure patients.
Thesis vd Borne V2.indd   48 20-2-2009   15:00:01
CHAPTER 3 | Cardiac remodeling in different mouse strains 
| page 49 
To study infarct thinning, BalbC, FVB and Swiss are best suitable. These • 
strains have relatively few myofibroblasts at 14 days post-MI which may 
explain the more profound secondary dilatation of the infarct area in these 
strains. Therefore, these models are well-suited to study interventions aim-
ing at the preservation of myofibroblasts in the infarct area. Moreover, their 
low frequency of infarct rupture and poor cardiac function make them the 
strain of choice to study the effect of therapies on infarct healing.
If a model with preserved cardiac function after MI is needed, one should • 
choose between C57Bl6, 129S6 or FVB. Obviously, 129S6 and –to a lesser 
extent- C57Bl6 have the disadvantage that a significant number of animals 
will be lost due to infarct rupture. This leaves FVB as the strain of choice for 
this kind of experiments.
        
        
 + − + + − − +/− 
 +/− +/− − − +/− + + 
 +/− +/− − + + + +/− 
 − + − − +/− + + 
 + +/− + + +/− − − 
 
 
Table 3.4    Overview of mouse model characteristics post MI
Limitations of the study
In order to limit the number of variables, we used young (10-12 weeks old) 
male mice in this study. It is well known that gender has a major influence on 
the outcome of experimental studies, including studies on infarct healing.88 Male 
mice have a higher rate of infarct rupture77, 89 and poorer cardiac function with 
maladaptive remodeling compared to female mice.89 Furthermore, remodeling 
post-MI is dependent on the age of the mice.90 Because most of the studies on 
the effect of genetic alterations on cardiac remodeling post-MI use young adult 
male mice, we have limited our study to this subgroup. However, we can not 
exclude that the results may be different when mice with other characteristics 
are used.
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ABSTRACT 
Background: Infarct rupture is a usually fatal complication of myocardial in-
farction (MI), for which no molecular mechanism has been described in humans. 
Experimental evidence in mouse models suggests that the degradation of the 
extracellular matrix by matrix metalloproteinases (MMPs) plays an important 
role in infarct rupture. The present study was designed to study the role of MMP-
2, -8 and -9 in human infarct rupture. 
Methods: Heart samples were obtained from patients who died from infarct 
rupture and control MI patients. The MMP activity was determined by zymog-
raphy and quantitative immunocapture activity assay. TIMP-1 levels were mea-
sured and immunohistochemistry for MMP-2 and MMP-9 was performed.
Results: The amounts of both total and active MMP-8 and MMP-9 were signifi-
cantly higher in ruptured infarct tissue than in control MI tissue, but no differ-
ences in MMP-2 activity were observed. Furthermore, the number of inflam-
matory cells was significantly higher in the ruptured infarcts than in control 
infarcts. 
Conclusions: These data suggest that increased MMP-8 and -9 activity in the 
infarct area, caused by a more prominent infiltration of inflammatory cells, con-
tribute to infarct rupture in humans. 
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INTRODUCTION
Infarct rupture is a life-threatening complication of myocardial infarction (MI), 
which usually occurs in the first week after acute MI.91-95 Rupture is most fre-
quent when the infarct is located in the left ventricular free wall,91 causing al-
most instantaneous death due to cardiac tamponade.96 Infarct rupture accounts 
for up to 10% of the mortality from acute MI.94, 97 The only clinical parameters 
that are generally associated with infarct rupture include transmural infarction, 
first episode of MI and a poor collateral circulation.98, 99 However, little is known 
about the molecular mechanisms that lead to infarct rupture in humans.
The progress in transgenic technology has fuelled research on mechanisms of 
infarct rupture in mice. These studies have shown that inhibition of plasminogen 
activation22, 23, 100 or targeted deletion of matrix metalloproteinase (MMP)-224, 83 
or MMP-923 reduces the incidence of infarct rupture in mice. Similar results have 
been observed using pharmacological inactivation of MMP-2.83 The combined 
results of these mouse studies suggest that excessive degradation of the extra-
cellular matrix in the infarct area can lead to infarct rupture. However, there is 
a paucity of data in humans, evaluating the possible role of these molecules in 
infarct rupture. 
The present study was undertaken to evaluate the possible contribution of ma-
trix metalloproteinases to infarct rupture in humans. We focused on MMPs as-
sociated with inflammatory processes, such as MMP-2, MMP-8 and -9. We ana-
lyzed the amounts of both the active and latent forms of MMPs in a unique set of 
samples obtained from ruptured human infarcts and compared them to infarcts 
of similar age that did not rupture. Since overexpression of tissue inhibitor of 
metalloproteinase-1 (TIMP-1) has been shown to protect against infarct rupture 
in mice,23 we  also assessed the TIMP-1 levels in human infarcts. In addition, we 
evaluated the extent of inflammatory cells in the infarct area. 
METHODS
Tissue selection 
Collection, storage and use of human heart tissue and patient data were per-
formed in agreement with the “Code for Proper Secondary Use of Human Tissue 
in the Netherlands” (http://www.fmwv.nl).  In this study, a set of samples of left 
ventricular (LV) tissue was obtained at autopsy, snap-frozen in liquid nitrogen 
and stored at –80 oC until further use. LV samples from 10 patients who died 
from infarct rupture (age 52 to 87 years; 8 males, 2 females) were included, as 
well as LV samples from 10 control MI patients who suffered from MI but died 
from causes other than infarct rupture (age 48 to 86 years; 4 males, 6 females). 
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The two groups were matched according to postinfarction survival times. The 
infarct area (identified by nitroblue tetrazolium (NBT) staining) was present at 
different anatomical locations as indicated in Table 4.1. Samples from both the 
infarct area and a non-infarcted area of the LV were collected from all patients. 
There was no significant difference in the time between death and autopsy be-
tween the two groups (rupture: 22.6±6.1 hours, control MI: 19.6±5.1 hours). 
For more patient data we refer to Table 4.1.
To expand our findings with immunohistochemistry, an additional set of tissue 
samples, which were formalin fixed and paraffin embedded, was investigated. 
Infarct age was determined by histological analysis of haematoxylin and eo-
sin-stained sections according to previously described criteria.3 Inflammatory 
cells were identified by cytological characteristics and counted in four randomly 
chosen fields (90.000 µm2 per field) of the border zone in 6 ruptured and 6 non-
ruptured control infarcts.
Zymography 
Protein was isolated from four 20 µm frozen tissue sections obtained from a 
subgroup of 6 ruptured and 6 control MI patients (see above) as previously 
described.22 MMP activity was visualized using zymography, as previously de-
scribed.11 Briefly, gelatin (final concentration of 0.66 mg/ml) was added to a 
10% standard Laemmli79 acrylamide polymerization mixture.  Ten µg (for MMP-
2 analysis) or 1 µg (for MMP-9 analysis) of non-denatured protein was loaded 
per lane(80). A protein standard with proven MMP-2 and -9 activity was loaded 
on each gel as a control. Following electrophoresis, gels were rinsed two times 
15 minutes in 2.5% Triton X-100 and incubated overnight at 37 0C in substrate 
buffer (50 mmol/L Tris HCl pH 8.5, 5 mmol/L CaCl2, and 0.02% NaN3).  After 
incubation, gels were stained with 0.1% Coomassie Blue R 250 in acetic acid:
methanol:water (1:4:5) and destained in the same solvent. The zones of pro-
teolytic activity were visualized as clear bands against a dark background. The 
gels were digitized and analyzed with image analysis software (Qwin version 
3.4.0, Leica, Cambridge, UK). The integrated optical density of the individual 
bands was determined and normalized against the value of a standard sample 
that was run on every gel. 
MMP immunocapture activity assay 
Total and active MMP-2, -8 and -9 were measured in 10 infarct rupture and 
10 control MI patients, using the Biotrak MMP-activity assay (Amersham/GE 
Healthcare, Buckinghamshire, UK) according to manufacturer’s instructions. In 
short: MMP-activity was analyzed in cardiac tissue homogenates using the pro-
form of a detection enzyme that is activated by captured active MMP into an 
active detection enzyme. The amount of active MMP was determined directly 
using this specific capture step. In order to measure the total MMP content, 
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MMP in its pro-form was activated using p-Aminophenylmercuric Acetate.101, 102 
Protein samples were isolated as described above. MMP activity was expressed 
in units/ml, in which a unit is defined as the extinction at 405 nm per time-unit 
in a two-step reaction (DA405*1000/t2).
TIMP-1 levels were measured in protein samples from ruptured and control MI 
patients using the human TIMP-1 ELISA kit (R&D Systems, Minneapolis, MN, 
USA) according to the manufacturer’s instructions. TIMP-1 levels are expressed 
in ng/ml. 
Immunohistochemistry
Histological sections (4 µm) were cut from paraffin-embedded tissue from all 
patients, mounted on glass slides coated with 3-aminopropyltriethoxysilane 
(APTS, Sigma-Aldrich, St. Louis MO, USA) and dried overnight in an incubator at 
37 oC. The sections were deparaffinated in xylene, rehydrated and endogenous 
peroxidase was blocked by incubation in methanol containing 0.3% H2O2 for 
15 minutes, followed by rinsing with Tris buffered saline, pH 7.5 (TBS). For 
antigen retrieval of MMP-9, a microwave pretreatment step was needed: these 
sections were treated by boiling in 0.01 M citrate buffer (pH 6.0) for 10 minutes 
in a microwave (750 Watt) and allowed to cool down for 15 minutes at room 
temperature (RT). Mouse monoclonal antibodies, raised against human MMP-2 
and MMP-9 (Merck Biosciences, Darmstadt Germany) were used. Sections were 
incubated with the primary antibodies for 1 hour at RT in the following dilutions: 
MMP-2 (1:20) and MMP-9 (1:30). After washing with TBS, biotinylated sheep 
anti-mouse IgG (Amersham, dilution 1:250) was applied to each section and 
incubated for 1 hour at RT. Subsequently, sections were washed and incubated 
with alkaline phosphatase coupled ABC reagent (DAKO, Glostrup, Denmark) 
for 30 min at RT. Alkaline phosphatase activity was visualized using New Fuch-
sin substrate (BioGenex, San Ramon, CA, USA), resulting in a red precipitate. 
The sections were counterstained with hematoxilin, dehydrated and aqueously 
mounted. 
Table 4.1    Overview of patient data
         
           
           
           

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Statistical analysis
All data are presented as means±SEM. Statistical analysis was performed using 
a Mann-Whitney U test; a P-value <0.05 was considered to indicate statistical 
significance. 
 
RESULTS
Inflammatory cells in the infarct area
Inflammatory cells were counted in the border zones of both infarct rupture and 
control MI samples. In each section 4 randomly selected fields of the border 
zone (90.000 µm2 each) were analyzed. Massive influx of inflammatory cells 
was observed in the ruptured infarcts (Figure 4.1A). In the control MI patients 
(Figure 4.1B) the influx of inflammatory cells was approximately one third of the 
level in the ruptured infarcts. (P < 0.001). (Figure 4.1C)
Histological analysis of inflammatory cells in infarct rupture and 
control MI patients
Representative images of H&E staining of the MI border zone in infarct rupture patients (A) and control 
MI patients (B). (C) Quantitative analysis of the inflammatory cells showed a significant increase in 
infarct rupture patients compared to control MI patients (P < 0.001). A field is defined as 90.000 µm2. 
Scale bar length is indicated in µm. For full color illustration, see page 160.
Figure 4.1
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Zymographic analysis of MMP-2 and MMP-9 in infarct rupture and 
control myocardial infarction patients    
(A) Gelatin zymography demonstrating the MMP activity in myocardial infarct tissue obtained from in-
farct rupture patients and control MI patients. The two top bands represent the latent and active form 
of MMP-9, respectively, whereas the two lower bands represent the latent and active form of MMP-2. 
(B) Quantification of the latent and active forms of MMP-2 and MMP-9 on zymography, expressed in in-
tensity units (IOD). Both latent and active MMP-9 are significantly higher in the infarct rupture patients 
compared to control MI patients. *: p<0.05 
MMP analysis
The amounts of both latent and active MMP-2 and MMP-9 in samples from rup-
tured infarcts were compared to samples of age-matched infarcts obtained from 
control MI patients by zymography (Figure 4.2A). The amount of latent MMP-
2 was similar in both groups, but the amount of active MMP-2 tended to be 
somewhat higher in the ruptured infarcts, although this did not reach statisti-
cal significance (p=0.18) (Figure 4.2B). Latent MMP-9 levels were significantly 
elevated in rupture samples compared to infarct tissue obtained from the control 
MI patients (p<0.05), and the active MMP-9 levels were more than 2-fold higher 
in rupture samples (p<0.05) (Figure 4.2B). 
 
To confirm and expand these findings, the amounts of total and active MMP-2, 
MMP-8 and MMP-9 were determined in an MMP activity assay. The amounts 
of both total and active MMP-8 and -9 were 1.8 to 8.4 fold higher (p<0.05) 
in rupture samples compared to control MI samples (Figure 4.3A, B). In con-
trast, total and active MMP-2 did not significantly differ between the two groups 
(Figure 4.3A-B). In addition, the amount of TIMP-1, determined by ELISA and 
expressed in ng/ml (Figure 4.3C), demonstrated a more than 2-fold increase in 
infarct rupture patients compared to control MI patients (p<0.05).
Figure 4.2
Thesis vd Borne V2.indd   57 20-2-2009   15:00:07
 page 58 |
Figure 4.3   MMP activity
MMP activity assay; total (A) and active (B) MMP-2, MMP-8 and MMP-9 are expressed as units per ml. 
Total and active MMP-2 are not significantly different between ruptured and control MI. However, both 
total and active MMP-8 and MMP-9 are significantly higher in the infarct rupture group. *: P<0.05, 
#: P< 0.01 (C) TIMP-1 levels, expressed in ng/ml, are significantly higher in infarct rupture patients 
compared to control MI patients. #: p<0.05
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MMP localization in the infarct rupture and control MI group
MMP-2 immunoreactivity was mainly observed in vital cardiomyocytes (Figure 
4.4A,B), but also in smooth muscle cells, fibroblast-like cells, endothelial cells 
and inflammatory cells. Necrotic cardiomyocytes, identified by the absence of 
nuclei, lacked immunoreactivity for MMP-2 (Figure 4.4A,C). No differences were 
observed in MMP-2 staining between the infarct rupture patients and the control 
MI patients. 
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Figure 4.4  Representative images of immunohistochemical staining for MMP-2
MMP-2 was mainly present in vital (V) cardiomyocytes (A-B) and decreased in ischemic (I) cardiomyo-
cytes (A,C). MMP-2 immunoreactivity showed the same pattern in ruptured and control MI. Scale bar 
length is indicated in µm. For full color illustration, see page 160.
MMP-9 was localized in and around the inflammatory cells both in the infarct 
rupture and control MI group (Figure 4.5A-D). However, in the infarct rupture 
group (Figure 4.5A,B) the number of positive cells and the staining intensity of 
MMP-9 appeared to be higher than in the control MI group (Figure 4.5C,D). This 
observation corroborates the increased amounts of MMP-9 in both zymography 
and activity assays as well as the higher number of inflammatory cells in the 
infarct rupture group.    
DISCUSSION 
To identify molecular mechanisms associated with infarct rupture in humans, 
we evaluated MMP-2, -8, -9 and TIMP-1 in myocardial specimens from victims 
of infarct rupture and compared them to infarct zones from uncomplicated MI. 
Total and active MMP-8 and -9 were significantly elevated, suggesting a possible 
role of matrix dissolution preceding rupture. Since remote areas of myocardium 
in patients with infarct rupture do not demonstrate upregulation of MMP activity 
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(data not shown), and inflammation around the infarct area is significantly more 
intense, it is likely that MMP upregulation is secondary to inflammation. The 
cause of the increased inflammatory response is currently subject of investiga-
tion in our lab.  
Infarct rupture typically occurs in the first week after a transmural MI. The first 
days after MI are characterized by an inflammatory response, migrating from 
the border zone to the center of the infarct area in approximately 14 days fol-
lowing MI. This inflammatory response is followed by the formation of granula-
tion tissue, which starts not earlier than 5 days after MI.83, 97 Therefore, the main 
constituents of 1-4 day old infarcts are necrotic cardiomyocytes, embedded in 
their original matrix, and inflammatory cells. The wound healing response after 
MI requires a delicately controlled proteolysis of the necrotic debris in the infarct 
area: too little proteolysis will hamper the progression of wound healing and too 
much proteolysis will deteriorate the integrity of the infarct area.23 MMPs play a 
central role in proteolysis within the infarct zone and therefore were subject of 
this study. 
The relationship between infarct rupture and activity of different members of 
the MMP family has been studied in mouse models. Either genetic or pharmaco-
logical inhibition of MMP-2 has been shown to protect against infarct rupture in 
Figure 4.5  Representative images of immunohistochemical staining for MMP-9
MMP-9 was mainly present in inflammatory cells (Figure 4.5A-D). Infarct rupture patients (Figure 
4.5A-B) showed more abundant staining than control MI patients (Figure 4.5C-D). Scale bar length is 
indicated in mm.  For full color illustration, see page 161.
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mice.24, 83 This has been attributed to a reduced macrophage infiltration of the 
infarct area, leading to a delayed post-MI remodeling.83 An increased MMP-9 ac-
tivity in ruptured infarcts has also been reported in animal studies.22, 23, 84, 103 The 
activity of MMP-9 increased as early as 1 day after MI and reached a maximum 
at 2-4 days after MI in mice,84 suggesting a link with neutrophil infiltration of the 
infarct area.3 Moreover, MMP-9 gene ablation protected against infarct rupture 
in mice.23 Another member of the MMP family, known to be produced by inflam-
matory cells like neutrophils and macrophages, is MMP-8.100, 104, 105 Although a 
role for MMP-8 in infarct rupture has not been reported to date, it is a likely 
candidate to contribute because of the increased influx of inflammatory cells in 
ruptured infarcts. 
In the present study, the activity of MMP-8 and -9 in ruptured infarcts was 
significantly increased. However, no increase in MMP-2 activity was observed, 
which is in disagreement with the protective role of MMP-2 inhibition in animal 
models.24, 83 This may reflect a difference in the pathophysiology of infarct rup-
ture between mice and men. Previous studies in humans have used indirect 
measurement of MMP-levels, either in pericardial fluid106 or plasma,107 to study 
MMP-levels during infarct healing and rupture in humans. In pericardial fluid, 
both MMP-2 and -9 were upregulated after acute myocardial infarction, but only 
MMP-9 was further elevated in a subgroup suffering from ventricular septum 
rupture.106  The profile of MMP-8 and -9 expression reported here is in agree-
ment with increased plasma levels of MMP-8 and -9, reported earlier, in patients 
after myocardial infarction although infarct rupture was not addressed in that 
study.107 However, it is to be noted that these studies only reported the latent 
forms of MMP due to the indirect nature of the sample collection. In the present 
study, MMP activity was determined directly in the source tissue, allowing sepa-
rate analysis of latent and active MMPs.
The localization of MMP-2 and -9 was determined using immunohistochemistry. 
MMP-2 immunoreactivity was observed in the cardiomyocytes, whereas MMP-9 
immunoreactivity was confined to the inflammatory cells in the infarct area. Be-
cause MMP-8 is well known to be expressed in neutrophils and macrophages,100, 105 
these observations indicate that the MMPs produced by the inflammatory cells 
may play a major role in infarct rupture. Elevated numbers of inflammatory cells 
in ruptured infarcts have previously been reported84 and were confirmed in the 
present study. Furthermore, we cannot rule out that latent MMPs, present in the 
interstitium are activated and also contribute to tissue proteolysis, although we 
expect this contribution to be of minor importance.
The activity of MMP has to be tightly regulated to prevent excessive matrix 
degradation. Members of the family of tissue inhibitors of metalloproteinases 
(TIMPs) can inhibit MMP activity. We determined the amount of TIMP-1, which 
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can inhibit a broad spectrum of MMPs by binding to active MMP, providing a 
localized regulation of MMP activity. TIMP-1 has previously been shown by our 
group to be upregulated after MI.100 We observed a significant upregulation 
of TIMP-1 in the ruptured infarcts compared to control infarcts in the present 
study. Although this observation may seem contra-intuitive, the increased TIMP-
1 levels apparently can not effectively counteract the increased MMP activity 
in the ruptured infarcts. Upregulation of TIMPs has also been demonstrated in 
other inflammatory processes, like multiple sclerosis.108 Moreover, TIMP-1 in-
creases when macrophages are activated with cytokines or LPS in vitro.109, 110 Al-
ternatively, TIMP-1 may prolong the life span of inflammatory cells in the tissue 
by specific blockade of their transmigration and by inhibiting their spontaneous 
apoptosis. In acute pyelonephritis, these entrapped and activated inflammatory 
cells excessively destroy the extracellular matrix.111 A similar mechanism may 
contribute to the increased inflammation and MMP-activity in infarct rupture.
 
One of the limitations of this study is the matching between ruptured patients 
and control MI patients. (see Table 4.1). The limited number of cases prevented 
a full match with respect to gender. Furthermore, patients with infarcts at dif-
ferent anatomical locations were included. However, the study was designed to 
match for postinfarction survival time in order to allow a fair comparison in MMP 
activity levels post-MI. Another limitation of the study is the timing of rupture of 
the included patients. The “classic” ruptures, as included in this study, occur at 
day 4-10 post-MI. Nowadays, with the advent of thrombolytic therapy, there is 
an increase in early ruptures, within the first day(s) post-MI. It is known that the 
timing of thrombolytic therapy is very critical, leading to a decrease in cardiac 
rupture when administered early, but an increase in the risk of cardiac rupture 
when administered late after the onset of MI.112 In the present study only one 
patient who received thrombolytic therapy was included. Therefore we cannot 
conclude that upregulation of MMP-8 and -9 activity is also responsible for trom-
bolysis-induced early infarct rupture. 
In conclusion, we report an increase in both latent and active MMP-8 and -9 in 
human ruptured infarcts, compared to control infarcts at the same time after 
MI. No difference in MMP-2 activity was observed, although this MMP also has 
been associated with infarct rupture in mouse models. The increased amounts 
of MMP-8 and -9 were likely produced by larger numbers of inflammatory cells in 
the ruptured infarcts compared to controls. These observations in humans may 
help develop therapeutic tools for this life-threatening complication of MI. 
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ABSTRACT 
Objective:  To evaluate intercellular adhesion complex proteins in myocardium 
in human infarct rupture. 
Background: Infarct rupture, a fatal complication of myocardial infarction (MI), 
has been attributed to a defective cell adhesion complex in a transgenic mouse 
model. 
Methods: Heart samples were collected from autopsies from infarct rupture 
and control (non-rupture) MI patients. Both infarcted and remote areas were 
included. Cell adhesion proteins including aE-catenin, b-catenin, g-catenin, and 
N-cadherin were characterized by immunohistochemistry and immunoblotting. 
Genetic analysis was undertaken to evaluate mutations and polymorphisms in 
the aE-catenin gene. In addition, infarct rupture was studied in transgenic mice 
heterozygous for aE-catenin C-terminal deficiency, mimicking the situation in 
human infarct rupture patients. 
Results: No aE-catenin was detected in 70% of remote samples of infarct rup-
ture hearts compared to 20% in control MI by immunohistochemistry. The immu-
noblot analysis confirmed a significant reduction in remote areas, and complete 
absence of aE-catenin in infarct areas from infarct rupture patients. No mutation 
or polymorphism of the aE-catenin gene was discovered. Other cell adhesion 
proteins were not significantly affected in remote areas of infarct rupture hearts. 
Three-fourths of the heterozygous aE-catenin C-terminal truncated mice died of 
infarct rupture, compared to one-fourth of the wild type littermates.
Conclusions: The data show a reduced expression and defective localization 
of aE-catenin in the intercalated disc region in patients dying of infarct rupture. 
The mechanism of lower expression of aE-catenin remains to be elucidated.
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INTRODUCTION
Although generally considered to be a rare complication of acute myocardial in-
farction (MI), myocardial infarct rupture remains a common cause of death,91, 93 
and accounts for approximately 10% of mortality.94, 97 Rupture is most frequent 
when the infarct area is located in the ventricular free wall91 and nearly al-
ways results in sudden death from massive blood loss into the pericardium, 
causing cardiac tamponade.91, 95 Most infarct ruptures occur within the first week 
of MI,94, 95 usually after transmural, first, or anterior MI, and in the setting of 
poor collateral circulation.99, 113 Little is known about the molecular mechanisms 
of infarct rupture. 
Recently, the role of defective intercellular adhesion complexes has been im-
plicated, based on an increased incidence of infarct rupture in mice lacking the 
aE-catenin gene.25  aE-catenin protein is a component of the cadherin/catenin 
cell adhesion complex, which mediates cell adhesion in many cell types.114 Loss 
of cell adhesion molecules has been associated with metastasis in many human 
cancers,115 underscoring their role in cell adhesion.  In myocardium, these cell 
adhesion complexes are located in the intercalated disks,116 and a weakened 
cardiomyocyte adhesion could facilitate inflammatory cell infiltration. Increased 
inflammatory cell influx and consequent upregulation and activation of matrix 
metalloproteinases have previously been reported to be associated with infarct 
rupture in animal studies19, 100 and in humans.117
The present study was undertaken to evaluate the role of cadherin and catenin 
proteins, especially aE-catenin, in patients dying of infarct rupture. In this case 
control study, we performed biochemical and immunohistochemical character-
ization of the adhesion complex proteins and compared with age matched post-
mortem myocardial tissue specimens obtained from MI patients dying of causes 
other than infarct rupture (control MI). The adhesion complex proteins were 
characterized in both infarcted and remote areas. The analysis of the aE-catenin 
gene was also performed to identify mutations or polymorphisms. In addition, 
to mimic these observations in an animal model, we studied the impact of MI in 
transgenic mice heterozygously deficient for the C-terminal part of aE-catenin 
and found a higher incidence of infarct rupture compared to their wild type lit-
termates. 
METHODS
Myocardial tissue specimens 
Collection, storage and use of human heart tissue and patient data were un-
dertaken in compliance with the “Code for Proper Secondary Use of Human 
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Tissue in the Netherlands” (http://www.fmwv.nl).  For the present study, the 
post-mortem myocardial tissue specimens were collected in 40 patients with MI, 
20 with infarct rupture and 20 without rupture (control MI).  For each patient, 
samples from the infarct area and from remote myocardial region were obtained 
(Table 5.1).
For the prospective part of the study, myocardial samples were obtained at au-
topsy (collected from 2001 to 2006). Part of the samples were snap frozen in 
liquid nitrogen, part was formalin fixed. Left ventricular (LV) myocardial samples 
were collected from 10 patients who died of infarct rupture (age 52 to 87 years; 
8 males, 2 female) (infarct rupture group). For comparison, LV samples were 
also collected from 10 MI patients who suffered from MI 3-7 days before death 
but died from causes other than infarct rupture (age 48 to 86 years; 4 males, 6 
females; control group). The two groups were similar according to post-MI sur-
vival times. Also, there was no significant difference in the time lapsed between 
death and autopsy between the two groups (rupture: 22.6 ± 6.1 hours, control 
MI: 19.6 ± 5.1 hours). The frozen tissue samples were stored at –80 °C and 
subsequently used for Western blotting and DNA isolation. The formalin-fixed 
Table 5.1    Characteristics of pateints included in this study
   
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
              
        


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tissues were embedded in paraffin, and the sections stained with hematoxylin 
and eosin to estimate the infarct age. In addition, all formalin-fixed tissue speci-
mens were used for immunohistochemical staining for catenin and cadherin 
family proteins.
For the retrospective part of the study, myocardial tissue samples were obtained 
from Maastricht Pathology Tissue Collection registry; autopsies were performed 
between 1996-2000). After review of the clinical histories, paraffin-embedded 
tissue samples from different areas of the heart were obtained from 10 patients, 
who had died of infarct rupture. The age of the patients (4 males and 6 females) 
ranged from 63 to 84 years; all 10 patients had sustained rupture of the LV free 
wall in the index episode and had no evidence of previous transmural MI. In ad-
dition, post-mortem myocardial specimens were also collected from 10 control 
patients (5 males and 5 females) who had suffered from transmural MI in past, 
but had died of unrelated causes. These patients revealed pathological evidence 
of an old-infarct with adequate infarct healing. The age of these patients ranged 
from 63 to 85 years and was similar with the patients in the infarct rupture 
group.
Immunohistochemistry
From paraffin-embedded tissue, 4 µm-thick  sections were cut, mounted on 
glass slides coated with 3-aminopropyltriethoxysilane (APTS, Sigma-Aldrich, St. 
Louis MO, USA) and dried overnight in an incubator at 37 °C. The sections were 
deparaffinated in xylene, rehydrated and endogenous peroxidase was blocked 
by incubation in methanol containing 0.3% hydrogen peroxide for 15 minutes, 
and rinsed with PBS. For antigen retrieval of b-catenin, g-catenin and N-cadher-
in, sections were boiled twice for 5 minutes in 10 mmol/L citrate buffer (pH 6.0). 
For aE-catenin, sections were boiled in citrate buffer for 10 minutes at 110 °C in 
an autoclave. The following primary antibodies were used: b-catenin monoclo-
nal antibody (dilution 1:500, Transduction Labs, Lexington KY, USA), g-catenin 
polyclonal antibody (dilution 1:50, Santa Cruz Biotechnology, Santa Cruz, Cal-
ifornia) and pan-cadherin monoclonal antibody (dilution 1:250, Sigma). This 
pan-cadherin antibody was raised against the C-terminal cadherin sequence, 
which is common in many cadherins including N-cadherin, the main cardiac 
form. Immunohistochemistry for aE-catenin was performed using two differ-
ent polyclonal antibodies raised against the C-terminal part of the aE-catenin 
protein (dilutions 1:50, Santa Cruz and 1:100 Neomarkers, Fremont CA, USA, 
respectively). All sections were incubated overnight with the antibody at 4 °C. 
The following secondary antibodies were used: biotinylated multilink Swine-anti 
goat, -mouse and -rabbit (dilution 1:400, DAKO, Glostrup, Denmark) and rab-
bit-anti goat (dilution 1:600, DAKO). The Vectastain ABC kit (Vector, Burlingame 
CA, USA) was used according to the manufacturer’s instructions to visualize the 
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binding of the primary antibodies. Sections were briefly counterstained with he-
matoxylin before mounting with Entellan (Merck, Darmstadt, Germany). 
Four sections per patient, obtained from different parts of the heart, were ana-
lyzed in a blinded way by two independent observers. The sections were includ-
ed into one of three categories: detectable staining of intercalated discs (ICD) in 
three or more sections per patient (+), detectable staining of ICD in one or two 
sections per patient (±), or no detectable staining of ICD (-).
Western blotting
For Western blotting, samples of the frozen heart tissue were placed in 500 
µl ice-cold Laemmli buffer (6.6% Glycerol, 1.5% SDS, 41.5 mmol/L Tris/HCl 
pH=8.0) and homogenized with a PRO200 tissue homogenizer (PRO Scientific, 
Oxford CT, USA). After sonication and centrifugation, the supernatant was col-
lected and protein content was measured using the BCA protein Assay (Pierce 
Biotechnology Inc., Rockford IL, USA).  Ten µg of total protein was denatured 
by boiling in Laemmli sample buffer (Biorad, Hercules CA, USA), separated on 
a 10% SDS-PAGE gel118 and transferred onto a Hybond C nitrocellulose mem-
brane (Amersham Biosciences, Little Chalfont, UK). After blocking (5% nonfat 
dry milk (Biorad), 0.1% Tween in TBS) for 1 hour, membranes were incubated 
overnight at 4 °C with primary antibodies directed against a-catenin 1:3000 
(Sigma-Aldrich, St. Louis, Missouri, USA) and a-tubulin (H-300) 1:500 (Santa 
Cruz, Santa Cruz CA, USA) for loading control. For this part of the study we were 
unable to use the aE-catenin antibodies that were used for immunohistochem-
istry, because these antibodies failed to produce a distinct band in our Western 
blot assay. The a-catenin antibody from Sigma is known to cross-react with both 
aE and aN-catenin, but since the latter subtype of a-catenin is not present in 
the heart the observed band represents aE-catenin. Anti-rabbit IgG  (PI 1000) 
1:5000, (Vector labs Inc., Burlingame, California, USA) was used as the second-
ary antibody and the membranes were developed using the Supersignal West 
Pico chemiluminescence kit (Pierce). Images of the blots were analyzed with 
image analysis software (Qwin, Leica, Cambridge, UK).
 
DNA isolation, PCR amplification and sequencing
In order to sequence the 16 coding exons of aE-catenin (CTNNA1, MIM:*116805), 
DNA was isolated from snap-frozen tissue samples from remote  parts of the 
hearts of both infarct rupture patients and control MI patients. In total, we in-
cluded tissue from 3 patients who died of infarct rupture and 3 patients who suf-
fered from recent MI (3-7 days post-MI) but died from causes other than infarct 
rupture. DNA was isolated from the tissue samples using the Dneasy Tissue kit, 
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
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PCR was performed in 25 µl reactions using PuReTaq Ready-To-Go PCR beads 
(Amersham). Both forward and reverse primers were used in a concentration 
of 10 µM (See Table 5.2). PCR reactions were performed in the Biorad I-cycler 
(Biorad). The PCR products were identified on a 1% agarose gel and purified 
using the High pure PCR purification kit (Roche diagnostics GmbH, Mannheim, 
Germany) according to the manufacturer’s instructions.
Cycle sequencing was performed using the BigDye Terminator v3.1 cycle se-
quencing kit (Applied Biosystems, Foster City CA, USA) according to manu-
facturer’s instructions. The forward primers of the PCR reactions were used as 
sequencing primers (see Table 5.2). In a 20 µl reaction volume, 3.2 pmol primer 
was added. The products of the sequence reactions were purified by ethanol 
precipitation and analyzed using an ABI Prism 3100 genetic analyzer (Applied 
Biosystems). 
Experimental myocardial infarction in aE-catenin deficient mice, tissue 
collection and processing 
Animals
Heterozygous aE-catenin C-terminal deficient mice were created using a gene 
trap strategy in R1 embryonic stem cells, which were a kind gift of Dr. P. Gruss, 
Germany. These embryonic stem cells where injected into C57Bl6 blastocysts to 
Primers used for PCR and sequencing of aE-catenin (CTNNA1, 
Ensembl id no. ENST00000302763)
Tabel 5.2
    °
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    





Thesis vd Borne V2.indd   69 20-2-2009   15:00:14
 page 70 |
generate aE-catenin deficient mice. In these mice, the mutation eliminates the 
carboxyl-terminal third of the protein and induces a complete loss of function 
phenotype.119 Since homozygous mice die in the blastocyst stage,119 we only 
used adult, male heterozygous mice (n=9) and compared them to their wildtype 
littermates (n=11). All experiments were conducted according to institutional 
guidelines and conformed to the guide of the care and use of laboratory animals 
published by the National Institutes of Health.
Experimental myocardial infarction
Experimental Myocardial infarction was induced as described previously.78 Brief-
ly, all mice received Buprenorphine 0.1 mg/kg subcutaneously as pain medica-
tion before surgery. Mice were anaesthetised using 3-4% Isoflurane, which was 
gradually decreased to 1.5-2.5% during surgery. The trachea was intubated to 
allow positive pressure respiration with room air (1.5 ml, 70/min). A ligature 
(6-0 prolene) was tied around the main left coronary artery after opening the 
skin, the left 4th intercostal space and the pericardial sac. Chest and skin were 
closed with 5-0 silk sutures. 
Tissue collection
Mice were scheduled to be sacrificed 7 days after MI. Half of the heart was snap 
frozen into liquid nitrogen and stored at -80 °C until further use. The other half 
was formalin fixed and paraffin embedded for immunohistochemistry. Ten mice 
died of acute rupture between 3 to 5 days, and the tissue samples were col-
lected similarly. The same protocol for Western blotting was used as described 
for human tissue. 
Statistical analysis
All data are presented as means±SEM. Statistical analysis was performed using 
a two-way ANOVA with 1 repeated measures factor with Bonferroni posthoc-test 
as applicable. For analysis of the semiquantitative immunohistochemistry data, 
a Chi-square test was performed. Survival was analyzed by a Kaplan Meier curve 
with a log-rank test for differences between groups. A P-value <0.05 was con-
sidered to indicate statistical significance. Graphpad Prism 4 software (Graph-
pad Software, Inc., San Diego, CA) was used for statistical analysis. 
 
RESULTS
Immunohistochemical localization of cellular adhesion motifs
To analyze the localization characteristics of the cell adhesion complex in infarcted 
and remote myocardium, immunohistochemistry was performed using antibod-
ies specific for various cadherin and catenin family proteins in both prospectively 
and retrospectively collected tissue samples.  In the infarct area we observed 
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Immunohistochemical characterization of cell adhesion complex 
proteins in the infarct area
Representative microphotographs of immunostaining for b-catenin (A-C), g-catenin (D-F), N-cadherin 
(G-I) and aE-catenin (J-L) in the infarct area of ruptured hearts (A,D,G,J), early (B,E,H,K) and late 
(C,F,I,L) control infarcts. A similar staining intensity for b-catenin, g-catenin and N-cadherin was 
observed in the intercalated disk regions of the cardiomyocytes in infarct rupture and the two control 
MI groups. aE-catenin staining was undetectable in the infarct area of infarct rupture patients (J). 
However, staining was observed in the early control infarcts (K) as also in the border zone (bz) of late 
control MI’s (L). Panel M-O shows H&E staining of the infarct area of ruptured patients (M), character-
ized by the necrotic cardiomyocytes and the massive influx of inflammatory cells. H&E staining of an 
early control MI (N) and the border zone of a late control MI (O) are also shown. Scale bar length is 
indicated in mm. For full color illustration, see page 162.
Figure 5.1
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Immunohistochemical characterization of cell adhesion complex 
proteins in the remote area
Representative images of immunostaining for b-catenin (A, B), g-catenin (C, D), N-cadherin (E, F) and 
aE-catenin (G,H) in remote parts of ruptured hearts (A,C,E,G) and control MI hearts without rupture 
(B,D,F,H). Abundant and similar staining for b-catenin, g-catenin and N-cadherin was observed in 
the intercalated disk regions of the cardiomyocytes in infarct rupture and control MI groups. For aE-
catenin, abundant staining of intercalated disks between cardiomyocytes was observed in the control 
MI hearts (H). On the contrary, 90% of the patients from the infarct rupture group showed either weak 
or no detectable aE-catenin staining (G). Scale bar length is indicated in mm. For full color illustration, 
see page 163. 
Figure 5.2
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staining for b-catenin (Figure 5.1A-B), g-catenin (Figure 5.1D-E) and N-cadherin 
(Figure 5.1G-H) in the cardiomyocytes of both infarct rupture and early control 
MI patients. In contrast, no immunohistochemical staining for aE-catenin was 
observed in the infarct area of the infarct rupture patients (Figure 5.1J), where-
as this staining was present in the early control MI group (Figure 5.1K). In the 
late control MI group, we detected staining with all four antibodies in surviving 
cardiomyocytes in the border zone of the infarct (Figure 5.1C,F,I,L). The H&E 
stained sections showed necrotic cardiomyocytes with increased numbers of 
inflammatory cells in the infarct area of infarct rupture patients (Figure 5.1M). 
To analyze whether the lack of aE-catenin in the infarct rupture patients was ac-
quired or already present prior to infarction, we analyzed the remote areas with 
all four antibodies (Figure 5.2). b-Catenin (Figure 5.2A-B), g-catenin (Figure 
5.2C-D) and N-cadherin (Figure 5.2E-F) showed abundant presence within the 
intercalated disks in the remote myocardial regions of both the infarct rupture 
patients and control MI patients. No differences were observed between these 
two groups (see Table 5.3). 
The results of immunohistochemical analyses of the remote myocardium with 
aE-catenin antibodies (raised against the C-terminal part of aE-catenin, ob-
tained from Sant Cruz) are shown in Figure 5.2G-H. In 70% of infarct rupture 
patients, no aE-catenin staining was observed in the intercalated disks in re-
mote region, whereas in 20% the staining was found to be low. In contrast, 
only in 20% of the control MI patients no aE-catenin could be demonstrated in 
the remote region (Table 5.3), a statistically significant difference (p< 0.0001). 
To confirm these findings, we used another antibody directed towards the C-
terminal part of aE-catenin (obtained from Neomarkers). The latter aE-catenin 
antibody yielded results similar to those obtained with the Santa Cruz antibody 
(data not shown). 
Immunohistochemical distribution of adhesion complex proteins 
in myocardial specimens obtained from patients with and without 
infarct rupture
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

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Western blotting
For semi-quantitative assessment of aE-catenin protein expression in infarct 
rupture and control MI patients, in both infarct and remote areas, we performed 
Western blotting (Figure 5.3) on the prospectively collected tissue samples. In 
the remote areas, densitometric analysis showed large amounts of aE-catenin 
in control MI patients. The expression was almost three-fold lower in the infarct 
rupture patients (p<0.01). In the infarct areas of the control MI group a slight, 
non-significant reduction in aE-catenin was detected compared to the remote 
areas of the same patients. In contrast, aE-catenin expression was almost com-
pletely absent in the infarct zone of infarct rupture patients (Figure 5.3A). 
We also performed Western blotting for b-catenin (Figure 5.3B), g-catenin (Fig-
ure 5.3C) and N-cadherin (Figure 5.3D). The remote tissue from both the infarct 
rupture and control MI patients demonstrated similar amounts of these cell 
adhesion molecules. Also, no significant difference was observed in b-catenin, 
g-catenin and N-cadherin content in the infarct area of infarct rupture patients 
compared to control MI patients. Furthermore, in the infarct rupture group b-
catenin, g-catenin and N-cadherin all decreased significantly in the infarct area 
compared to remote myocardium.
Sequencing
To evaluate potential mutations or polymorphism of the aE-catenin gene in the 
infarct rupture patients that could lead to expression of a dysfunctional pro-
tein i.e. unable to localize to the intercalated discs, we sequenced each of the 
16 coding exons of aE-catenin (CTNNA1) in 3 infarct rupture and 3 control 
MI patients with transmural infarcts. Although more than 20 SNPs have been 
described for the aE-catenin gene, we only observed a single SNP in exon 16 
(rs1059110, G to A) in this study. In the rupture group we observed the follow-
ing variants: one patient was GG, one patient was GA and one patient was AA. 
In the control group two patients were GG  and one patient was AA. Based on 
these limited results, we conclude that there is no evidence for a role of this SNP 
in infarct rupture. 
 
aE-catenin in experimental myocardial infarction 
Heterozygous aE-catenin C-terminal deficient mice were used to study the ef-
fect of reduced aE-catenin content on infarct rupture, to mimic clinical scenario 
in ruptured MI patients. After induction of MI, only 25% of the heterozygous 
mice were alive 7 days post MI, as compared to 75% of their wild type litter-
mates (see Figure 5.4A). All mice died of infarct rupture, diagnosed by massive 
blood loss in the thoracic cavity. Kaplan Meier analysis demonstrated signifi-
cantly higher mortality in the heterozygous mice (p=0.038). Interestingly, no 
evidence of spontaneous heart muscle disease was obtained in non-infarcted 
heterozygous mice up to 70 weeks after birth (data not shown). 
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Immunoblotting studies for characterization of cell adhesion 
complex proteins
Upper panel: representative Western blots of tissue obtained from infarct rupture patients and con-
trol MI patients, both from remote (non-ischemic) and infarct areas. A: aE-catenin, B: b-catenin, C: 
g-catenin and D: N-cadherin; a-tubulin was used for normalization of the samples. Lower panel: Quan-
titative analysis of adhesion complex proteins, expressed as protein/a-tubulin ratio. Significantly less 
aE-catenin was detected in the remote area of infarct rupture patients (n=10) compared to control 
MI patients (n=10). In the infarct area, aE-catenin was undetectable in the infarct rupture group but 
readily detectable in the control MI group. Similar levels of b-catenin, g-catenin and N-cadherin were 
observed in the remote areas of infarct rupture and control MI groups, although more extensive degra-
dation of these proteins was detected under ischemic conditions. #p<0.05, *p<0.01, **p<0.001  
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Immunohistochemical characterization revealed less intense staining of the in-
tercalated disks in the heterozygous mice compared to wild type littermates 
(Figure 5.4C). On the contrary, other components of the cell adhesion complex 
proteins revealed no differences between wild type and transgenic mice (data 
Figure 5.3
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Heterozygous aE-catenin C-terminal deficient mice show 
susceptibility to infarct rupture post-myocardial infarction
A: Kaplan Meier curve analysis of heterozygous aE-catenin C-terminal deficient mice (n=9) showed 
significantly lower rupture-free survival post MI (#: p=0.038) compared to their wildtype littermates 
(n=11). B: Macroscopic image of infarct rupture (T=tweezers). The arrow points at the tear in the 
infarct area, showing the blood loss through the ventricular wall. C: Representative images of Immu-
nohistochemical analysis of aE-catenin, showing less intense staining of the intercalated disks in the 
heterozygous mice compared to wildtype littermates. D-G: Upper panels: Representative Western blot 
analysis for aE-catenin (D), b-catenin (E), g-catenin (F) and N-cadherin (G) in heterozygous C-terminal 
aE-catenin deficient mice and their wildtype littermates, both from septum (non-ischemic) and infarct 
tissue; b-actin was used for normalization of the samples. Lower panels: Quantitative analysis of 
adhesion complex proteins, expressed as protein/b-actin ratio, demonstrating significantly lower aE-
catenin in mice heterozygously deficient for C-terminally truncated aE-catenin (n=9) compared to their 
wildtype littermates (n=11). The other cell adhesion proteins were unaffected, although N-cadherin 
showed more degradation under ischemic conditions in the heterozygous mice. #p<0.05, *p<0.01, 
**p<0.001  For full color illustration, see page 164.
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not shown). Similarly, Western blotting also demonstrated a significant decrease 
in aE-catenin protein expression in the heterozygous mice compared to their 
wild type littermates (Figure 5.4D; P<0.05). The reduction of aE-catenin in 
the heterozygous mice was similar to that observed in the infarct rupture pa-
tient group. Other adhesion complex proteins in the transgenic mice remained 
unaffected (Figure 5.4E-G). After MI however, a reduced g-catenin and N-cadher-
in expression was observed in the infarct zone of the heterozygous mice, com-
pared to uninfarcted tissue obtained from interventricular septum (p<0.01).
 
DISCUSSION
Characterization of the cell adhesion complex proteins in the myocardial speci-
mens obtained from infarct rupture patients demonstrates a significantly re-
duced expression of aE-catenin and a lack of localization of this protein in the 
intercalated disks of both the infarct area and the remote, non-ischemic parts of 
infarct rupture hearts. These observations suggest that infarct rupture patients 
have an intrinsic defect in their cell adhesion complex which may have little ef-
fect on normal cardiac function, but may predispose the myocardium to rupture 
after transmural MI. The defective expression and localization of adhesion com-
plex protein is not determined genetically. We sequenced the 16 exons that form 
the entire coding region of aE-catenin in infarct rupture patients and compared 
these sequences to those obtained from control MI group. A single SNP was 
observed, however this SNP was not consistently linked to the infarct rupture 
group. Therefore, mutations that affect aE-catenin at the protein level are un-
likely to explain its reduced amounts and lack of localization in infarct rupture 
patients. However, this does not rule out that aE-catenin mutations that affect 
mRNA splicing and stability are present in infarct rupture patients. These muta-
tions have been shown to reduce the stability of the cadherin/catenin complex 
in human cancer cells.115 Unfortunately, mRNA obtained from postmortem tissue 
samples is severely damaged and cannot be used to study this hypothesis. 
Interestingly, phosphorylation of the Tyr148 residue of a-catenin has been shown 
to enhance its interaction with b-catenin at the adherens junction.120 More-
over,  several phosphorylation sites on b-catenin (Tyr142, 489, 654) and cadherin 
(Ser684, 686, 692) have been proposed to play a role in the formation of the adhe-
rens junction complex.114, 121, 122 Analysis of the effect of these posttranslational 
modifications on cell adhesion complex formation in cardiomyocytes and their 
relation to infarct rupture is desirable.  
To test the role of defective adhesion protein complex in infarct rupture in an 
animal model, we used mice heterozygous for C-terminal truncated aE-catenin. 
Deletion studies have shown that the C-terminus is required for strong cell ad-
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Cartoon depicting the role of a defective intercellular adhesion 
complex in infarct rupture in humans
In the left part of the cartoon, the normal components of the cell adhesion complex of cardiomyo-
cytes from patients with normal infarct healing are shown. In the uninjured cardiomyocytes of normal 
hearts, aE-catenin is localized in the intercalated disks. Ischemia induces death of the cardiomyocytes 
in the infarct area, as shown by the loss of their nucleus. However, the integrity of the infarct area is 
sufficiently preserved by the adhering cardiomyocytes, and the wound healing and granulation tissue 
formation continue. As shown in the right side of the cartoon, aE-catenin is not localized in the interca-
lated disks of the cardiomyocytes in rupture-prone hearts. After ischemia, this abnormal cell adhesion 
complex causes the dead cardiomyocytes in the infarct area to loosen up their connections, causing 
further deterioration of the integrity of the infarct area and subsequently leading to infarct rupture. For 
full color illustration, see page 165.
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Figure 5.5
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hesion.123 The immunohistological and Western blotting characteristics of the cell 
adhesion molecules in these mice were remarkably similar to those observed 
in human infarct rupture victims: Significantly reduced aE-catenin expression 
was observed localized to intercalated disk region in remote myocardium in 
comparison to normal expression and distribution of other components of the 
cell adhesion complex (b-catenin, g-catenin and N-cadherin). Induction of MI in 
these mice resulted in a significantly higher frequency of infarct rupture than 
their wild type littermates. Interestingly, when not exposed to cardiac ischemia 
these heterozygous mice did not show any signs of cardiac malfunction for up 
to 70 weeks of age. 
The alterations in the cell adhesion complex, observed in the infarct rupture pa-
tients and animals, seems to affect the integrity of myocardial skeleton in the in-
farct area, even though most of the cardiomyocytes are necrotic (Figure 5.5). A 
reduced cardiomyocyte adhesion could facilitate the migration of inflammatory 
cells into the infarct area, explaining the high numbers of these cells reported in 
ruptured infarcts; attendant upregulation and activation of proteolytic enzymes 
may further facilitate infarct rupture.19, 117, 124 
Conclusions: The present study demonstrates that a decreased aE-catenin 
cell adhesion protein expression and localization predispose to infarct rupture. 
The results of this study lead to the hypothesis that infarct rupture is associ-
ated with an abnormality of the cell adhesion complex of the cardiomyocytes. 
Further research on the mechanisms that control the localization of cell adhe-
sion molecules in the intercalated disks will be needed to better understand this 
proposed molecular mechanism of infarct rupture. 
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ABSTRACT 
Objectives. To evaluate interstitial alterations in myocardial remodeling using a 
radiolabeled Cy5.5-RGD imaging peptide (CRIP) that targets myofibroblasts.
Background. Collagen deposition and interstitial fibrosis contribute to cardiac 
remodeling and heart failure (HF) after myocardial infarction (MI). Evaluation 
of myofibroblastic proliferation should provide indirect evidence of the extent of 
fibrosis.
Methods. Of the 46 Swiss-Webster mice, MI was induced in 41 by coronary 
artery occlusion and 5 were used unmanipulated. Of the 41 mice, 6, 6, and 5 re-
ceived intravenous Tc-99m labeled CRIP for microSPECT-CT imaging after 2, 4, 
and 12 weeks of MI; 8 received captopril or captopril with losartan up to 4 weeks 
after MI.  Scrambled CRIP was used 4 weeks after MI in 6 mice; the remaining 
10/46 mice received unradiolabeled CRIP for histological characterization. 
Results. Maximum CRIP uptake was observed in the infarct area; quantitative 
uptake (percent injected dose per gram, %ID/g) was highest at 2 weeks 
(2.75±0.19%), followed by 4 (2.26±0.04%), and 12 (1.74±0.11%) weeks 
compared to unmanipulated mice (0.59±0.09%).  The uptake was higher at 12 
weeks in the remote areas.  The uptake was histologically traced to myofibro-
blasts. Captopril alone (1.78±0.16%) and with losartan (1.13±0.14%) signifi-
cantly reduced tracer uptake; scrambled CRIP (0.74 ± 0.07%) was similar to 
CRIP uptake in normal myocardium.
Conclusions. Radiolabeled CRIP allows for noninvasive visualization of intersti-
tial alterations during cardiac remodeling, and is responsive to anti-angiotensin 
treatment.  If proven clinically feasible, such a strategy would help identify post-
MI patients likely to develop heart failure.
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INTRODUCTION
Heart failure (HF) is evolving as one of the most important cardiovascular health 
problems worldwide. In the United States alone, approximately 5 million people 
suffer from manifest heart failure and over 500000 new cases are diagnosed 
every year.125 The syndrome of HF post-MI is characterized by a relentless course 
of myocardial remodeling and functional deterioration,30, 32, 126 which continues 
to occur even after the initial causative injury has abated.4, 127  In addition to 
replacement fibrosis in the region of myocardial infarction (MI),  the interstitial 
fibrosis in the non-infarcted myocardium significantly contributes to adverse re-
modeling and heart failure (HF).52  In fact, presence of fibrosis remote from the 
infarct zone accounts for two-thirds of the fibrous tissue in the cardiomyopathic 
heart.52, 128-130 The magnitude of myocardial fibrosis is correlated to the extent 
of ventricular dysfunction.131 It is conceivable that an ability to noninvasively 
detect the process of myocardial fibrosis would allow assessment of likelihood of 
evolution of HF after MI. 
The collagen production and fibrosis in the myocardium is associated with 
myofibroblastic proliferation.127 Myofibroblasts demonstrate upregulation of 
angiotensin receptors and integrin moieties, which in turn may promote col-
lagen genes and reduce metalloproteinase genes.70 Such effects of integrin 
upregulation are prevented by abrogation of autocrine TGF-b signaling.70 The 
RGD probes (peptides containing the arginine-glycine-aspartate motif) that bind 
to integrins such as avb3 have been used to identify neovascularization in post-
infarct animal models.132 Since integrin avb3 is associated with the supermature 
focal adhesions on the cell membrane of myofibroblasts, we hypothesized that 
appropriately labeled RGD probe should identify myofibroblasts in post-infarct 
myocardium.56  In addition, scrutiny of the pro-collagen I sequence revealed 
RGD binding domains, such as DDX, and could also constitute a target for RGD-
based imaging. Therefore, uptake of RGD probe should indirectly represent the 
rate of fibrogenesis or collagen deposition. 
In the present study, we used Cy5.5-RGD imaging peptide (CRIP) labeled with 
technetium-99m (Tc), for feasibility of imaging the process of active myocardial 
fibrosis in a murine model of post-MI ventricular dysfunction. The noninvasive 
imaging ability of the radiolabled probe was compared with echocardiographic pa-
rameters of left ventricular geometric changes and pathological characterization 
of interstitial alterations. The fluorescent moiety of the targeting peptide allowed 
better histological characterization of the probe localization. An antibody against 
the fluorescent moiety of CRIP was used to immuno-electronmiroscopically trace 
the localization of CRIP. In addition, in vitro experiments were performed for 
characterization of the CRIP binding to mature and pro-collagen.
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METHODS
Experimental Myocardial Infarction in Mice 
The experimental protocol was approved by the Institution Animal Care and 
Use Committee of the University of California, Irvine, School of Medicine.  In 
41 adult Swiss Webster male mice (age: 4 months; body weight: ~50 g) MI 
was induced, under pentobarbital (75 mg/kg) and isoflurane gas anesthesia 
(2.0–3.0%) using a stereomicroscope (Leica MZ FL III, Leica, Switzerland).  For 
this purpose, animals were placed on a heating pad in supine position, endo-
tracheal intubation was performed under direct laryngoscopy and mechanical 
ventilation was maintained with a small animal respirator (Harvard Apparatus; 
tidal volume = 250 µl, rate = 210 breaths/min). After thoracotomy, the lateral 
branch of LCA was ligated with a 6.0-prolene suture 3 to 4 mm below the tip of 
left atrium.  Successful ligation was verified by visual inspection of the LV apex 
for myocardial blanching indicating interruption in coronary flow.  The chest and 
skin were closed in layers with 5.0-silk sutures. Animals were gradually weaned 
from the respirator.
For the evaluation of serial changes in collagen synthesis by radiolabeled CRIP 
imaging, animals were divided into groups as 2 weeks (n= 6), 4 weeks (n= 
6) and 12 weeks (n= 5) after infarction (Table 6.1).  Two groups of 4 animals 
each were treated with either captopril (60 mg/kg/day) alone or in combination 
with losartan (captopril 30 mg/kg/day, losartan 10 mg/kg/day) dissolved in the 
drinking water, to evaluate if molecular imaging with CRIP would allow determi-
nation of efficacy of therapeutic intervention. Five unmanipulated control mice 
were subjected to CRIP imaging for comparison with the infarcted mice after a 
4-week wait. In addition, 6 animals, 4 weeks after MI, were imaged with Tc-la-
beled scrambled peptide (scrambled CRIP, AH-112298) to ensure the specificity 
of CRIP. In the remaining 10 mice, non-radiolabeled CRIP was used for patho-
logical characterization of the target using fluorescence microscopy and immu-
noelectron microscopy. 
Echocardiography 
All animals were subjected to extensive echocardiographic studies for the as-
sessment of myocardial infarct size, LV cavity dimensions and ventricular func-
tion.
Table 6.1    Classification of animals used in the study
* C+L: Captopril and losartan
       
       
       
       
       
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Echocardiographic examination was performed under 2% isoflurane anesthesia 
for the assessment of infarct size, left ventricular (LV) cavitary dimensions and 
ventricular function before nuclear imaging. Echocardiograms were recorded 
with a commercially available ultrasound system (Sequoia™, Siemens) using a 
14-MHz linear probe (15L8, Siemens) (MountainView, CA). An advanced high 
frame rate imaging technique, acoustic capture (Paragon®, Siemens), was ad-
opted for image acquisition allowing temporal resolution of 8-10 msec (frame 
rate, 100-120 per s).  B-mode images of LV parasternal long-axis and paraster-
nal short-axis views at base, mid and apical LV levels were digitally stored as 
movie loops in 2-3 cardiac cycle length. Still images of LV M-mode as well as 
pulsed wave Doppler spectrum of mitral valve inflow and aortic valve forward 
flow were acquired at a sweep of 100 mm/s. Infarct area and LV area were 
measured by tracing endocardial borders on long axis images, and infarct-to-LV 
ratio was calculated. LV wall thicknesses and cavity dimensions were measured 
on LV M-mode spectrum as recommended by the American Society of Echocar-
diography guidelines,133 followed by calculation of % fractional shortening and 
ejection fraction. 
Figure 6.1    The structure and manipulation of CRIP
CRIP is a 2.5 kD, 10 amino acid-peptide, which contains an RGD-motif and has a bi-cyclic structure 
formed by a disulfide bridge and a thioether bridge. It is conjugated to both a fluorescent cyanine 
dye (Cy5.5) and the chelating agent cPN216 for radiolabeling with technetium-99m; the dye moiety 
and the chelating agent are conjugated through the lysine side-chain at the N- and C-terminal ends, 
respectively. For the preparation of scrambled CRIP, the order of the amino acids in CRIP was mixed 
so the sequence did not express the RGD-motif. The dye and the chelating agent were conjugated 
similarly (not shown). 
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CRIP and Scrambled CRIP: Structure and Radiolabeling
CRIP and scrambled CRIP were the kind gift of GE Healthcare, AS, Oslo, Norway. 
CRIP (AH110863, Figure 6.1) is a 2.5 kD peptide conjugated to both a fluores-
cent cyanine dye Cy5.5, and the chelating agent cPN216; the latter is linked 
for radiolabeling of the peptide with technetium-99m. The peptide comprises 
10 amino acids, contains an RGD-motif, and has a bi-cyclic structure formed by 
a disulfide and a thioether bridge. The dye moiety and the chelating agent are 
conjugated to the peptide via the side-chain of lysine residue at the N- and C-
terminal ends, respectively.  A scrambled version of CRIP (AH-112298) was also 
prepared, where the order of the amino acids in CRIP has been altered so that 
the sequence does not express an RGD-motif. The dye and the chelating agent 
are conjugated at the same positions.  
For radiolabeling, 50 μg of tracer was dissolved in 50 μl of MeOH and then added 
to freeze dried kit.  1.0 ml of 99mTcO4
- was added to the compound and left at 
room temperature for 20-30 min.  Radiolabeling was confirmed by instant thin-
layer chromatography with radiopurity of more than 90%. For nuclear imaging, 
170±2.5 MBq (4.6±0.1 mCi) of Tc-CRIP was injected through the tail vein and 
imaging was performed after 3.5 hours. 
Micro-SPECT Imaging with Tc-CRIP and Micro-CT
Radionuclide imaging was performed using a dual-head micro single-photon 
emission computed tomography (SPECT) gamma camera with micro-CT 
(X-SPECT, Gamma Medica, Inc., Northridge, CA) under isoflurane anesthesia. 
In vivo micro-SPECT images of the heart were acquired in 64×64 scaffold, 32 
steps at 120 sec per step on 140 keV photopeak of 99mTc with 15% window 
using a low-energy high-resolution, pinhole collimator.  After SPECT acquisi-
tion, micro-CT images were acquired without moving the mice.  The micro-CT 
used an X-ray tube operating at 50 kVp and 0.6 mA, and images were acquired 
for 0.5 sec per view for 256 views in 360° rotation.  The micro-SPECT images 
were converted to 256×256 scaffold and fused with micro-CT studies, allowing 
simultaneous scintigraphic and anatomic information in all tomographic scans 
in three different axes.  After in vivo imaging, animals were sacrificed with an 
overdose of pentobarbital (150 mg/kg).  Hearts were carefully explanted and 
planar images of the ex-vivo heart were acquired for 15 min in 128×128 matrix 
using a low-energy, high-resolution, pinhole collimator.  Thereafter, hearts were 
cut into 3 bread-loaf slices (infarct, peri-infarct, and remote regions), using a 
mouse heart matrix (Zivic laboratories, Inc). The quantitative radiotracer uptake 
was determined by a gamma scintillation counter (1480 Wizard 3”; Wallac Co., 
USA).  Biodistribution studies for the lung, liver, spleen, and kidney uptake were 
also undertaken. 
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Histopathological Characterization of Myocardial Specimens 
After the nuclear imaging studies, the apical (predominantly containing infarct 
tissue), mid myocardium (peri-infarct) and basal (predominantly containing 
non-infarcted remote tissue) myocardial slices were washed in PBS, fixed over 
night with 4% paraformaldehyde in PBS (pH 7.4 at 4°C) and stored in PBS with 
0.02% sodium azide at 4°C until used. The specimens were further processed 
by dehydration in a graded series of ethanol for paraffin-embedding. The blocks 
were cut in 5 µm sections, transferred to vectabond reagent treated slides (Vec-
tor SP-1800), dried overnight and stored until ready for use.
Masson’s trichrome staining was used to determine infarct size. After deparaf-
finization and rehydration, sections were placed in working Weigert’s iron he-
matoxylin for 10 minutes and tepid water rinsed for 10 minutes. Tissue sections 
were then incubated in Biebrich Scarlet-Acid Fuchsin Solution for 5 minutes, dif-
ferentiated in Phosphotungstic-Phosphomolybdic Acid for 5 minutes and stained 
in Aniline Blue for 8 minutes. After rinsing with 1% Gallic Acedic Acid (GAA), 
sections were dehydrated and mounted in permanent mount medium.
Sirius Red staining eliminates cytoplasmic staining, revealing thin septa and 
collagen fibers clearly and enabling quantitative morphometric measurements. 
Sections were treated in 0.2% aqueous phosphomolybdic acid for 5 min and 
subsequently incubated for 60 min with 0.1% Sirius Red F3BA (C.I. 35780, 
Polysciences, Northhampton, UK) in saturated picric acid and washed for 2 min 
with 0.01 N HCL.  Sections were rinsed in 70% ethanol for 30 seconds, then de-
hydrated, mounted with cover-slip and the amount of collagen was quantified,23 
The quality of collagen fibers was further investigated by Sirius red polarization 
microscopy, allowing semi-quantification of the mature, thick, tightly packed 
orange/red fibers and the newly formed, thin, loosely assembled yellow/green 
fibers.134-137
Alpha smooth muscle actin (ASMA) was used to determine myofibroblasts in the 
infarct area. After deparaffinization, rehydration and blocking of endogenous 
peroxidase, sections were incubated for 2 hours at room temperature using 
anti-alpha smooth muscle actin (ASMA monoclonal antibody, Sigma, dilution 
1:2000). After washing in PBS, sections were incubated with secondary anti-
body (rabbit anti mouse HRP, DAKO, 1:500) for 1 hour at room temperature. 
Sections were briefly counterstained with haematoxylin. 
Fluorescence microscopy
For localization of the target sites for CRIP, non-radiolabeled probe was injected 
intravenously in animals with 2 week old MI. After 3.5 hours, mice were sacri-
ficed and hearts were excised. Frozen section of 5 μm were cut and rehydrated 
in PBS. Sections were incubated for 2 hours at room temperature using anti-
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ASMA antibody (Sigma, 1:2000). After washing in PBS, sections were incubated 
with secondary antibody for 1 hour at room temperature (donkey anti-mouse 
IgG FITC, Jackson ImmunoResearch Europe, Newmarket, Suffolk, UK). Sections 
were examined using a Nikon Eclipse E-800 microscope.
In vitro studies for CRIP binding
Modified ELISA assays were developed for defining the interaction of CRIP and 
collagen I and III (Sigma Aldrich).  In addition, a procollagen-I peptide was cus-
tom constructed containing a DDX sequence (H2N-GPP-GKN-GDD-GEA-GKP-
GR-COOH). This sequence is common for mouse and human procollagen-I. The 
analysis was conducted using a Biacore 3000 system (Biacore, GE Healthcare, 
Uppsala, Sweden), that enabled the detection of noncovalent interactions be-
tween CRIP and procollagen I peptide in real time applying the physical principle 
of surface plasmon resonance. The analysis involved immobilization of synthetic 
peptide sequence on sensor chips CM5, followed by assessment of soluble CRIP 
or scrambled CRIP  to the immobilized ligand. The change in refractive index 
at the chip surface layer as the soluble components associated with the ligand 
and subsequently dissociated, was expressed as resonance units (RU). To com-
pensate for nonspecific background binding, an unmodified control surface was 
used. The change in resonance units at this surface was subtracted from the 
change in resonance units at the ligand surface.
Immuno electron microscopy
Immuno electron microscopy was performed according to previously described 
methods.138 In short: hearts were perfused with 0.2% glutaraldehyde in 2% 
paraformaldehyde and 0.1M phosphate buffer (PB), pH 7.4. Hearts were excised 
and stored for 60 min in the above mentioned solution before storage in 1% 
paraformaldehyde and 0.1 M PB, pH 7.4 at 4 °C for at least 24 hours. Tissue 
samples were stored in 2.3 M sucrose in 0.1 M PB, sections were cut and placed 
on a grid in methyl cellulose/2.3 M sucrose solution (1:1). Anti-cyanine antibody 
was used (Acris antibodies, Hiddenhausen, Germany) to untrastructurally trace 
CRIP localization. After protein A gold labeling, sections were examined using a 
Philips CM100 microscope (Eindhoven, The Netherlands). 
Statistical Analysis
All data are represented as mean±sem. To determine the statistical significance 
of differences in quantitative scintigraphic data, echocardiographic parameters, 
and histopathologic observations, 1-way ANOVA was performed followed by 
post-hoc Bonferonni test for multiple comparisons. Correlations were deter-
mined using linear regression analysis. Due to the small number of mice in 
each group, the assumptions of the 1-way ANOVA and linear regression models 
should be regarded as exploratory rather than definitive. P values < 0.05 were 
considered as statistically significant. 
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RESULTS
CRIP: Target Affinity and Localization Characteristics
The probe localization characteristics were determined by fluorescence micros-
copy of myocardial tissue sections of hearts explanted 2 weeks after MI from 
animals injected with (non radiolabeled) CRIP (Figure 6.2). The uptake was 
predominantly observed in the myocardial infarct zone. Colocalization of ASMA 
in the same cells as CRIP positive cells by fluorescence microscopy suggested 
probe specificity for myofibroblasts. Similarly, immuno electron microscopic ex-
amination was performed wherein intravenously administered CRIP in 2-week 
old infarcts was localized by immunogold labeled anti-Cy antibody. The uptake 
was confirmed in the myofibroblasts, which were ultra structurally identified by 
the presence of large amounts of rough endoplasmic reticulum. A small amount 
of internalized CRIP was seen within the myofibroblasts. No uptake of the probe 
was observed in the collagen fibers. In vitro binding assays revealed CRIP up-
take by activated avb3/5 with an affinity of 1-3nM, but not by typical collagen 
receptors such as a1b1 or a5b1 or platelet receptor aIIb3. Also, CRIP did not 
bind to mature collagen type I or III fibers. However, a specific noncovalent 
interaction of CRIP was observed with custom-made DDX-sequence containing 
pro-collagen I peptide. (Figure 6.2) 
Table 6.2   Echocardiographic parameters of LV remodeling and function
Radionuclide Imaging with Tc-CRIP
The infarct size in all untreated animals was similar (Table 6.2). The left ven-
tricular cavity dimensions (both end systolic and end-diastolic) were greater 
at 2, 4 and 12 weeks post-MI, and the % fractional shortening and ejection 
fraction decreased post-MI compared to normal control animals. In vivo micro-
SPECT imaging demonstrated Tc-CRIP uptake in the infarct area (Figure 6.3). 
The use of micro-CT identified precise localization of the radioactivity in the 
cardiac region and allowed differentiation of the uptake in apical myocardium 
from the radiotracer sequestration in the liver.  The ex vivo planar images of the 
explanted heart specimens confirmed the results of in vivo imaging and demon-
    
      ° °
       
       
       
       
       
       
       
               
        
               

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Figure 6.2   Characterization of target binding of CRIP
Probe targeting was evaluated 3.5 H after intravenous administration of CRIP in 2-week post-MI ani-
mals. The localization of the Cy5.5 fluorescence (red) was clearly observed in the infarct and peri-in-
farct zone in vivo (A, arrowheads). A 30-micron whole mouse slice demonstrates myocardial uptake of 
the probe (B, square); intense uptake is seen in the kidney which serves as the route of excretion. (C), 
Magnification of the area enclosed by the square in (B) demonstrates fluorescent probe localization in 
the subendocardium. (D-E) For further characterization of the probe targets, we correlated the uptake 
of intravenously administered CRIP in 2 week post-MI animals (red, D) with concurrent staining of the 
sections by anti-ASMA antibody (green, E), colocalization is shown by overlay (F) The localization of 
CRIP was observed in spindle shaped myofibroblasts in the infarct area. CRIP and ASMA colocalization 
is seen in transversely sectioned myofibroblasts in (G). For immuno EM, similarly intravenously admin-
istered CRIP was traced by gold labeled anti-cy antibody (black immunogold partikels 10 nm). CRIP 
clearly localized with myofibroblasts (H), containing characteristic abundance of rough endoplasmatic 
reticulum (I). No uptake was seen in mature collagen fibers (J). (K) shows sensograms (Biacore 3000 
instrument) obtained with CRIP and scrambled CRIP exposure to a surface with a immobilized peptide 
sequence H2N-GPP-GKN-GDD-GEA-GKP-GR-COOH, aa221-240 from procollagen-I. In addition, RGD 
imaging peptide without Cy5.5 dye was also used in the experiment (RIP). The higher RU values for 
CRIP than RIP is due to the higher molecular weight of CRIP. For full color illustration, see page 166.
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In vivo microCT, microSPECT and fusion images in frontal projection in 
unmanipulated control and 4-week post-MI animals 3H after radiolabeled 
CRIP administration
No uptake of Tc-CRIP was observed in the unmanipulated animal (top row). On the other hand, intense 
anterior uptake is seen in the infarcted mouse (bottom row). The cardiac localization is confirmed in 
the CT fusion image. For full color illustration, see page 167. 
strated maximum uptake in infarct and border zone. Minimal increase in uptake 
was seen in the remote area (Figure 6.4). In contrast to CRIP, scrambled CRIP 
did not show uptake in the infarcted myocardium, showing that CRIP uptake is 
RGD-dependent and specific. Similarly, no Tc-CRIP uptake was seen in the un-
manipulated hearts. 
The uptake in the infarcted region was maximum in the 2-week old MI. There 
was statistically significant reduction in uptake in 4 and 12-week old infarcts 
(Figure 6.4). The quantitative Tc-CRIP uptake in the myocardial tissue speci-
mens was calculated and represented as percent injected dose per gram 
(%ID/g) of tissue. It can be presumed that the quantitative uptake represents 
the extent of the process of myocardial fibrosis. As observed in the in vivo and 
ex vivo images, the maximum radiotracer uptake was observed in the infarcted 
myocardium (%ID/g: 2.75±0.19%) at 2 weeks which was 5-fold higher than 
the control myocardial specimens (0.59±0.09%; p<0.0001) (Figure 6.4B). This 
uptake was significantly higher compared to 4 (2.26±0.04%; p<0.0038) and 
12 (1.74±0.11%; p<0.0001) weeks after MI. The CRIP uptake in the remote 
myocardium was higher than in the control myocardial specimens and increased 
significantly by 12 weeks (1.04±0.06%), as compared to control myocardial 
specimens (0.68±0.07%; p=0.001). The uptake in the infarct area had no cor-
relation with MI size determined either by akinetic echo segments or Masson 
Figure 6.3
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Ex vivo images of the explanted hearts in control and post-MI 
animals with radiolabeled CRIP and scrambled CRIP
A. Ex Vivo Images. Control heart with RGD probe and 4-week post-MI heart with scrambled sequence 
show no radiotracer uptake. On the other hand, intense CRIP uptake is seen in 2-week post-MI animal. 
The uptake in the infarcted area was highest in mice 2 weeks after MI, followed by 4, and 12 weeks 
after MI. B. Quantitative Tc-CRIP uptake in the infarct (apex), peri-infarct (mid), and remote (base) 
areas.  The %ID/g uptake in the infarct area is highest in mice 2 weeks after MI, followed by 4, and 
12 weeks after MI.  On the other hand, the uptake in peri-infarcted and remote areas shows trends 
towards higher uptake from 2 to 12 weeks after MI.  No uptake of scrambled peptide was seen in the 
infarct zone. Quantitative data confirmed the findings of ex vivo images. For full color illustration, 
see page 168. 
Figure 6.4
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trichrome staining (r=-0.17, -0.12 respectively; p=ns). The nontarget organ 
distribution of Tc-CRIP demonstrated kidney to be the major organ of radiation 
burden (and excretion), (see Table 6.3). The tracer clearance was fast and only 
8% of the tracer could be recovered in the circulation at 2 hours as compared to 
5 minutes after administration; CRIP T½ was calculated as 28 minutes. 
Two additional groups of 4 animals each were treated with either captopril alone 
or in combination with losartan. Upon ultrasound examination, the neurohu-
moral antagonists prevented ventricular dilation and preserved ventricular func-
tion (Table 6.2). The CRIP uptake at 4 weeks after MI, was significantly reduced 
after captopril (1.78±0.16%, p=0.0004) or captopril+losartan (1.13±0.14%, 
p=0.0001) treatment compared to untreated animals (Figure 6.5).  
Table 6.3  Tracer Uptake (%ID/g) in organs and blood
Histopathological Assessment 
The histological sections demonstrated large infarcts involving the anterior LV 
wall (Figure 6.6); infarct size was similar in all animals. Over the 3 months 
following infarction, LV wall demonstrated significant thinning and the extent 
of inflammation gradually subsided. Myofibroblasts, expressing alpha smooth 
muscle actin, were present at 2 weeks post MI in the infarct area and decreased 
over time. The replacement and interstitial collagen was analyzed by picrosirius 
red polarization microscopy of myocardial specimens (Figure 6.7) obtained from 
infarct and remote regions. Although the total collagen content in the infarct re-
gion remained similar over time, the thin, newly formed (yellow-green) collagen 
fibers reduced and correlated with the radiotracer uptake (r2=0.34; p=0.05) 
(Figure 6.7A,C,E). In the remote region, the overall collagen deposition was 
markedly lower as compared to the infarct region (Figure 6.7A-B). However, 
both collagen content and (yellow-green) thin collagen fibers increased sub-
stantially in the remote region over time (Figure 6.7D). There was a direct cor-
relation between tracer uptake and the thin collagen fiber deposition (r2=0.45; 
p=0.001) (Figure 6.7F). The direct correlation of CRIP uptake with ASMA-posi-
tive myofibroblasts and thin collagen fibers suggests that collagen production is 
decreased in the infarct zone over time. 
     
     
     
     
     
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Radiolabeled CRIP uptake after anti-angiotensin therapy in post- 
MI animals
A. Ex Vivo Images 4 weeks post-MI. In 4-week post-MI animals, captopril treatment alone and in 
combination with losartan demonstrates significantly lower radiotracer uptake as observed in gamma 
images of the ex vivo explanted hearts. B. Quantitative Tc-CRIP uptake was significantly lower after 
therapeutic intervention in infarcted and nonsignificantly lower in non-infarcted areas. For full color 
illustration, see page 169.
Figure 6.5
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DISCUSSION
The present study demonstrates the feasibility of noninvasive assessment of 
interstitial alterations in post-infarction ventricular myocardium by technetium-
99m labeled CRIP. The lack of binding of scrambled CRIP (which carries a de-
ranged RGD-motif) confirms that the CRIP binding is RGD-dependent and spe-
cific. Fluorescence and immunoelectron microscopy confirmed the binding of 
CRIP to the myofibroblasts. The CRIP uptake paralleled newly formed, thin, 
yellow-green collagen fiber production, suggesting that the CRIP uptake should 
indirectly represent the rate of collagen deposition. CRIP did not bind to the 
mature collagen fibers. 
The uptake of CRIP in the infarct area was significantly higher at 2 weeks com-
pared to 4 or 12 weeks after MI; the uptake almost completely resolved by 52 
weeks in the infarct area (data not shown). The time-response curve of CRIP 
uptake in post MI hearts may parallel the expression dynamics of avb3, as ob-
served in hepatic stellate cells.139 Myofibroblasts evolve and are activated by 
inflammatory cytokines elicited in the area following the insult. Collagen and 
other matrix molecules are produced and integrins are upregulated to attach the 
cells to the matrix for survival and proliferation. The expression of b3 integrins 
is associated with angiogenesis in the peri-infarct zone and peaks around 7 days 
after MI as part of the remodeling process. Subsequently as inflammation re-
solves, collagen fibrils are cross linked by tranglutaminase activity and no more 
ligands are available for avb3 binding and the cells disappear through apoptosis 
or anoxis.139 Therefore, after 12 month there are large amounts of collagen but 
no more integrins for CRIP to bind to; in other words, there is fibrosis but little 
fibrogenesis or myofibroblasts in mouse infarcts. However, since myofibroblasts 
have been reported up to 20 years after MI in well-healed human infarcts,13 the 
binding characteristics of CRIP may be more favorable in humans than rodent 
hearts. 
Unlike the infarcted zone, the CRIP uptake in the remote myocardium was high-
er at 12 weeks. It is well established that alterations in interstitial collagen 
can significantly influence the size and shape of the cardiac chamber as well 
as ventricular function and hence ventricular remodeling.140 Excessive collagen 
deposition or pathological fibrosis contributes to LV dysfunction and poor prog-
nosis in MI patients by inducing myocardial stiffness, promoting development of 
arrhythmias and adversely affecting systolic function.141  
The myocardium contains an endogenous RAS system, and activation of renin-
angiotensin-aldosterone axis results in cardiac fibroblast proliferation and fibro-
sis.59, 142 This response is transduced by AT1 receptors which are far more abun-
dant on cardiac fibroblasts than on myocytes.143 Angiotensin II acts through the 
upregulation of additional fibrogenic growth factors, which mediate or augment 
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Figure 6.6  Histological assessment of control heart and 4 weeks post MI
Masson’s trichrome (A,D) and Picro Sirius Red (B,E) staining, and Sirius Red staining with polarized 
light (C, F-H)  in remote (A-C) and infarct center or border regions (D-H) in a heart 4 weeks after MI. 
The remote area is from the base of the heart as indicated by the enclosed mitral valve. The remote 
region shows minimal fibrosis (A) and collagen deposition (B,C). On the other hand, the infarct region 
shows significant wall thinning and fibrosis (D) with evidence of collagen deposition (E,F). The two ar-
eas from (F) are magnified to demonstrate collagen deposition in infarct center (G) and infarct border 
(H). Immunohistochemical characterization with anti-ASMA antibody (brown) of the infarct zone at 2 
(I), 4 (J) and 12 (K) weeks reveal progressive decrease in the number of myofibroblasts over time. For 
full color illustration, see page 170.
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the effects of angiotensin II, including TGFb1. Upregulation of angiotensin pro-
duction, AT1 receptors and increased collagen mRNA in myofibroblasts is as-
sociated with healing infarct scars,144 and anti-angiotensin therapy may inhibit 
myocardial remodeling. The uptake of the Tc-CRIP was markedly reduced by 
captopril alone and more so in combination with losartan.  Although angiotensin 
II levels decrease initially with ACE inhibitor therapy,145, 146 their levels may rise 
gradually over time due to alternative conversion pathways. Therefore, a com-
bination therapy of an ACE inhibitor with an angiotensin receptor blocker (ARB) 
acts synergistically and may benefit greater than either agent used alone.  The 
present study demonstrated relatively superior effect of combination therapy in 
reduction of fibrogenesis compared to captopril therapy alone.  Although OP-
TIMAAL and VALIANT studies did not substantiate the concept of combination 
therapy in post MI patients,147, 148 ValHeFT and CHARM studies have demon-
strated the superior efficacy of combination therapy in reduction of morbidity in 
heart failure patients with (CHARM Addition)85 or without (ValHeFT)63 improve-
ment in survival. Since both agents are known to favorably alter the prognosis 
in patients with heart failure and the present study demonstrates decrease in 
collagen deposition after captopril±losartan treatment, it is possible that the 
decrease in collagen deposition is a favorable phenomenon. Alternatively, we 
hypothesize that the impact of anti-angiotensin therapy on the infarct zone may 
be relatively lower as compared to the remote region, wherein all collagen for-
mation may get abrogated. As such, evaluation of the impact of therapy at 12 
weeks could have offered more information.
Since LV remodeling post-MI is the leading cause of heart failure and is a deter-
minant of morbidity and mortality,30, 149 it is important to predict the likelihood 
of occurrence of cardiac remodeling. It is possible to detect the occurrence of 
collagen formation post-MI by measuring procollagen I and III in serum. The 
measurements of these markers have been shown to provide independent infor-
mation pertaining to left ventricular function150, 151 and survival152, 153 in patients 
with heart failure. However, these markers are not specific and may not be of 
value in patients with other conditions associated with collagen formation such 
as arthritis.154 The potential value of radiolabeled CRIP is its ability to noninva-
sively localize at the site of interstitial alterations and collagen formation in the 
myocardium, and therefore may provide information about evolution of heart 
failure. Our pilot clinical study with a radiolabeled RGD peptide in patients at 3 
and 8 weeks after MI has shown the feasibility of interstitial imaging. In these 
patients, 1-year follow-up magnetic resonance imaging study confirmed the ex-
tent of fibrosis detected earlier by the radiolabeled RGD uptake.155 
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Figure 6.7  Collagen fiber analysis in remote and infarct regions
The total collagen content in the infarcted area (A) remains similar with the passage of time, where-
as it increases significantly in the remote region (B). Further characterization of the collagen fibers 
by polarization reveals that the thin or new collagen fibers (green) decreased in the infarct region 
(suggestive of cessation of collagen production and maturation of the collagen fibers) (C) and in-
creased substantially in the remote area (D) (suggesting ongoing production of the new collagen with 
increasing total collagen content). The prevalence of new collagen fibers paralleled the CRIP uptake 
and demonstrated a significant direct correlation, both in infarct and remote zone (E, F). For full color 
illustration, see page 171. 
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ABSTRACT 
Objectives: Employing molecular imaging techniques, we examined interstitial 
alterations during post-myocardial infarction (MI) remodeling and assessed the 
efficacy of anti-angiotensin and anti-mineralocorticoid intervention, alone and 
in combination. 
Background: The antagonists of the renin-angiotensin-aldosterone axis restrict 
myocardial fibrosis and cardiac remodeling after MI, and contribute to improved 
survival.  Radionuclide imaging with technetium-99m-labeled Cy5.5 RGD imag-
ing peptide (CRIP) targets myofibroblasts and indirectly allows monitoring of the 
extent of collagen deposition post-MI.
Methods: 99mTc-CRIP was intravenously administered for gamma imaging af-
ter 4 weeks of experimental MI in 63 Swiss-Webster mice and in 6 unmanipu-
lated (disease control) mice.  Of 63 animals, 50 were treated with captopril (C), 
losartan (L), spironolactone (S) alone, or in combination (CL, SC, SL, and SCL) 
for 4 weeks; 8 (treatment control) mice received no treatment. In all animals, 
echocardiography was performed for infarct size determination and develop-
ment of cardiac remodeling. Hearts were characterized histopathologically for 
the presence of myofibroblasts, and thick and thin collagen fiber deposition.  
Results: Acute MI size was similar in all groups. The quantitative CRIP percent 
injected dose per gram uptake was highest in the infarct area of untreated 
control mice (2.30±0.05%), and decreased significantly in animals treated with 
one agent (C,L or S; 1.71±0.08%; p=0.0002 ). Addition of two (CL, SC, or SL 
1.31±0.08%; p<0.0001 ) or three agents (SCL; 1.16±0.11%; p<0.0001) dem-
onstrated further reduction in tracer uptake. Decrease in echocardiographic LV 
function, strain and rotation parameters, as well as histologically-verified depo-
sition of thin collagen fibers was significantly reduced in treatment groups, and 
correlated with CRIP uptake. 
Conclusions: Radiolabeled CRIP allows evaluation of the efficacy of neurohumoral 
antagonists post-MI and reconfirms superiority of combination therapy. If prov-
en clinically, molecular imaging of the myocardial healing process may help plan 
an optimal treatment for patients susceptible to heart failure.
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INTRODUCTION 
Upregulation of the renin-angiotensin-aldosterone axis after myocardial infarc-
tion (MI) contributes to the process of cardiac remodeling and hence evolution of 
heart failure.156-159 Although this remodeling process is initiated by myocyte loss, 
interstitial and myocytic alterations continue to occur inexorably even after the 
initial injury has abated.3, 4, 160 Anti-angiotensin,62, 64, 161 and anti-aldosterone162 
treatments effectively control this process, and delays or prevents the develop-
ment of heart failure.65, 163-165 These therapeutic interventions reduce the extent 
of interstitial collagen deposition, which is considered to be the basis of their 
efficacy.156, 157 Combination of these agents has been shown to be more effective 
than the solitary agents.61, 63 
The efficacy of pharmacologic intervention in a clinical milieu is variable, and it is 
desirable to define optimal use of anti-remodeling agents for individual patients. 
While pharmacogenomics has been proposed as an important determinant of 
such a strategy,166, 167 the role of phenotypic characterization by novel imaging 
methods is also being explored.159 It has recently been reported that the extent 
of new collagen deposition can be assessed by molecular imaging employing 
technetium-99m-labeled Cy5.5-RGD-imaging peptide (CRIP).71 Through RGD-
based targeting, CRIP binds to the myofibroblasts in the healing infarct and cor-
relates with the extent of new collagen deposition after experimental MI.71 In our 
preliminary experiment we proposed that such imaging strategy may have a role 
in identifying the impact of a therapeutic intervention on collagen deposition and 
hence the efficacy of the therapy. In the present study, we evaluated the effect 
of an angiotensin converting enzyme inhibitor (ACE-I), an angiotensin receptor 
blocker (ARB), and a selective aldosterone receptor antagonist (SARA), individu-
ally and in combination, on infarct healing, employing CRIP imaging.  
METHODS
The present study was performed in 69 Swiss-Webster mice. Of these, myocar-
dial infarction was produced in 63 mice by occlusion of the left coronary artery 
(LCA). Echocardiograms were obtained before and after coronary occlusion to 
demonstrate the basal LV dimensions and function, and the infarct size. Of the 
63 infarcted mice, 20 mice received a single agent intervention (1Rx); 8, 6 and 
6 animals were started on spironolactone (S), captopril (C), losartan (L), respec-
tively. 22 of 63 animals received dual therapy (2Rx); 6, 8, and 8 were started 
on a combination of captopril + losartan (CL), spironolactone + captopril (SC) or 
spironolactone + losartan (SL), respectively. 8 of 63 post-MI animals received a 
combination of three neurohumoral antagonists (3Rx, spironolactone + captopril 
+ losartan (SCL) (Table 7.1). Eight post-MI animals did not receive any pharma-
cologic agent and served as treatment controls (No Rx) and 5 post-MI animals 
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received a scrambled version of the imaging peptide (sCRIP) to serve as tracer 
controls. In addition, 6 unmanipulated animals were included in the imaging 
protocol as disease control animals.  After 4 weeks, all animals again underwent 
echocardiographic examination for the characterization of the remodeling pro-
cess and received Tc-99m labeled CRIP intravenously. 3.5 hours after CRIP ad-
ministration, hearts were explanted and ex vivo imaging was performed using a 
microSPECT camera. The hearts were then sectioned into three cross-sectional 
bread loaf slices to represent apical (predominantly infarct), middle and the 
basal (predominantly remote) areas. All samples were gamma-counted for 
quantitative CRIP (and sCRIP) uptake. Subsequently, all myocardial specimens 
were processed for histopathological characterization, particularly the extent of 
myofibroblastic proliferation, and thick and thin collagen fiber deposition.
Experimental Myocardial Infarction in Mice 
This Experimental protocol was approved by the Institutional Animal Care and 
Use Committee of the University of California Irvine School of Medicine.  In 
63 adult Swiss Webster male mice (age, 3 months; body weight, ~50 g), the 
lateral branch of the LCA was ligated under Pentobarbital (75 mg/kg i.p.) and 
gas anesthesia (2.0–3.0% isoflurane) to induce MI.  Briefly, animals were first 
placed on a heating pad, in the supine position. Endotrachial intubation was per-
formed under direct laryngoscopy and mechanical ventilation maintained with 
a small animal respirator (Harvard Apparatus; tidal volume = 250 µl, rate = 
210 breaths/min). After thoracotomy, the lateral branch of the LCA was ligated 
at the root with a 6.0-prolene suture. Successful ligation was verified by visual 
inspection of myocardial blanching and akinesis or dyskinesis of the apical seg-
ment.  The chest cavity was closed in layers with 6.0-silk, and the skin closed 
with 4.0-silk sutures.  Animals were gradually weaned from the respirator. Six 
of the 69 mice were left unmanipulated as disease control mice for comparison 
with the post-MI mice.  
Various treatment groups, dosage schedules and quantitative 
99mTc-CRIP uptake
Table 7.1
        
        
        
        
        
        
        
        
        
        
        



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Treatment Protocols after Myocardial Infarction in Mice 
Spironolactone (Innovative Research of America, Sarasota, FL) was adminis-
tered via a subcutaneous pellet, releasing 1 mg/day, placed under the skin on 
the back, immediately after MI surgery.  Captopril (Sigma, St Louis, MO) and 
Losartan (kind gift of Merck, Rahway, NJ) were administered in the drinking wa-
ter in a concentration of 60 mg/kg/day and 20 mg/kg/day, respectively. When 
combination of anti-angiotensin therapy was given, the dosages were halved. 
The animals received the intervention for 4 weeks starting on the post-MI day 0 
(Table 7.1).
Echocardiography 
Echocardiographic studies were performed in all mice for the evaluation of left 
ventricular dimensions and function. All animals underwent three echocardio-
graphic studies; performed at baseline level, immediately after MI, and the last 
study was performed at 4 weeks post-MI, just before CRIP imaging. Mice were 
anesthetized with 2% isoflurane, and echocardiograms were made (Sequoia, 
Siemens, Mountviews, CA) using a 14-MHz linear probe (15L8, Acuson). An 
advanced high frame rate imaging technique (Paragon®, Siemens, Mountviews, 
CA) was adopted to increase temporal resolution at a frame rate of 120 fps. 
B-mode images of LV parasternal long-axis, parasternal short-axis, and apical 
views were digitally acquired at 2-3 cardiac cycle lengths. Images of LV short-
axis were standardized at three levels, base, mid and apex. M-mode imaging 
was unified according to the American Society of Echocardiography guidelines 
for measurements of wall thickness, chamber dimensions, and functional pa-
rameters.133 Infarction area (Ainf) and LV area (ALV) were measured by tracing 
relative endocardial borders respectively on the long-axis images. Myocardial in-
farction percentage (MI%) was calculated as Ainf/ALVx100. LV cavity dimensions, 
ejection fraction (EF), strain and rotation were calculated. 
 
Radionuclide Imaging with 99mTc-CRIP 
CRIP (AH110863, kind gift of GE Healthcare/Amersham Health AS, Oslo, Nor-
way) is a 2.5 kD peptide conjugated to both a fluorescent cyanine dye Cy5.5, 
and the chelating agent cPN216; which is linked for radiolabeling of the pep-
tide with technetium-99m. The peptide comprises 10 amino acids, contains an 
RGD-motif, and has a bi-cyclic structure formed by a disulfide and a thioether 
bridge. The dye moiety and the chelating agent are conjugated to the peptide 
by the side-chains of lysine residues at the N- and C-terminal ends, respectively. 
CRIP, by RGD-based targeting, binds to myofibroblasts,71 and is labeled with 
Technetium-99m for radionuclide imaging. For radiolabeling, 50 μg of CRIP was 
dissolved in 50 μL of MeOH and then added to freeze dried kit. 1.0 ml of 99mTcO4
- 
was added to the compound and left at room temperature for 20-30 min. Instant 
thin-layer chromatography confirmed radiopurity of more than 90%. 3.7±0.02 
mCi (137±0.7 MBq) of 99mTc-CRIP was injected intravenously through the tail 
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vein. At 3.5 hours after CRIP administration, mice were sacrificed with an over-
dose of pentobarbital (150 mg/kg i.p.). Hearts were carefully dissected and 
planar images of ex vivo hearts were acquired for 15 min in 128 × 128 matrix 
using a low-energy, high-resolution pinhole collimator, mounted in a dual-head 
micro single-photon emission computed tomography (SPECT) gamma camera 
(X-SPECT, Gamma Medica, Inc., Northridge, CA). Thereafter, hearts were cut 
into apical, middle and basal slices. The quantitative 99mTc-CRIP uptake was 
determined with a gamma scintillation counter (1480 Wizard 3”; Wallac Co.). 
CRIP biodistribution and radiation burden to lung, liver, spleen, and kidney was 
also determined.
Histological Evaluation of Myocardial Specimens
After completion of the nuclear studies the three broad-loaf slices were washed 
in PBS, fixed in 4% paraformaldehyde in PBS over 24 hours, processed and 
embedded in paraffin and 4 µm sections were prepared. After deparaffinization 
and rehydration, sections were stained with haematoxylin & eosin, Masson’s 
trichrome and picro-sirius red. After deparaffinization and rehydration, sections 
were placed in working Weigert’s iron hematoxylin for 10 minutes and tepid 
water rinsed for 10 minutes for Masson’s trichrome staining. Tissue sections 
were then incubated in Biebrich Scarlet-Acid Fuchsin Solution for 5 minutes, dif-
ferentiated in Phosphotungstic-Phosphomolybdic Acid for 5 minutes and stained 
in Aniline Blue for 8 minutes. After rinsing with 1% Gallic Acedic Acid (GAA), 
sections were dehydrated and mounted in permanent mount medium.
For picro-sirius red, sections were incubated for 5 min with 0.2% aqueous phos-
phomolybdic acid and subsequently incubated for 90 min with 0.1% sirius red 
F3BA (C.I. 35780, Polysciences, Northhampton, UK) in saturated aqueous picric 
acid and washed for 2 min with 0.01 M HCl. Sections were then dehydrated 
and mounted with cover-slip. The relative collagen areas in the infarcted, and 
remote areas, were determined under a microscope (×200) coupled to a com-
puterized morphometry system (Quantimet, Leica, Cambridge, UK). The quality 
of collagen fibers was further investigated by Sirius red polarization microscopy, 
allowing quantification of the thick, tightly packed, more mature orange/red 
fibers and the newly formed, thin, loosely assembled yellow/green fibers.134, 135 
Approximately 4-5 fields per section were analyzed in the myocardium.
Alpha smooth muscle actin (ASMA) was used to determine myofibroblasts in the 
infarct area. After deparaffinization, rehydration and blocking of endogenous 
peroxidase, sections were incubated for 2 hours at room temperature using 
anti-alpha smooth muscle actin (ASMA monoclonal antibody, Sigma, dilution 
1:2000). After washing in PBS, sections were incubated with secondary anti-
body (rabbit anti mouse HRP, DAKO, 1:500) for 1 hour at room temperature. 
Sections were briefly counterstained with haematoxylin. ASMA area was quan-
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tified by Quantimet analysis in 4-5 fields per section. ASMA uptake was only 
counted for myofibroblasts and care was taken not to include ASMA uptake 
observed in vasculature. 
Statistical Analysis 
Data are presented as mean±sem. Quantitative radiotracer uptake was calcu-
lated as percent total injected dose per gram (%ID/g) of tissue. Radiotracer up-
take and echocardiographic measurements were expressed as mean ± standard 
deviation. Based on our previous study,71 CRIP uptake was reduced by >25% 
in the captopril group compared to the untreated group, and in combination 
treatment (losartan plus captopril) compared to single therapy (captopril alone) 
group; as such we propose that having at least 6 mice per group is sufficient to 
detect, with at least 90% power and alpha=0.01, reductions in the uptake of 
CRIP of at least 25% in treated compared to untreated animals, or 2 vs. 1 agent 
groups. This confirms that our current study is well-powered.  To determine 
the statistical significance of differences among 1 Rx, 2 Rx and 3 Rx treatment 
groups, one-way ANOVA followed by post-hoc Bonferroni’s test for multiple 
comparisons was used. The correlation between the quantitative tracer uptake 
and echocardiographic parameters or histological characteristics was evaluated 
by linear regression analysis. P values < 0.05 were considered as statistically 
significant. 
RESULTS
99mTc-CRIP Uptake and Pharmacologic Intervention 
Maximum CRIP uptake was observed in the infarct zone of the untreated post-MI 
mice. CRIP uptake was substantially reduced in the treated animals (Table 7.1; 
Figure 7.1A); no CRIP uptake was seen in the unmanipulated hearts. Scrambled 
CRIP, which has a deranged RGD sequence, did not show uptake in the infarcted 
myocardium, and demonstrated that CRIP uptake is RGD-dependent and spe-
cific. 
The quantitative CRIP uptake in the myocardial tissue specimens was calculated 
and represented as percent injected CRIP dose per gram (%ID/g) of myocardial 
tissue. CRIP uptake in the infarcted area was observed to be the highest in the 
untreated MI group (No Rx; 2.30±0.05%). There was a significant reduction in 
CRIP uptake in the infarct area in all treated animals (1.46±0.06%) compared 
to the untreated animals (p<0.0001). The reduction of uptake was significant 
even when the animals were treated with a single neurohumoral antagonist 
(1Rx, 1.71±0.08%, p=0.0002) (Figure 7.1B). Each agent was independently 
effective; spironolactone (1.80±0.15%; p=0.0011), captopril (1.72±0.13%; 
p=0.0059) and losartan (1.58±0.11%; p<0.0001) (Table 7.1). 
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Radiolabeled CRIP uptake after neurohumoral antagonist treatment 
in post-MI animals
 A. Disease control (unmanipulated) heart with RGD probe shows no radiotracer uptake in ex vivo im-
age of the heart. On the other hand, intense CRIP uptake is seen in 4-week untreated (no Rx) post-MI 
animals (upper panel, right). The uptake in the infarcted area is reduced after neurohumoral treat-
ment with solitary agents and combination therapy (middle and lower panels). Losartan (L) images are 
displayed twice (middle panel) for the convenience of comparison.  C= captopril, S= spironolactone. 
B. Quantitative Tc-CRIP uptake in the infarct (apex, above) and remote (base, below) areas. The 
%ID/g uptake in the infarct area is highest in untreated mice, followed by treatment with one (1Rx), 
two (2Rx) and three (3Rx) agents, respectively. On the other hand, the uptake in the remote area 
shows no significant differences between treated and untreated animals. Quantitative data confirmed 
the findings of ex vivo images. For full color illustration, see page 172.
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Figure 7.1
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Use of two neurohumoral antagonists (2Rx, 1.31±0.09%) influenced the up-
take to a greater extent than a single agent (1Rx, 1.71±0.08%) treatment 
(p=0.0005) (Figure 7.1B). Uptake with various combinations was as follows; CL 
(1.37±0.22%; p<0.0001), SC (1.28±0.15%; p<0.0001), and SL (1.29±0.11%; 
p<0.0001) (Table 7.1). Combination of all 3 agents further reduced the CRIP 
uptake (3Rx, 1.16±0.11%) in the infarct area (Figure 7.1B). The decrease in 
CRIP uptake in triple treated animals was significantly lower than one agent 
treatment (p=0.0001), but was statistically insignificantly reduced compared to 
two-agent therapy (p=0.33) (Figure 7.1). 
CRIP uptake in the remote myocardium was increased, although statistically 
insignificantly, in the untreated post-MI animals (0.92±0.08) as compared to 
the unmanipulated control animals with no infarcts (0.68±0.07, p=0.07) (Figure 
7.1B). The tracer uptake was minimally reduced in the treated groups. It seems 
that we would need a longer study to observe a statistically significant resolution 
of tracer uptake in response to therapeutic intervention (Table 7.1). We believe 
so because our previous study demonstrated that an increase in CRIP uptake in 
the remote area occurred only at 12 weeks after MI.71 
Echocardiographic examination and remodeling characteristics
As shown in Table 7.2, initial MI size was similar in all animal groups. Over 
the 4-week follow-up period, there was a reduction in LV ejection fraction in 
untreated post-MI (30±3%) animals compared to unmanipulated disease 
control animals (64±2%, p<0.0001). Neurohumoral antagonists significantly 
prevented the functional loss (EF 44±1%), compared to untreated animals 
p=0.0016). Similar to LV ejection fraction, there was a significant decrease in 
the myocardial strain development in untreated animals (-4.59±0.7 unit %) 
compared to unmanipulated (-12.00±0.9unit %) animals (p<0.0001); loss of 
myocardial strain was significantly prevented by treatment with neurohumoral 
agents (-8.04±0.3 unit %, p=0.0005). The strain development in 1Rx 
(-7.17±0.5 unit %, p=0.0126), 2Rx (-8.28±0.5unit %, p=0.0011) and 3Rx 
(-9.33±0.56 unit %, p<0.0001) groups was better preserved compared to the 
untreated control group. However, the preservation of strain development did 
not reach statistical significance on comparison of 1Rx vs. 2Rx (p=0.1304), 
or 2Rx vs. 3Rx (p=0.2530) agents; 3Rx was statistically significantly better 
than the 1Rx intervention (p=0.0168).  The results of loss of apical rotation or 
counterclockwise twist of the LV were similar to the loss of strain development. 
The rotation in all (0.55±0.03°, p<0.0001), 1Rx (0.49±0.04°, p=0.0006), 2Rx 
(0.57±0.04°, p<0.0001) and 3Rx (0.63±0.06°, p<0.0001) groups was preserved 
compared to the untreated control group. However, once again, the prevention 
of rotational loss did not reach statistical significance on comparison of 1Rx 
vs. 2Rx (p=0.1684), or 2Rx vs. 3Rx (p=0.3601) agents; 3Rx was statistically 
significantly better than the 1Rx intervention (p=0.0481). The LV ejection 
Thesis vd Borne V2.indd   109 20-2-2009   15:01:13
 page 110 |
fraction, strain development and rotation correlated with %ID/g CRIP uptake 
(r2=0.309, 0.397 and 0.469, respectively; p<0.0001, <0.0001 and <0.0001) 
(Figure 7.2)
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Histopathological characterization of the treated and untreated 
animals
Masson’s trichrome staining was performed for infarct localization in control, untreated and treated ani-
mals (A).  In addition, histological staining was performed with picro sirius red to demonstrate collagen 
deposition, which on polarized light allowed identification of the quality of collagen, in the infarct (B,C) 
and remote regions (D,E). The left column presents control animals, middle column shows untreated 
animals (no Rx) and the right column shows animals treated with 3Rx neurohumoral antagonists (SCL). 
The remote region shows minimal fibrosis and collagen deposition (D). On the other hand, infarct 
region shows significant wall thinning (A) and fibrosis with evidence of substantial collagen deposi-
tion in untreated animals (B, NoRx). 3Rx treated animals show reduced fibrosis (A, SCL) and collagen 
deposition (B, SCL) in the infarcted area. The Sirius staining under polarized light provides distinction 
of thick red-orange and thin yellow-green collagen fibers in the infarct region (C). For full color images, 
see page 173.
Figure 7.3
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The extent of collagen deposition and myofibroblast count in 
various animal groups
Histologic characterization of infarct and remote myocardium and cor-
relation with CRIP uptake
Masson’s trichrome and picro sirius red staining (Figure 7.3) of the myocardial 
slices allowed the assessment of total collagen content, and the composition 
in thick and thin collagen fibers. The percent collagen content in the infarct-
ed area in untreated animals was 79±1%, which reduced substantially in the 
treated animals (66±1%, p<0.0001) (Figure 7.4A, Table 7.3). The collagen con-
tent decreased in animals treated with 1Rx (71±2%, p=0.006), 2Rx (64±1%, 
p<0.0001), or 3Rx  (65±2%, p=0.0008) agents (Figure 7.4A). The results were 
similar for the yellow-green collagen fiber deposition in the infarcted myocardium 
suggesting decrease in new or thin collagen fiber synthesis (Figure 7.4C). The 
new, thin collagen fibers correlated with CRIP uptake in the infarct (r2=0.5475, 
p<0.0001) (Figure 7.4E). In the remote region, the overall collagen deposition 
was markedly lower as compared to the infarct region. The collagen content of 
the untreated remote myocardium (NoRx, 2.1±0.2%) was significantly higher 
than the unmanipulated hearts (0.73±0.1%, p<0.0001)(Figure 7.4B). A marked 
decrease in collagen content and yellow-green collagen fiber deposition was ob-
served in the remote region after treatment (Figure 7.4D, Table 7.3); collagen 
content in treated animals was not different from unmanipulated animals. There 
was a direct correlation between tracer uptake and thin collagen fiber deposition 
in the remote region (r2=0.3473; p<0.0001) (Figure 7.4F). 
We performed ASMA staining for quantification of the myofibroblasts (Figure 
7.5A). The ASMA positive area was substantially larger in the untreated animals 
(NoRx, 6.11±2.6 µm2) compared to the unmanipulated animals (0.007±0.01 
µm2, p=0.013). Treatment with 1Rx  (4.91±0.8 µm2, p=0.51), 2Rx  (2.22±1.0 
µm2, p=0.037) or 3Rx  (1.54±0.5 µm2, p=0.039) interventions substantially 
restricted the myofibroblast prevalence (Figure 7.5B, Table 7.3). There was a 
directly proportional relationship between CRIP uptake and ASMA positive area 
(r2=0.5828, p<0.0001) (Figure 7.5C). 
Table 7.3
    


  

 

  
        
        
        
        
        
        
        
        
        
               

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Figure 7.4  Collagen fiber deposition in infarct and remote regions
The total collagen content decreases with treatment in the infarcted (A), as well as the remote (B) ar-
eas. Further characterization of the collagen fibers by polarization reveals that the thin or new yellow-
green collagen fibers decreased both in the infarct (C) and remote (D) regions after treatment. This 
indicates cessation of new collagen production and maturation of the collagen fibers after treatment. 
The prevalence of new collagen fibers paralleled the CRIP uptake and demonstrated a significant direct 
correlation, both in infarct (E) and remote (F) regions. For full color images, see page 174.
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The direct correlation between radiotracer uptake and ASMA-positive myofibro-
blasts as well as radiotracer uptake and thin collagen fibers suggests that treat-
ment with neurohumoral antagonists results in decreased new collagen produc-
tion in the infarct zone.
DISCUSSION
Molecular imaging in myocardial remodeling
The present study employs molecular imaging of myofibroblasts during infarct 
healing. The radiotracer, CRIP, contains an RGD sequence, and binds to myofi-
broblasts through activated avb3/5 integrins with an affinity of 1-3nM.71 RGD is 
also known to commonly target the integrin expression associated with neoan-
giogenesis early after MI and macrophage influx during infarct healing. We have 
observed that after 2 weeks of infarct healing, myofibroblasts comprise a pre-
dominant target for RGD probes.71 In addition, a specific noncovalent interaction 
of CRIP was also observed with custom-made DDX-sequence contained within 
pro-collagen I. The previous study using CRIP had demonstrated the feasibility 
of noninvasively imaging the extent of myofibroblasts prevalence in a post-MI 
mouse model.71 The CRIP uptake receded over time in the infarct region with 
substantial resolution over 3 months after the myocardial injury.  This previous 
report also demonstrated that the uptake was significantly reduced at 4 weeks 
upon treatment with captopril alone or in combination with losartan, and pro-
posed that CRIP uptake could monitor the efficacy of neurohumoral antagonists 
and help identify the optimum level of therapeutic intervention.71 A simultane-
ously conducted clinical study, using RGD-seeking peptide demonstrated the 
feasibility of molecular imaging early after MI.155 The radiotracer uptake after MI 
predicted the extent of eventual magnetic resonance imaging-verified fibrosis 
after one year. Based on these results, the present study investigated the ef-
fect of various anti-remodeling agents, alone or in combination, on the extent 
of myocardial interstitial alterations. The present study demonstrated the ef-
ficacy of neurohumoral antagonists to reduce collagen formation/deposition in 
a 4-week post-MI mouse model.  This study also reconfirmed that combination 
of two neurohumoral antagonists was superior to an individual agent used for 
intervention; three agents decreased the radiotracer uptake further albeit not 
significantly. The radiotracer uptake correlated closely with parameters of de-
pressed myocardial mechanics, the quantitative prevalence of myofibroblasts 
and thin fiber collagen deposition. The data obtained in the present study cor-
roborate with information provided by the estimation of collagen synthesis and 
fragmentation markers in the ser.150, 151, 153 Procollagen type III amino-terminal 
peptide (PNIIIP) is decreased in chronic heart failure patients using anti-angio-
tensin and anti-aldosterone treatment.152, 168 
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Radiolabeled CRIP uptake and the prevalence of ASMA-verified 
myofibroblasts 
Immuohistochemical staining with ASMA antibody allowed quantitative assessment of myofibroblasts 
infiltration in the infarct and remote regions (A). The left column presents control animals, the middle 
column shows untreated animals (no Rx) and the right column shows 3Rx-animals (SCL). There is a 
marked decrease in number of myofibroblasts in the infarct region in 2Rx and 3Rx groups (B). There 
is a significant direct correlation between the extent of myofibroblasts and the CRIP uptake in infarct 
region (C). For full color images, see page 175.
What is the optimum therapy?
The clinical role of ACE-inhibitors, ARB, and SARA has been conclusively demon-
strated in trials confirming the reduction in morbidity and mortality in patients 
with overt heart failure.62-64,85,161,162 These agents also decrease the likelihood 
of developing heart failure in patients with asymptomatic decrease in LV ejec-
Figure 7.5
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tion fraction,65, 164 as well as those predisposed to development of heart failure 
but normal LV ejection fraction.163,169 It is also established that anti-angiotensin 
agents in combination are superior to any agent used alone. The combination 
of ACE-I with ARB in the presence of beta blockers ± aldosterone inhibitors re-
duces the combined endpoint of mortality16 and hospitalization for worsening of 
heart failure.63 The experimental data from the present study confirm the supe-
rior effect of combination of two agents. However, addition of the third agent did 
not decrease the uptake significantly.  It is encouraging to observe the efficacy 
of an imaging agent to identify difference in infarct healing, which could be of 
translational clinical benefit.
 
Is lack of collagen deposition favorable?
The present study raises an important question about the relevance of decrease 
in collagen deposition in the post-infarct patients. Total abolition of collagen 
deposition, which has been evaluated in clodronate liposome treated animals 
(wherein infarct healing becomes defective with minimal collagen deposition 
and inefficient necrotic myocyte removal),170 leads to higher tendency of an-
eurysmal formation and infarct rupture. On the other hand, direct myocardial 
injection of collagen in experimental infarcts leads to dense collagen deposition 
and prevents myocardial remodeling.171 Such experiments suggest that the col-
lagen deposition may not necessarily be harmful. On the other hand, the use of 
ACE-I or SARA allow reduction of collagen deposition as demonstrated by circu-
lating collagen degradation products.168 The present study demonstrated a de-
crease in collagen deposition with suppression of angiotensin-aldosterone axis. 
Since neurohumoral antagonists lead to favorable clinical outcomes, conceivably 
reduced collagen deposition should be of benefit. Although the present study 
is not capable of explaining these paradoxical observations, it is possible that 
predominant decrease of collagen content observed in the remote myocardium 
in the present study, and the collagen fiber maturation (to thick fibers) observed 
in the infarct region may contribute to a more balanced healing.
Conclusions: The present study demonstrates that CRIP imaging allows for 
the evaluation of the efficacy of anti-remodeling therapy. It also reconfirms the 
superiority of combination therapy over a solitary use of neurohumoral antago-
nists. If proven clinically, molecular imaging of the remodeling processes could 
facilitate individualizing the treatment for patients susceptible to heart failure.
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GENERAL DISCUSSION AND CONCLUSIONS
Myocardial infarction is a frequent cardiovascular event in the Western world. 
Due to improved clinical management, acute mortality post-MI has been re-
duced and more patients enter the phase of cardiac wound healing. In this 
thesis we investigated myocardial infarct healing and focused on complications 
of the wound healing process, in particular infarct rupture and heart failure due 
to dilatation. 
Infarct rupture
The results of mouse studies suggest that excessive degradation of the extracel-
lular matrix in the infarct area can lead to infarct rupture, since targeted dele-
tion of matrix metalloproteinases (MMP)-224,83 or MMP-923 reduces the incidence 
of infarct rupture post-MI, while overexpression of tissue inhibitor of metallo-
proteinase-1 (TIMP-1) has been shown to protect against infarct rupture.23 The 
role of defective intercellular adhesion complexes has also been implicated, as 
an increased incidence of infarct rupture has been reported in mice lacking the 
aE-catenin gene.25 However, molecular mechanisms involved in infarct rupture 
in humans have not been described so far. We hypothesized that cell adhesion 
molecules, especially aE-catenin, and upregulation of MMP’s are also involved in 
the process of infarct rupture in humans. 
In the studies described in chapter 4 and 5 we investigated the levels of MMP-2, 
-8 and -9, TIMP-1 and aE-catenin in cardiac tissue samples from patients who 
died of infarct rupture post-MI. We found significantly elevated total and active 
levels of MMP-8 and MMP-9 secondary to an augmented inflammatory response 
in these tissue samples compared to matched non-ruptured control MI samples 
(chapter 4). Furthermore, we observed a reduced expression and defective lo-
calization of aE-catenin in the intercalated disks of uninjured cardiomyocytes in 
the same infarct rupture patients (chapter 5). These results could be mimicked 
in an animal model with reduced aE-catenin expression, where three-fourths of 
the heterozygous aE-catenin C-terminal truncated mice died of infarct rupture, 
compared to one-fourth of the wildtype littermates. These results suggest that 
weakened cardiomyocyte adhesion, due to reduced expression and mislocaliza-
tion of aE-catenin, facilitates increased inflammatory cell infiltration. Based on 
the results in mice and men, our working model is that the increased inflam-
matory cell influx, resulting from a defective cell adhesion complex, and the 
subsequent upregulation and activation of MMP-8 and -9 affect the integrity of 
the extracellular matrix, thereby facilitating infarct rupture. This working model 
is depicted in Figure 8.1.
In chapter 3 we studied the effect of genetic background on wound healing 
post-MI. In this extensive experimental study, examining five different mouse 
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Cartoon of molecular mechanisms that can lead to infarct rupture 
in humans
In the left part of the cartoon, the wound healing post-MI in patients with normal infarct healing is 
shown whereas the right part of the cartoon focuses on the defective wound healing as proposed in in-
farct rupture patients. In the uninjured cardiomyocytes of normal hearts, aE-catenin is localized in the 
intercalated disks. Ischemia induces death of the cardiomyocytes in the infarct area, as shown by the 
loss of their nuclei. However, apparently the adhering cardiomyocytes still can form an effective barrier 
against inflammatory cells and ventricular blood. In the normal heart, the wound healing will com-
mence and granulation tissue will replace the dead cardiomyocytes, taking over the barrier function 
against the ventricular blood. In the rupture-prone heart, however, aE-catenin is reduced and poorly 
localized in the intercalated disks of the cardiomyocytes. After ischemia, this abnormal cell adhesion 
complex causes the dead cardiomyocytes in the infarct area to loosen up their connections, giving 
access to more inflammatory cells. The MMPs deposited by these inflammatory cells induce extensive 
degradation of the extracellular matrix in the infarct area, causing further deterioration of the integrity 
of the infarct area and subsequently leading to infarct rupture. For full color image, see page 176.
Figure 8.1
Thesis vd Borne V2.indd   120 20-2-2009   15:01:33
CHAPTER 8 |  General discussion 
| page 121 
strains, it became clear that infarct rupture frequency in mice is highly depen-
dent on genetic background. Infarct rupture occurred in 62% of 129S6 mouse, 
whereas only 5% of BalbC mice died of infarct rupture. The high incidence of in-
farct rupture was associated with high systolic blood pressure and an increased 
influx of inflammatory cells. However, although MMP-9 was slightly increased at 
day 3 post-MI, there were no significant differences in MMP-levels between the 
five mouse strains. A possible explanation could be the timing of tissue collec-
tion. At day three of the experiment, when we measured MMP-activity, none of 
the mice had ruptured, suggesting that MMP activity had not yet fully developed. 
Furthermore, as only 62% of these mice develop infarct rupture, this further 
reduces the average MMP level in this group.
Heart failure
Ischemic heart disease is the leading cause of chronic heart failure in the West-
ern world.27 After MI, the heart undergoes a complex process of structural and 
molecular remodeling, which is beneficial at first, and contributes to the mainte-
nance of the cardiac output. However, the remodeling can become deleterious, 
marked by ventricular dilatation, infarct wall thinning, replacement and intersti-
tial fibrosis with a corresponding progressive impairment of the contractile func-
tion, leading to heart failure.30 About 22% of male and 46% of female patients 
suffering from MI will develop heart failure within 6 years.27 The prevalence of 
heart failure is similar in black and white males; however, in black women the 
prevalence of heart failure is higher than in white women and it is even higher 
than in males.27 This suggests the involvement of genetic and gender factors 
in human heart failure. It is of paramount importance to detect patients at 
risk of heart failure as soon as possible in order to start optimal treatment and 
decrease the risk of clinical symptoms of heart failure. We hypothesized that 
molecular imaging is a tool to study heart failure development and the effects 
of heart failure treatment post-MI in order to prevent the clinical syndrome of 
heart failure.
As the genetic background turned out to be an important determinant of cardiac 
dilatation and heart failure, we studied the development of heart failure post-MI 
in five different mouse strains in chapter 3. Cardiac dilatation was most marked 
in Swiss mice and was associated with reduced ejection fraction and cardiac 
contractility. Furthermore, these mice showed secondary dilatation of the infarct 
area between 14 and 28 days post-MI, which was paralleled by a low number of 
myofibroblasts in the infarct area at day 14 post-MI. Myofibroblasts are impor-
tant in wound healing post-MI, depositing replacement collagen in the infarct 
area to create a strong scar and can be anticipated to prevent secondary dila-
tation by their contractile properties. However, post-MI there are also changes 
in the remote zone, far away from the infarct. Interstitial fibrosis deposited in 
the remote zone increases mechanical stiffness and contributes to diastolic and 
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systolic dysfunction.34 In this respect we hypothesize that the cardiac myofi-
broblast, and consequently fibrotic remodeling, is a predictive marker for heart 
failure, which makes it a suitable candidate for molecular imaging. Hence, in 
chapter 6 we evaluated interstitial alterations in myocardial remodeling in the 
mouse using a radiolabeled Cy5.5-RGD imaging peptide (CRIP) that targets 
the myofibroblasts. The maximum uptake was observed at 2 weeks post-MI in 
the infarct region and it decreased gradually by week 12; uptake in the remote 
areas only exceeded baseline values at 12 weeks. The uptake was histologically 
traced to the myofibroblasts. This study demonstrated the feasibility of noninva-
sive imaging of interstitial changes during cardiac remodeling.
In chapter 7 we used the same technique to asses the efficacy of anti-angio-
tensin and anti-mineralocorticoid intervention. Myofibroblasts express AT1 re-
ceptors and it is known that activation of the endogenous RAAS system in the 
myocardium results in cardiac fibroblast proliferation and fibrosis.34 Indeed, we 
found that radiolabeled CRIP allows evaluation of the efficacy of neurohumoral 
antagonists in cardiac remodeling post-MI and that it is sensitive enough to 
detect therapy-induced alterations in the cardiac interstitium. We also recon-
firmed the superiority of combination therapy: clinical trials have shown that 
ACE inhibitors with ARB’s or aldosterone antagonists improve the outcome in 
survivors post-MI.63, 168 CRIP imaging offers a novel tool for assessing efficacy 
of heart failure therapy, allowing individualized monitoring and optimization of 
pharmacotherapy.
Outlook 
Molecular imaging is a rapidly developing technique that aims to visualize biolog-
ical and physiological processes of disease in a repetitive and non-invasive way. 
After unraveling the molecular pathway of infarct rupture in humans, one can 
imagine the advantage of molecular imaging in detecting patients post-MI who 
are at risk of infarct rupture. It can be speculated that aE-catenin would be a 
good marker to detect patients at risk of infarct rupture, since the decreased ex-
pression and mislocalization is likely to be present even before the onset of isch-
emia. However, aE-catenin is present inside the cell which makes it technically 
harder to detect. Furthermore, infarct rupture patients still do have aE-catenin, 
albeit at lower levels. Whether molecular imaging techniques will be sensitive 
enough to detect the decrease in aE-catenin remains to be determined. If so, 
patients admitted with a transmural MI can be screened immediately post-MI for 
lower aE-catenin levels or mislocalization.  Other possible targets will be MMP’s 
or inflammatory cells.  In a mouse model, MMP-2 and -9 has already been im-
aged using a near-infrared fluorescent probe172 or a 99mTc-labeled MMP-probe,173 
indicating that MMP targeting post-MI is feasible. However, imaging MMP activity 
may be too late in the process since increased activated MMP’s already lead to 
rupture. Therefore, imaging inflammatory cells is a more logical approach. This 
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Implementation of molecular imaging strategies in the clinical 
management of MI patients
After 2-3 days post-MI polymorphonuclear leukocytes infiltrate the infarcted area. At this time, when 
the infarct wall is at its weakest, the infarct area may rupture, often leading to sudden death. Imaging 
inflammatory cells or aE-catenin at this time would allow identification of patients at risk of infarct 
rupture, as indicated by (-) in the cartoon. Timely identification will allow administration of aggressive 
therapy in order to prevent infarct rupture. When low levels of inflammatory cells or high aE-catenin 
levels are detected the risk of infarct rupture is low as indicated by (+) in the cartoon. In the hearts 
that do not rupture, there is matrix remodeling and granulation tissue formation that by 3 weeks in-
cludes removal of necrotic debris, mononuclear cell infiltration, increased numbers of myofibroblasts 
and capillaries, and an increase in collagen deposition. Imaging the myofibroblasts at this time point 
would identify patients at risk of developing heart failure post-MI, as indicated by the (-) in the car-
toon. Aggressive treatment at an early phase may prevent heart failure development and lead to a 
well healed infarct. Patients with sufficient myofibroblasts in the infarct area, as indicated by (+) in 
the cartoon have a low risk of heart failure and are likely to develop a well healed scar. Figure adapted 
from: E. Creemers and J. Cleutjens  
Figure 8.2
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can be accomplished by imaging of for instance myeloperoxidase activity by 
MRI. Myeloperoxidase is produced by inflammatory cells and can serve as a sur-
rogate marker for the extent of tissue inflammation in myocardial infarction.174 
Screening patients with a transmural MI for an increased inflammatory response 
would allow identification of patients at risk of infarct rupture. These patients 
can be treated with aggressive b-blockade to decrease the cardiac work load or 
even be sedated for the first 10 days post-MI. During that time granulation tis-
sue can form and the risk of rupture is reduced (See Figure 8.2). 
For heart failure it is a different story. The impact of heart failure, both in patient 
burden and cost of medical treatment, is very high. The estimated direct and 
indirect cost of heart failure in the United States for 2008 is 34.8 billion dollars.27 
In the Netherlands the yearly costs for heart failure patients are between 136 
and 455 million euro’s.175 As a result of the increasing number of survivors post-
MI, hence increasing incidence of heart failure, and the lack of a cure for this 
condition, it is of utmost importance to detect patients at risk of heart failure 
before the disease becomes clinically manifest. In that way they can be treated 
optimally in order to prevent symptomatic heart failure (See Figure 8.2). 
Although BNP and Galactin-3 are good markers for heart failure, they are mea-
sured in plasma rather than directly in the heart. Furthermore, we would like 
to detect the risk of heart failure as early as possible, preferably before plasma 
BNP and Galactin-3 plasma levels are elevated. Our pre-clinical studies showed 
a potential value of CRIP in its ability to non-invasively localize the site of inter-
stitial alterations and collagen formation in the myocardium, and therefore may 
provide information about the evolution of heart failure. Furthermore it allowed 
the evaluation of the efficacy of anti-remodeling therapy. If corroborated clini-
cally, molecular imaging of remodeling processes could detect patients at risk 
for heart failure at an early stage and could facilitate individualizing the treat-
ment for patients susceptible for heart failure. A clinical pilot study with a radio-
labeled RGD peptide in patients 3 and 8 weeks post-MI has shown the feasibility 
of imaging interstitial alterations. In these patients, 1-year follow-up magnetic 
resonance imaging confirmed the extent of fibrosis detected in the early stage 
by radiolabeled RGD peptide.155 
In conclusion, alterations in the cadherin/catenin cell adhesion complex may 
lead to weakened cardiomyocyte adhesion, allowing excessive inflammatory cell 
infiltration and subsequent MMP activation, which is presented as a novel mo-
lecular mechanism for infarct rupture post-MI in humans. These observations 
provide novel insights to develop diagnostic tools for infarct rupture. Further-
more, the feasibility of myofibroblast imaging may serve as an early marker for 
heart failure development. If proven clinically, this molecular imaging technique 
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of the myocardial infarct healing process may identify patients at risk for heart 
failure at an early stage and may help plan an optimal treatment regimen for 
patients susceptible for heart failure.
Thesis vd Borne V2.indd   125 20-2-2009   15:01:36
 page 126 |
Thesis vd Borne V2.indd   126 20-2-2009   15:01:36
9ReferencesSummary
Samenvatting
Full Color Illustrations
Thesis vd Borne V2.indd   127 20-2-2009   15:01:37
 page 128 |
Thesis vd Borne V2.indd   128 20-2-2009   15:01:37
CHAPTER 9 |  References
| page 129 
Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease 
Study. Lancet 1997;349:1269-76.
Cleutjens JP. The role of matrix metalloproteinases in heart disease Cardiovasc Res 1996;32:816-
21.
Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infarcted myocardium: simply dead tis-
sue, or a lively target for therapeutic interventions. Cardiovasc Res 1999;44:232-41.
Volders PG, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ. Interstitial collagen 
is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Car-
diol 1993;25:1317-23.
Antman EM, Braunwald E. Acute myocardial infarction. In: Heart disease, a textbook of cardiovas-
cular medicine. Braunwald E, editor. Philadelphia: WB Saunders Company; 2001. p. 1114-231.
Soonpaa MH, Daud AI, Koh GY, et al. Potential approaches for myocardial regeneration. Ann N Y 
Acad Sci 1995;752:446-54.
Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. 
Circ Res 1998;82:1111-29.
Lagrand WK, Niessen HW, Wolbink GJ, et al. C-reactive protein colocalizes with complement in hu-
man hearts during acute myocardial infarction. Circulation 1997;95:97-103.
Matsumori A, Furukawa Y, Hashimoto T, et al. Plasma levels of the monocyte chemotactic and ac-
tivating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardi-
al infarction. J Mol Cell Cardiol 1997;29:419-23.
Sturk A, Hack CE, Aarden LA, Brouwer M, Koster RR, Sanders GT. Interleukin-6 release and the 
acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 
1992;119:574-9.
Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in 
the rat myocardium after infarction. J Mol Cell Cardiol 1995;27:1281-92.
Tyagi SC, Campbell SE, Reddy HK, Tjahja E, Voelker DJ. Matrix metalloproteinase activity ex-
pression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 
1996;155:13-21.
Willems IE, Havenith MG, De Mey JG, Daemen MJ. The alpha-smooth muscle actin-positive cells 
in healing human myocardial scars. Am J Pathol 1994;145:868-75.
Willems IE, Arends JW, Daemen MJ. Tenascin and fibronectin expression in healing human myo-
cardial scars. J Pathol 1996;179:321-5.
Bishop JE, Laurent GJ. Collagen turnover and its regulation in the normal and hypertrophying 
heart. Eur Heart J 1995;16 Suppl C:38-44.
Chien KR. Stress pathways and heart failure. Cell 1999;98:555-8.
Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, Anversa P. Myocyte nuclear and possible 
cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in hu-
mans. J Am Coll Cardiol 1994;24:140-9.
Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hy-
pertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. 
Circ Res 1991;69:107-15.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
REFERENCES
Thesis vd Borne V2.indd   129 20-2-2009   15:01:37
 page 130 |
Wehrens XH, Doevendans PA. Cardiac rupture complicating myocardial infarction. Int J Cardiol 
2004;95:285-92.
Birnbaum Y, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF. Ventricular free wall rupture 
following acute myocardial infarction. Coron Artery Dis 2003;14:463-70.
Batts KP, Ackermann DM, Edwards WD. Postinfarction rupture of the left ventricular free wall: clin-
icopathologic correlates in 100 consecutive autopsy cases. Hum Pathol 1990;21:530-5.
Creemers E, Cleutjens J, Smits J, et al. Disruption of the plasminogen gene in mice abolishes 
wound healing after myocardial infarction. Am J Pathol 2000;156:1865-73.
Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metallopro-
teinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac fail-
ure. Nat Med 1999;5:1135-42.
Hayashidani S, Tsutsui H, Ikeuchi M, et al. Targeted deletion of MMP-2 attenuates early LV rup-
ture and late remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Phys-
iol 2003;285:H1229-35.
Sheikh F, Chen Y, Liang X, et al. alpha-E-catenin inactivation disrupts the cardiomyocyte ad-
herens junction, resulting in cardiomyopathy and susceptibility to wall rupture. Circulation 
2006;114:1046-55.
Katz AM. The cardiomyopathy of overload: an unnatural growth response. Eur Heart J 1995;16 
Suppl O:110-4.
Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report 
from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 
Circulation 2008;117:e25-146.
Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial in-
farct expansion. Circulation 1988;78:186-201.
Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastol-
ic dysfunction. Jama 1994;271:1276-80.
Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental obser-
vations and clinical implications. Circulation 1990;81:1161-72.
Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-33.
Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 
2006;367:356-67.
Schocken DD, Benjamin EJ, Fonarow GC, et al. Prevention of heart failure: a scientific statement 
from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiolo-
gy, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Re-
search Interdisciplinary Working Group; and Functional Genomics and Translational Biology Inter-
disciplinary Working Group. Circulation 2008;117:2544-65.
Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocar-
dial remodeling and failure. Annu Rev Pharmacol Toxicol 2005;45:657-87.
Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin In-
vest 2003;112:1776-84.
Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to 
cardiac fibrosis. Nat Med 2007;13:952-61.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Thesis vd Borne V2.indd   130 20-2-2009   15:01:37
CHAPTER 9 |  References
| page 131 
Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte 
subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation 
of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-63.
Squires CE, Escobar GP, Payne JF, et al. Altered fibroblast function following myocardial infarction. 
J Mol Cell Cardiol 2005;39:699-707.
Hinz B, Gabbiani G. Mechanisms of force generation and transmission by myofibroblasts. Curr 
Opin Biotechnol 2003;14:538-46.
Serini G, Bochaton-Piallat ML, Ropraz P, et al. The fibronectin domain ED-A is crucial for myofibro-
blastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998;142:873-81.
Wang J, Chen H, Seth A, McCulloch CA. Mechanical force regulation of myofibroblast differentiation 
in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003;285:H1871-81.
Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 
2003;200:500-3.
Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial in-
farct repair. Am J Pathol 2003;163:2433-40.
Foo IT, Naylor IL, Timmons MJ, Trejdosiewicz LK. Intracellular actin as a marker for myofibroblasts 
in vitro. Lab Invest 1992;67:727-33.
Muro AF, Chauhan AK, Gajovic S, et al. Regulated splicing of the fibronectin EDA exon is essential 
for proper skin wound healing and normal lifespan. J Cell Biol 2003;162:149-60.
Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one 
function, multiple origins. Am J Pathol 2007;170:1807-16.
Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. 
A study of structure and function. J Exp Med 1972;135:719-34.
Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity dur-
ing the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
Sun Y, Kiani MF, Postlethwaite AE, Weber KT. Infarct scar as living tissue. Basic Res Cardiol 
2002;97:343-7.
Beltrami CA, Finato N, Rocco M, et al. Structural basis of end-stage failure in ischemic cardiomy-
opathy in humans. Circulation 1994;89:151-63.
Eyden B. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis 
on ultrastructure. J Submicrosc Cytol Pathol 2007:7-166.
Blankesteijn WM, Essers-Janssen YP, Verluyten MJ, Daemen MJ, Smits JF. A homologue of Dros-
ophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat 
heart. Nat Med 1997;3:541-4.
Rosenkranz S, Flesch M, Amann K, et al. Alterations of beta-adrenergic signaling and cardiac 
hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 
2002;283:H1253-62.
Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force per-
ception and transmission. Eur J Cell Biol 2006;85:175-81.
Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biolo-
gy. Matrix Biol 1998;16:387-98.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
Thesis vd Borne V2.indd   131 20-2-2009   15:01:37
 page 132 |
Hong HH, Uzel MI, Duan C, Sheff MC, Trackman PC. Regulation of lysyl oxidase, collagen, and 
connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest 
1999;79:1655-67.
Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II gen-
eration. Circulation 1997;96:4065-82.
Harada K, Sugaya T, Murakami K, Yazaki Y, Komuro I. Angiotensin II type 1A receptor knockout 
mice display less left ventricular remodeling and improved survival after myocardial infarction. 
Circulation 1999;100:2093-9.
Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in 
patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003;362:759-66.
Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in 
patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival 
Study ELITE II. Lancet 2000;355:1582-7.
Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic 
heart failure. N Engl J Med 2001;345:1667-75.
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative 
North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. 
N Engl J Med 1987;316:1429-35.
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and con-
gestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293-302.
Verjans JWH, Lovhaug D, Narula N, et al. Noninvasive imaging of angiotensin receptores after 
myocardial infarction. J Am Coll Cardiol- Cardiovascular imaging 2008;1:354-62.
Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart fail-
ure in the adult: a report of the American College of Cardiology/American Heart Association Task 
Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation 
and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-82.
Szabo Z, Speth RC, Brown PR, et al. Use of positron emission tomography to study AT1 receptor 
regulation in vivo. J Am Soc Nephrol 2001;12:1350-8.
Dilsizian V, Eckelman WC, Loredo ML, Jagoda EM, Shirani J. Evidence for tissue angiotensin-con-
verting enzyme in explanted hearts of ischemic cardiomyopathy using targeted radiotracer tech-
nique. J Nucl Med 2007;48:182-7.
Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin alpha(v)
beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. 
J Immunol 2005;175:7708-18.
van den Borne SW, Isobe S, Verjans JW, Petrov A, Lovhaug D, Li P, et al. Molecular Imaging of 
interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol. 
2008;51:2184-92.
Verjans JW, Wolters SL, Lax M, et al. Imaging αvβ3/β5 Integrin Upregulation In Patients After 
Myocardial Infarction. Circulation 2007;116-II:3288.
van den Borne SW, Cleutjens JP, Hanemaaijer R, et al. Increased matrix metalloproteinase-8 and 
-9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2009; 
18:37-43.
Linder CC. Genetic variables that influence phenotype. Ilar J 2006;47:132-40.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
Thesis vd Borne V2.indd   132 20-2-2009   15:01:37
CHAPTER 9 |  References
| page 133 
Hoover-Plow J, Shchurin A, Hart E, et al. Genetic background determines response to hemostasis 
and thrombosis. BMC Blood Disord 2006;6:6.
Majid A, He YY, Gidday JM, et al. Differences in vulnerability to permanent focal cerebral ischemia 
among 3 common mouse strains. Stroke 2000;31:2707-14.
Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ. Mouse model of post-infarct ventricular rupture: 
time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 
2005;65:469-77.
Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Chronic myocardial infarc-
tion in the mouse: cardiac structural and functional changes. Cardiovasc Res 1999;41:586-93.
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 
Nature 1970;227:680-5.
Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase(s) activity by zy-
mography in microquantities of rat myocardium and uterus. Clin Biochem 1993;26:191-8.
van de Schans VA, van den Borne SW, Strzelecka AE, et al. Interruption of Wnt signaling attenu-
ates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 2007;49:473-80.
Fang L, Gao XM, Moore XL, et al. Differences in inflammation, MMP activation and collagen dam-
age account for gender difference in murine cardiac rupture following myocardial infarction. J Mol 
Cell Cardiol 2007;43:535-44.
Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted deletion or phar-
macological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin 
Invest 2005;115:599-609.
Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP. Temporal changes in matrix metalloproteinase ex-
pression and inflammatory response associated with cardiac rupture after myocardial infarction in 
mice. Life Sci 2004;74:1561-72.
McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart 
failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhib-
itors: the CHARM-Added trial. Lancet 2003;362:767-71.
Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventric-
ular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-90.
Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background 
genotype? Trends Neurosci 1996;19:177-81.
Du XJ. Gender modulates cardiac phenotype development in genetically modified mice. Cardio-
vasc Res 2004;63:510-9.
Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remod-
eling after acute myocardial infarction in mice. Life Sci 2004;75:2181-92.
Bujak M, Kweon HJ, Chatila K, Li N, Taffet G, Frangogiannis NG. Aging-related defects are associ-
ated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. J Am 
Coll Cardiol 2008;51:1384-92.
Julian DG. Why do patients die after myocardial infarction? J Cardiovasc Pharmacol 1991;18:S80-2.
McMullan MH, Maples MD, Kilgore TL, Jr., Hindman SH. Surgical experience with left ventricular 
free wall rupture. Ann Thorac Surg 2001;71:1894-8; discussion 1898-9.
Pretre R, Benedikt P, Turina MI. Experience with postinfarction left ventricular free wall rupture. 
Ann Thorac Surg 2000;69:1342-5.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
Thesis vd Borne V2.indd   133 20-2-2009   15:01:37
 page 134 |
Reeder GS. Identification and treatment of complications of myocardial infarction. Mayo Clin Proc 
1995;70:880-4.
Stout B, Ferrell L, Wray T, Mayes C. Myocardial rupture. Your patient’s survival may depend on 
you. Postgrad Med 1991;90:115-22.
Antman EM, Braunwald E. Acute myocardial infarction. Heart disease, a textbook of cardiovascu-
lar medicine. In: Braunwald E, editor. Philadelphia: WB Saunders&Co;1997. p.1184-268.
Davis N, Sistino JJ. Review of ventricular rupture: key concepts and diagnostic tools for success. 
Perfusion 2002;17:63-7.
Olsen EGJ. Ischemic disease of the myocardium and its complications. In: Silver MD, editor. Car-
diovascular Pathology. New York: Churchill Livingstone; 1983. p. 671-717.
Pasotti M, Prati F, Arbustini E. The pathology of myocardial infarction in the pre and post inter-
ventional era. Heart 2006;92(11):1552-6.
Creemers EE, Cleutjens JP, Smits JF, Daemen MJ. Matrix metalloproteinase inhibition after myo-
cardial infarction: a new approach to prevent heart failure? Circ Res 2001;89:201-10.
Chapman RE, Scott AA, Deschamps AM, et al. Matrix metalloproteinase abundance in human 
myocardial fibroblasts: effects of sustained pharmacologic matrix metalloproteinase inhibition. J 
Mol Cell Cardiol 2003;35:539-48.
Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH. A novel and simple immunocap-
ture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from 
patients with Sjogren’s syndrome contain increased latent and active gelatinase-B levels. Matrix 
Biol 1998;17:657-65.
Creemers EE, Davis JN, Parkhurst AM, et al. Deficiency of TIMP-1 exacerbates LV remodeling af-
ter myocardial infarction in mice. Am J Physiol Heart Circ Physiol 2003;284:H364-71.
Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Fac-
tor Rev 2006;17:217-23.
Herman MP, Sukhova GK, Libby P, et al. Expression of neutrophil collagenase (matrix metallopro-
teinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional pro-
filing. Circulation 2001;104:1899-904.
Kameda K, Matsunaga T, Abe N, et al. Increased pericardial fluid level of matrix metalloprotei-
nase-9 activity in patients with acute myocardial infarction: possible role in the development of 
cardiac rupture. Circ J 2006;70:673-8.
Webb CS, Bonnema DD, Ahmed SH, et al. Specific temporal profile of matrix metalloproteinase 
release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Cir-
culation 2006;114:1020-7.
Bar-Or A, Nuttall RK, Duddy M, et al. Analyses of all matrix metalloproteinase members in 
leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 
2003;126:2738-49.
Ardans JA, Economou AP, Martinson JM, Jr., Zhou M, Wahl LM. Oxidized low-density and high-
density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated 
monocytes. J Leukoc Biol 2002;71:1012-8.
Saren P, Welgus HG, Kovanen PT. TNF-alpha and IL-1beta selectively induce expression of 92-kDa 
gelatinase by human macrophages. J Immunol 1996;157:4159-65.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
Thesis vd Borne V2.indd   134 20-2-2009   15:01:37
CHAPTER 9 |  References
| page 135 
Chromek M, Tullus K, Lundahl J, Brauner A. Tissue inhibitor of metalloproteinase 1 activates nor-
mal human granulocytes, protects them from apoptosis, and blocks their transmigration during 
inflammation. Infect Immun 2004;72:82-8.
Honan MB, Harrell FE, Jr., Reimer KA, et al. Cardiac rupture, mortality and the timing of throm-
bolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-67.
Olsen EGJ. Ischemic disease of the myocardium and its complications. In: Silver MD, ed. Cardio-
vascular pathology. 2nd edition ed. New York: Churchill Livingstone, 1983:671-717.
Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/
dephosphorylation of beta-catenin. Curr Opin Cell Biol 2005;17:459-65.
Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 
2003;94:575-81.
Severs NJ. The cardiac gap junction and intercalated disc. Int J Cardiol 1990;26:137-73.
van den Borne SWM, Cleutjens JPM, Hanemaaijer R, et al. Increased MMP-8 and -9 activity in 
patients with infarct rupture after myocardial infarction. Cardiovasc Pathol accepted for publica-
tion.
Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 
Nature 1970;227:680-685.
Torres M, Stoykova A, Huber O, et al. An alpha-E-catenin gene trap mutation defines its function 
in preimplantation development. Proc Natl Acad Sci U S A 1997;94:901-6.
Burks J, Agazie YM. Modulation of alpha-catenin Tyr phosphorylation by SHP2 positively effects 
cell transformation induced by the constitutively active FGFR3. Oncogene 2006;25:7166-79.
Harris TJ, Peifer M. Decisions, decisions: beta-catenin chooses between adhesion and transcrip-
tion. Trends Cell Biol 2005;15:234-7.
Brembeck FH, Schwarz-Romond T, Bakkers J, Wilhelm S, Hammerschmidt M, Birchmeier W. Es-
sential role of BCL9-2 in the switch between beta-catenin’s adhesive and transcriptional func-
tions. Genes Dev 2004;18:2225-30.
Imamura Y, Itoh M, Maeno Y, Tsukita S, Nagafuchi A. Functional domains of alpha-catenin re-
quired for the strong state of cadherin-based cell adhesion. J Cell Biol 1999;144:1311-22.
Birnbaum Y, Fishbein MC, Blanche C, Siegel RJ. Ventricular septal rupture after acute myocardial 
infarction. N Engl J Med 2002;347:1426-32.
Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics--2006 update: a report 
from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. 
Circulation 2006;113:e85-151.
Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left 
ventricle of the rat. Circ Res 1985;57:84-95.
Cleutjens JP, Blankesteijn WM, Daemen MJ, Smits JF. The infarcted myocardium: simply dead tis-
sue, or a lively target for therapeutic interventions. Cardiovasc Res 1999;44:232-41.
Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and fu-
ture prospects. Circulation 1987;75:IV11-9.
Gerdes AM, Capasso JM. Structural remodeling and mechanical dysfunction of cardiac myocytes 
in heart failure. J Mol Cell Cardiol 1995;27:849-56.
Francis GS, McDonald KM. Left ventricular hypertrophy: an initial response to myocardial injury. 
Am J Cardiol 1992;69:3G-7G; discussion 7G-9G.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
Thesis vd Borne V2.indd   135 20-2-2009   15:01:37
 page 136 |
Heeneman S, Cleutjens JP, Faber BC, et al. The dynamic extracellular matrix: intervention strat-
egies during heart failure and atherosclerosis. J Pathol 2003;200:516-25.
Meoli DF, Sadeghi MM, Krassilnikova S, et al. Noninvasive imaging of myocardial angiogenesis 
following experimental myocardial infarction. J Clin Invest 2004;113:1684-91.
Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventri-
cle by two-dimensional echocardiography. American Society of Echocardiography Committee 
on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc 
Echocardiogr 1989;2:358-67.
Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial col-
lagen with picrosirius red staining and circularly polarized light. Basic Res Cardiol 1994;89:397-
410.
MacKenna DA, Omens JH, McCulloch AD, Covell JW. Contribution of collagen matrix to passive 
left ventricular mechanics in isolated rat hearts. Am J Physiol 1994;266:H1007-18.
Szendroi M, Vajta G, Kovacs L, Schaff Z, Lapis K. Polarization colours of collagen fibres: a sign of 
collagen production activity in fibrotic processes. Acta Morphol Hung 1984;32:47-55.
Andrade GB, Riet-Correa F, Montes GS, Battlehner CN, Saldiva PH. Dating of fibrotic lesions by 
the Picrosirius-polarization method. An application using the lesions of Lechiguana (bovine focal 
proliferative fibrogranulomatous panniculitis). Eur J Histochem 1997;41:203-9.
Liou W, Geuze HJ, Slot JW. Improving structural integrity of cryosections for immunogold label-
ing. Histochem Cell Biol 1996;106:41-58.
Zhou X, Jamil A, Nash A, et al. Impaired proteolysis of collagen I inhibits proliferation of hepatic 
stellate cells: implications for regulation of liver fibrosis. J Biol Chem 2006;281:39757-65.
Jugdutt BI, Amy RW. Healing after myocardial infarction in the dog: changes in infarct hydroxy-
proline and topography. J Am Coll Cardiol 1986;7:91-102.
Whittaker P, Boughner DR, Kloner RA. Role of collagen in acute myocardial infarct expansion. 
Circulation 1991;84:2123-34.
Pfeffer JM, Fischer TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular re-
modeling after myocardial infarction. Annu Rev Physiol 1995;57:805-26.
Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS. Angiotensin II stimulates cardiac myocyte hy-
pertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 
1998;40:352-63.
Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000;46:250-6.
Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting 
enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myo-
cardial infarction in the rat. Circulation 1994;89:2273-82.
Wollert KC, Drexler H. The kallikrein-kinin system in post-myocardial infarction cardiac remod-
eling. Am J Cardiol 1997;80:158A-161A.
Dickstein K, Kjekshus J. Effects of losartan and captopril on mortality and morbidity in high-risk 
patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myo-
cardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002;360:752-60.
Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction 
complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349:1893-
906.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
Thesis vd Borne V2.indd   136 20-2-2009   15:01:37
CHAPTER 9 |  References
| page 137 
White HD, Braunwald E. Applying the open artery theory: use of predictive survival markers. Eur 
Heart J 1998;19:1132-9.
Poulsen SH, Host NB, Jensen SE, Egstrup K. Relationship between serum amino-terminal propep-
tide of type III procollagen and changes of left ventricular function after acute myocardial infarc-
tion. Circulation 2000;101:1527-32.
Radovan J, Vaclav P, Petr W, et al. Changes of collagen metabolism predict the left ventricular re-
modeling after myocardial infarction. Mol Cell Biochem 2006;293:71-8.
Zannad F, Radauceanu A. Effect of MR blockade on collagen formation and cardiovascular disease 
with a specific emphasis on heart failure. Heart Fail Rev 2005;10:71-8.
Cicoira M, Rossi A, Bonapace S, et al. Independent and additional prognostic value of aminoter-
minal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J 
Card Fail 2004;10:403-11.
Kotaniemi A, Risteli J, Aho K, Hakala M. Increased type I collagen degradation correlates with dis-
ease activity in reactive arthritis. Clin Exp Rheumatol 2003;21:95-8.
Verjans JW, Wolters SL, Lax M, et al. Imaging avb3/b5 Integrin Upregulation in Patients After 
Myocardial Infarction. Circulation 2007;116-II:3288.
Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angio-
tensin-aldosterone system. Circulation 1991;83:1849-65.
Weber KT, Anversa P, Armstrong PW, et al. Remodeling and reparation of the cardiovascular sys-
tem. J Am Coll Cardiol 1992;20:3-16.
Pitt B. Aldosterone blockade in patients with systolic left ventricular dysfunction. Circulation 
2003;108:1790-4.
Shirani J, Narula J, Eckelman WC, Narula N, Dilsizian V. Early imaging in heart failure: exploring 
novel molecular targets. J Nucl Cardiol 2007;14:100-10.
Anversa P, Capasso JM. Cardiac hypertrophy and ventricular remodeling. Lab Invest 1991;64:441-5.
Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dini-
trate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in pa-
tients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J 
Med 1999;341:709-17.
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-
enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes 
Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients 
with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricu-
lar enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669-77.
Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left 
ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
McNamara DM, Holubkov R, Janosko K, et al. Pharmacogenetic interactions between beta-block-
er therapy and the angiotensin-converting enzyme deletion polymorphism in patients with con-
gestive heart failure. Circulation 2001;103:1644-8.
149.
150.
151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
Thesis vd Borne V2.indd   137 20-2-2009   15:01:37
 page 138 |
Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- 
and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 
2002;347:1135-42.
Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover 
may contribute to survival benefit of spironolactone therapy in patients with congestive heart 
failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. 
Circulation 2000;102:2700-6.
Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascu-
lar events. N Engl J Med 2008;358:1547-59.
van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage deple-
tion impairs wound healing and increases left ventricular remodeling after myocardial injury in 
mice. Am J Pathol 2007;170:818-29.
Dai W, Wold LE, Dow JS, Kloner RA. Thickening of the infarcted wall by collagen injection im-
proves left ventricular function in rats: a novel approach to preserve cardiac function after myo-
cardial infarction. J Am Coll Cardiol 2005;46:714-9.
Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL. Near-infrared fluorescent imaging 
of matrix metalloproteinase activity after myocardial infarction. Circulation 2005;111:1800-5.
Su H, Spinale FG, Dobrucki LW, et al. Noninvasive targeted imaging of matrix metalloproteinase 
activation in a murine model of postinfarction remodeling. Circulation 2005;112:3157-67.
Nahrendorf M, Sosnovik D, Chen JW, et al. Activatable magnetic resonance imaging agent re-
ports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammato-
ry effects of atorvastatin on ischemia-reperfusion injury. Circulation 2008;117:1153-60.
Reitsma JB, Mosterd A, Koek HL. Hart- en vaatziekten in Nederland 2002, cijfers over ziekte en 
sterfte. Nederlandse Hartstichting 2002;november.
167.
168.
169.
170.
171.
172.
173.
174.
175.
Thesis vd Borne V2.indd   138 20-2-2009   15:01:38
9ReferencesSummary
Samenvatting
Full Color Illustrations
Thesis vd Borne V2.indd   139 20-2-2009   15:01:38
 page 140 |
Thesis vd Borne V2.indd   140 20-2-2009   15:01:38
CHAPTER 9 |  Summary
| page 141 
SUMMARy
The process of myocardial infarct healing is very complex and can lead to several 
complications. The present thesis focuses on two common complications of myo-
cardial infarction, associated with the healing process. The first complication 
is infarct rupture, which occurs in the early phase post-MI, typically between 
3-6 days after the infarction. It is a usually lethal complication of acute MI for 
which no adequate treatment is available. Risk factors for infarct rupture are a 
transmural infarction, first infarction and a poor collateral circulation. Animal 
experiments have shown a role for matrix metalloproteinases and cell adhesion 
proteins in the development of infarct rupture. However, molecular mechanisms 
involved in infarct rupture in humans have not been described so far. The first 
hypothesis of this thesis is that cell adhesion molecules, especially aE-catenin, 
and upregulation of MMP’s are involved in the process of infarct rupture in hu-
mans.
The second complication related to wound healing post-MI is heart failure, a 
condition in which the heart is unable to provide sufficient cardiac output to 
meet the metabolic and oxygen demands of the peripheral tissues. Due to the 
advances in diagnosis and management of the acute phase of MI, the preva-
lence of patients with manifest heart failure increases. Most available treatment 
strategies alleviate the symptoms, but none of the current therapies is able to 
cure heart failure. Therefore the only rational therapy for heart failure is to pre-
vent its development. This illustrates the utmost importance to develop strate-
gies for early detection of individuals at risk to develop heart failure so that early 
prevention and treatment may be initiated. This leads to the second hypothesis 
of this thesis; molecular imaging is a tool to study the process of heart failure 
and the effects of heart failure treatment post-MI.
In chapter 2 an overview is given of literature describing the process of myo-
cardial infarct healing with a focus on the role of the myofibroblast. Furthermore, 
molecular targets in the myofibroblasts amenable to imaging are described as 
well as experimental studies attempting to image the myofibroblasts. 
In chapter 3 we studied infarct healing post-MI in different mouse strains that 
are frequently used in cardiovascular research, in order to study the effect of 
the genetic background on the outcome of these studies. In five different mouse 
strains (BalbC, C57Bl6, FVB, 129S6 and Swiss) myocardial infarction was in-
duced and infarct healing was studied. Infarct rupture, typically occurring at 
3-6 days post-MI, was most frequent in 129S6 mice (62%), followed by C57Bl6 
(36%), FVB (29%), Swiss (23%) and BalbC (5%). The high incidence of infarct 
rupture in 129S6 mice correlated with elevated systolic blood pressure and an 
increased influx of inflammatory cells at day 3 post-MI. Acute heart failure was 
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observed in 28% of FVB mice in the first week post-MI, but was rare in other 
groups. Cardiac dilatation was most marked in Swiss mice with a more than 
3-fold increase in end-systolic volume compared to sham, and was least promi-
nent in 129S6 mice. The dilatation correlated with decreased hemodynamic 
measurements and a decreased ejection fraction. Secondary thinning of the 
infarct area between day 14 and 28 was significant in BalbC, FVB and Swiss, but 
absent in C57Bl6 and 129S6. We concluded that the outcome of infarct healing 
in mice is strongly dependent on genetic background. Therefore, results from 
studies on pharmacological or genetic interventions in which different mouse 
strains were used should be compared with caution. The results of the present 
study allowed us to provide guidelines for the choice of a mouse strain that is 
most suitable to study a certain aspect of infarct healing. 
Since it is known from literature that matrix metalloproteinases (MMP’s) play an 
important role in the development of infarct rupture post-MI in mice, we studied 
the role of these MMPs in post mortem heart samples of patients who died of in-
farct rupture post-MI (chapter 4). We observed an increased MMP-8 and MMP-9 
activity in the infarct area, probably caused by a more prominent infiltration of 
inflammatory cells in the border zone of the infarct, which is likely to contribute 
to infarct rupture in humans.
Furthermore, we studied the role of cellular adhesion proteins in post-mortem 
heart samples of patients who died of infarct rupture post-MI (chapter 5). We 
observed a reduced expression and defective localization of aE-catenin in the 
intercalated disk region in infarct rupture patients. The mechanism of lower 
expression of aE-catenin remains to be elucidated. A diminished adhesion of 
the cardiomyocytes may facilitate the infiltration of inflammatory cells into the 
infarct area, leading to excessive MMP activity and subsequently to infarct rup-
ture and thus may provide a molecular mechanism for infarct rupture post-MI 
in humans.
The next two chapters of this thesis focused on molecular imaging of myofi-
broblasts to visualize cardiac remodeling post-MI. In chapter 6 we evaluated 
interstitial alterations in myocardial remodeling using a radiolabeled Cy5.5-RGD 
imaging peptide (CRIP) that targets the myofibroblasts. Maximum CRIP uptake 
was observed in the infarct area with the highest uptake at 2 weeks post-MI, 
followed by 4 and 12 weeks compared to unmanipulated animals. In the remote 
areas the uptake was not significantly different from control values at 2 and 4 
weeks, but the uptake increased significantly at 12 weeks post-MI. The uptake 
was traced to the myofibroblasts and correlated with the extent of collagen de-
position. We conclude that radiolabeled CRIP allows for noninvasive visualization 
of interstitial alterations during cardiac remodeling. 
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In chapter 7 we investigated whether this imaging probe can detect the efficacy 
of pharmacological intervention after MI. Antagonists of the renin-angiotensin-
aldosteron axis restrict myocardial fibrosis and cardiac remodeling post-MI and 
contribute to improved survival. Since the activating effect of Angiotensin II on 
myofibroblast proliferation and activity is well established, interference in the 
RAAS system can be anticipated to affect myofibroblast number and activity. 
Therefore, evaluation of myofibroblasts should provide indirect evidence of the 
extent of fibrosis and the efficacy of therapy. We induced MI in mice and treated 
them with captopril, losartan or spironolactone alone or in combination for 4 
weeks post-MI. The CRIP uptake was highest in untreated control animals and 
decreased significantly in animals treated with one agent. Treatment with two or 
three agents demonstrated a further reduction in tracer uptake. We concluded 
that radiolabeled CRIP allows evaluation of the efficacy of neurohumoral antago-
nists post-MI and reconfirms superiority of combination therapy. 
In conclusion, in this thesis alterations in the cadherin/catenin cell adhesion 
complex and the subsequent excessive inflammatory response are presented 
as a novel molecular mechanism for infarct rupture post-MI in humans. These 
observations provide novel insights to develop diagnostic tools for prevention 
of infarct rupture. Furthermore, the feasibility of myofibroblast imaging as an 
early marker for heart failure development is demonstrated. If proven clinically, 
this molecular imaging technique of the myocardial infarct healing process may 
identify patients at risk for heart failure at an early stage and may help plan an 
optimal treatment regimen for patients susceptible for heart failure.
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SAMENVATTING
Het proces van wondgenezing na een myocard infarct (MI) is erg complex en 
kan leiden tot diverse complicaties. In dit proefschrift richten we ons op twee 
veelvoorkomende complicaties na myocard infarct die geassocieerd zijn met het 
wondgenezingsproces. De eerste complicatie is infarctruptuur, een complicatie 
die optreedt in de eerste fase na MI, meestal binnen 3-6 dagen na het infarct.
Aangezien er geen adequate behandeling mogelijk is, sterven de meeste patiën-
ten aan een infarctruptuur. Infarctruptuur is geassocieerd met een transmuraal 
infarct, een eerste episode van een myocard infarct en een slechte collaterale 
circulatie. Dierexperimenten hebben een rol voor matrix metalloproteinases 
(MMP’s) en celadhesie eiwitten aangetoond in de ontwikkeling van infarctrup-
tuur. Echter, er zijn geen moleculaire mechanismen beschreven die de ontwikke-
ling van infarctruptuur in mensen verklaren. De eerste hypothese van dit proef-
schrift is dat in de humane situatie celadhesie moleculen, met name aE-catenin, 
en een opregulatie van MMP’s betrokken zijn bij het proces van infarctruptuur. 
Een tweede complicatie die gerelateerd is aan wondgenezing na een myocard 
infarct is hartfalen. Dit is een conditie waarbij het hart onvoldoende output kan 
leveren om aan de metabole en zuurstof behoefte van de perifere weefsels te 
voldoen. Door de vermindering van de acute sterfte na een myocard infarct is 
het aantal patiënten dat een infarct overleeft, en daardoor kans heeft om hart-
falen te ontwikkelen, gestegen. De beschikbare behandelingen verlichten de 
symptomen van hartfalen, maar kunnen hartfalen niet genezen. Het is uitermate 
belangrijk om nieuwe technieken te ontwikkelen zodat patiënten met een risico 
op hartfalen in een vroeg stadium kunnen worden opgespoord, nog voordat de 
patiënt klachten heeft. Hierdoor kan de behandeling in een heel vroeg stadium 
worden gestart en kan de ontwikkeling van de symptomen van hartfalen worden 
tegengegaan. Dit leidt tot de tweede hypothese van dit proefschrift; moleculaire 
beeldvorming is een techniek om het proces van hartfalen te bestuderen en kan 
tevens de effecten van de behandeling van hartfalen in kaart brengen. 
In hoofdstuk 2 wordt een literatuuroverzicht gegeven van het proces van 
wondgenezing na myocardinfarct met een focus op de myofibroblasten. Ver-
der worden moleculaire targets beschreven die gebruikt zouden kunnen worden 
voor imaging en wordt een overzicht gegeven van experimentele studies waarin 
is getracht om myofibroblasten te imagen. 
In hoofdstuk 3 hebben we infarctgenezing na MI bestudeerd in verschillende 
muizenstammen die veelvuldig in cardiovasculair onderzoek worden gebruikt. 
Het doel was de effecten van de genetische achtergrond op de resultaten van 
deze studies te bestuderen. Vijf verschillende muizen stammen (BalbC, C57Bl6, 
FVB, 129S6 and Swiss) werden geïncludeerd, MI werd geïnduceerd en infarct 
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genezing werd bestudeerd. Infarctruptuur werd waargenomen tussen 3-6 da-
gen na MI en trad het meest frequent op in 129S6 muizen (62%), gevolgd door 
C57Bl6 (36%), FVB (29%), Swiss (23%) en BalbC (5%). De hoge incidentie 
van infarctruptuur in de 129S6 muizen was geassocieerd met een hoge systole 
bloeddruk en een grotere influx van ontstekingscellen op dag 3 na MI. Acuut 
hartfalen werd gezien in 28% van de FVB muizen in de eerste week na MI, 
maar kwam zelden voor in de andere groepen. Cardiale dilatatie was het meest 
uitgesproken in Swiss muizen, met een meer dan 3-voudige stijging in het eind 
systole volume in vergelijking met sham geopereerde muizen. De dilatatie cor-
releerde met een verminderde contractie en relaxatie van het hart en een lagere 
ejectiefractie. Cardiale dilatatie kwam het minste voor in 129S6 muizen. Secon-
daire dilatatie van het infarct tussen dag 14 en 28 na MI trad op in BalbC, FVB 
en Swiss muizen, maar was afwezig in C57Bl6 en 129S6. Uit de bevindingen in 
hoofdstuk 3 concluderen we dat de infarct heling na MI in muizen sterk afhanke-
lijk is van hun genetische achtergrond. Voorzichtigheid is geboden bij het verge-
lijken van resulaten die zijn verkregen in verschillende muizenstammen. Verder 
bieden de uitkomsten een richtlijn voor het kiezen van een geschikte muizen-
stam om bepaalde aspecten van cardiale remodelering na MI te bestuderen. 
Uit de literatuur is bekend dat in experimentele muismodellen matrix metal-
loproteinases (MMP’s) een belangrijke rol spelen in de ontwikkeling van infarc-
truptuur na MI. In hoofdstuk 4  bestudeerden we de rol van deze MMP’s in 
post-mortem hartweefsel van patiënten die waren overleden aan een infarctrup-
tuur.  De resulaten van deze studie laten zien dat een verhoogde activiteit van 
MMP-8 en MMP-9 in het infarctgebied, veroorzaakt door een grotere influx van 
ontstekingscellen, leidt tot infarctruptuur in mensen. 
In hoofdstuk 5 bestudeerden we de rol van cel adhesie eiwitten in post-mor-
tem hart weefsel van patiënten die waren overleden aan infarct ruptuur na MI. 
De resultaten lieten een verminderde expressie zien van aE-catenine in patiën-
ten overleden aan infarctruptuur. Tevens bleek dat bij deze patiënten minder 
aE-catenin in de intercalairschijven aanwezig was en dat dit eiwit dus niet goed 
gelokaliseerd is in de hartspiercel. Alhoewel het precieze mechanisme dat leidt 
tot een lagere expressie van aE-catenin nog verder onderzocht moet worden, is 
op basis van de resultaten uit hoofdstuk 4 en 5 een mogelijk mechanisme be-
schreven dat kan leiden tot infarctruptuur na MI in mensen, en dat als startpunt 
kan dienen voor de ontwikkeling van (preventieve) geneesmiddelen.
Hoofdstukken 6 en 7 van dit proefschrift richten zich op moleculaire imaging 
van myofibroblasten om zodoende de cardiale remodelering na MI in beeld te 
brengen. In hoofdstuk 6 hebben we gekeken naar interstitiële veranderingen 
tijdens remodelering van het myocard. Hiervoor hebben we gebruik gemaakt 
van een radioactief gelabeled Cy5.5-RGD imaging peptide (CRIP) dat aan my-
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ofibroblasten bindt. Maximale CRIP opname werd gezien in het infarct gebied 
met de hoogste opname 2 weken na MI, gevolgd door 4 en 12 weken na MI in 
vergelijking tot dieren zonder MI. De CRIP opname in het niet-geïnfarceerde 
restmyocard verschilde niet van controle waarden 2 en 4 weken na infarct maar 
was verhoogd op 12 weken na MI. De CRIP opname was gerelateerd aan het 
aantal myofibroblasten en correleerde met de hoeveelheid collagen depositie. 
Concluderend laat deze studie zien dat radioactief gelabeld CRIP interstitiële 
veranderingen gedurende cardiale remodelering op een niet-invasieve manier 
in kaart kan brengen. 
In hoofdstuk 7 hebben we gekeken of deze imaging probe de effecten van far-
macologische interventies na MI kan detecteren. Antagonisten van de renine-an-
giotensine-aldosteron-as kunnen myocardiale fibrose en cardiale remodelering 
verminderen en leiden tot een verbeterde overleving. Aangezien myofibroblas-
ten AT1 receptoren tot expressie brengen is het waarschijnlijk dat beïnvloeding 
van het RAAS system een effect heeft op de myofibroblasten. Imaging van my-
ofibroblasten zou indirect de hoeveelheid fibrose moeten weergeven.  Direct 
na infarcering werden de muizen 4 weken behandeld met captopril, losartan of 
spironolactone alleen of in combinatie. De CRIP opname was het hoogste in on-
behandelde controle dieren en verminderde significant in de dieren die met mo-
notherapie waren behandeld. Behandeling met twee of drie medicijnen liet een 
verdere reductie in probe opname zien. Concluderend liet deze studie zien dat 
radioactief gelabeled CRIP de mogelijkheid biedt om de effecten van farmacolo-
gische interventie te evalueren. Verder bevestigde deze studie de superioriteit 
van combinatie therapie in de behandeling van hartfalen.
 
Concluderend beschrijft dit proefschrift twee belangrijke complicaties van wond-
genezing na een myocardinfarct. Enerzijds wordt een nieuw moleculair mecha-
nisme beschreven voor infarctruptuur na MI in mensen. Anderzijds laat het een 
mogelijkheid zien om myofibroblasten te imagen als een vroege marker voor 
hartfalen. Als deze techniek klinisch wordt bewezen, zouden patiënten met een 
risico op hartfalen in een vroeg stadium kunnen worden gedetecteerd en kan 
een optimaal behandelplan voor deze patiënten worden opgesteld, om zodoen-
de het ontstaan van hartfalen te voorkomen.
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The top row shows a normal heart, a transverse heart section, and associated normal heart histology. 
Acute myocardial infarction occurs when there is occlusion of one of the coronary arteries (occlusion 
of the left anterior descending coronary artery is represented by a black dot over the artery). The first 
phase of the wound healing process (12-18 hours post-infarction) is characterized by eosinophilia and 
nuclear pyknosis (second row, far right panel). Between days 1 and 4 post infarction the nuclei may 
disappear and polymorphonuclear leukocytes infiltrate into the infarcted area with removal of necrotic 
fibers (third row, phase 2). At this time, when the infarct wall is weakest, the myocardium may 
rupture, often leading to sudden death. In the hearts that do not rupture, there is matrix remodeling 
and granulation tissue formation that by 3 weeks includes removal of necrotic debris, mononuclear 
cell infiltration, increased numbers of fibroblasts and capillaries, and an increase in collagen deposition 
(fourth row, phase 3). After three months, the infarcted region thins and is replaced by scar tissue 
(bottom row, phase 4). The remaining viable myocardium may remodel and become dysfunctional, 
leading to heart failure. Scale bar length is indicated in micrometers. Figure adapted from: E. Creemers 
and J. Cleutjens.
Figure 1.1   The different phases of wound healing post-myocardial infarction
The myofibroblasts expresses several targets that might be of interest for molecular imaging. 
Angiotensin receptor, Frizzled-2 receptor and TGF-b receptors are reasonable candidates and easily 
accessible to targeting tracer molecules because of their extracellular localization. avb3 integrins are 
expressed in the supermature focal adhesions and may constitute yet another candidate. However, 
specificity and efficacy of these targets needs to be determined because these targets are presented 
on numerous other cell types.  
Figure 2.2   Potential targets for myofibroblast imaging
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In vivo microscopic imaging shows a 3-week old myocardial infarction in a mouse model for myocardial 
infarction. After administration of green fluorescent angiotensin peptide analog (APA) increased uptake 
in the infarct area is observed (A). Sections show no uptake of APA in the remote zone (B) and clear up-
take in non-myocytic cells in the infarct region (C). The angiotensin receptor positive cells (D, green), 
also stained positive for ASMA (E, red) showing colocalization (F, yellow) indicating that AT receptors 
are present on myofibroblasts. 
Figure 2.3   Optical imaging of angiotensin receptors
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In vivo imaging with radiolabeled CRIP showed intense uptake in the infarct area two weeks post MI. 
The uptake decreased over time. The cardiac localization is confirmed in CT fusion image and ex vivo 
images. 
Figure 2.4   In and Ex vivo images of radiolabeled CRIP imaging
SPECT Fusion Ex Vivo
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The MIBI scan (first row) shows apical perfusion defects in the short axis (SA), vertical axis (VA) and 
horizontal axis (HA) at baseline. RIP imaging at 3 and 8 weeks post MI (row 2 and 3) show uptake cor-
responding to the infarct area and borderzone delineated by the MIBI scan. The cardiac MR one year 
post-MI shows scar formation corresponding to RIP uptake (row 4). 
MIBI at baseline, RIP imaging at 3 and 8 week post-MI and cardiac 
MRI 1 year post-MI
SA VA HA
MIBI Baseline
RIP 3 weeks
RIP 8 weeks
MRI 12 months
Figure 2.5
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Figure 3.2  Survival and causes of death between 5 different mouse strains
A: Kaplan Meier curve analysis of 5 different mouse strains showed significant differences in survival 
(p=0.004). BalbC mice showed the highest survival, 85% of these mice were still alive at day 28 post-
MI. The BalbC mice were followed by Swiss (69%), C57Bl6 (56%) FVB (37%) whereas only 33% of 
the 129S6 mice were still alive at 28 days post-MI. B: The causes of death in the post-MI mice were 
infarct rupture and early heart failure in the first week post-MI. Of the 129S6 mice, 62% died of infarct 
rupture, as compared to only 5% of the BalbC mice. Death due to acute heart failure in the first week 
post-MI mainly occurred in the FVB mice (28%). 
A
B
Figure 3.1   Flow chart of the experimental protocols
Of each mouse strain, mice were divided into 4 groups. All MI mice were subjected to baseline 
echocardiography, MI surgery and echo and hemodynamic measurements at the experimental time 
point. As a control, sham operated mice of every strain were used. They underwent echocardiography 
before MI and at day 3, 14 and 28. Hemodynamic measurements were executed at day 28. 
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Figure 3.3   Echocardiographic measurements
Echocardiographic measurements were performed in sham operated and in post-MI mice. The values 
measured at baseline in the sham operated mice remained similar over time and are represented by 
the grey rectangle. Post-MI, end systolic volume (ESV) and end diastolic volume (EDV) increased in all 
mouse strains, with the highest increase in Swiss mice (Fig. 3.3 A,B). The ejection fraction (EF) and 
fractional shortening (FS) decreased after MI surgery in all mouse strains with the highest decrease in 
Swiss and BalbC mice. BalbC (green), C57Bl6 (black), FVB (yellow), 129S6 (red), Swiss (blue). 
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Inflammatory cell influx and MMP-activity at day 3 post-myocardial 
infarction
Inflammatory cells were counted at the infarct borderzone 3 days post-MI. A: Quantitative analysis 
showed a significant difference in influx of inflammatory cells between the 5 mouse strains (p=0.0074). 
129S6 mice had a significant higher number of inflammatory cells in the infarct area compared to FVB 
and Swiss mice. (*: p<0.05) and Swiss (#: p<0.01) mice. A field is defined as 90.000 mm2. B: Gelatin 
zymography demonstrating the activity of matrix metalloproteinases (MMP)-2 and -9 in myocardial 
infarct tissue obtained from 3 day old infarcts. Quantification of the latent forms of MMP-2 and MMP-9, 
expressed in intensity units (IOD), showed slightly higher latent-MMP-9 levels in 129S6 mice; how-
ever this did not reach statistical significance. Active MMP-levels were difficult to detect in these tissue 
samples. 
In
fla
m
m
at
or
y 
ce
lls
/fi
el
d
IO
D
 *
 1
0
4
30
20
10
0
BalbC FVB 129S6 Swiss
L-MMP2 L-MMP9
70
60
50
40
30
20
10
0
C57Bl6
BalbC C57Bl6 FVB 129S6 Swiss
Figure 3.5
A
B
Thesis vd Borne V2.indd   159 20-2-2009   15:02:11
 page 160 |
250
200
150
100
50
0
Rupture Control MI
Infarct Rupture Control MI
50 50
A B
C
in
fla
m
m
at
or
y 
ce
lls
/fi
el
d
A
10
B C
10
100
V
I
Histological analysis of inflammatory cells in infarct rupture and 
control MI patients
Representative images of H&E staining of the MI border zone in infarct rupture patients (A) and control 
MI patients (B). (C) Quantitative analysis of the inflammatory cells showed a significant increase in 
infarct rupture patients compared to control MI patients (P < 0.001). A field is defined as 90.000 µm2. 
Scale bar length is indicated in µm. 
Figure 4.1
Figure 4.4  Representative images of immunohistochemical staining for MMP-2
MMP-2 was mainly present in vital (V) cardiomyocytes (A-B) and decreased in ischemic (I) cardiomyo-
cytes (A,C). MMP-2 immunoreactivity showed the same pattern in ruptured and control MI. Scale bar 
length is indicated in µm. 
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Figure 4.5  Representative images of immunohistochemical staining for MMP-9
MMP-9 was mainly present in inflammatory cells (Figure 4.5A-D). Infarct rupture patients (Figure 
4.5A-B) showed more abundant staining than control MI patients (Figure 4.5C-D). Scale bar length is 
indicated in mm.  
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Immunohistochemical characterization of cell adhesion complex 
proteins in the infarct area
Representative microphotographs of immunostaining for b-catenin (A-C), g-catenin (D-F), N-cadherin 
(G-I) and aE-catenin (J-L) in the infarct area of ruptured hearts (A,D,G,J), early (B,E,H,K) and late 
(C,F,I,L) control infarcts. A similar staining intensity for b-catenin, g-catenin and N-cadherin was ob-
served in the intercalated disk regions of the cardiomyocytes in infarct rupture and the two control 
MI groups. aE-catenin staining was undetectable in the infarct area of infarct rupture patients (J). 
However, staining was observed in the early control infarcts (K) as also in the border zone (bz) of late 
control MI’s (L). Panel M-O shows H&E staining of the infarct area of ruptured patients (M), character-
ized by the necrotic cardiomyocytes and the massive influx of inflammatory cells. H&E staining of an 
early control MI (N) and the border zone of a late control MI (O) are also shown. Scale bar length is 
indicated in mm. 
Figure 5.1
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Immunohistochemical characterization of cell adhesion complex 
proteins in the remote area
Representative images of immunostaining for b-catenin (A, B), g-catenin (C, D), N-cadherin (E, F) and 
aE-catenin (G,H) in remote parts of ruptured hearts (A,C,E,G) and control MI hearts without rupture 
(B,D,F,H). Abundant and similar staining for b-catenin, g-catenin and N-cadherin was observed in 
the intercalated disk regions of the cardiomyocytes in infarct rupture and control MI groups. For aE-
catenin, abundant staining of intercalated disks between cardiomyocytes was observed in the control 
MI hearts (H). On the contrary, 90% of the patients from the infarct rupture group showed either weak 
or no detectable aE-catenin staining (G). Scale bar length is indicated in mm. 
Figure 5.2
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Heterozygous aE-catenin C-terminal deficient mice show 
susceptibility to infarct rupture post-myocardial infarction
Figure 5.4
Cartoon depicting the role of a defective intercellular adhesion 
complex in infarct rupture in humans
In the left part of the cartoon, the normal components of the cell adhesion complex of cardiomyo-
cytes from patients with normal infarct healing are shown. In the uninjured cardiomyocytes of normal 
hearts, aE-catenin is localized in the intercalated disks. Ischemia induces death of the cardiomyocytes 
in the infarct area, as shown by the loss of their nucleus. However, the integrity of the infarct area is 
sufficiently preserved by the adhering cardiomyocytes, and the wound healing and granulation tissue 
formation continue. As shown in the right side of the cartoon, aE-catenin is not localized in the interca-
lated disks of the cardiomyocytes in rupture-prone hearts. After ischemia, this abnormal cell adhesion 
complex causes the dead cardiomyocytes in the infarct area to loosen up their connections, causing 
further deterioration of the integrity of the infarct area and subsequently leading to infarct rupture. 
Figure 5.5
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Ischemia Ischemia
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actin
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Continued 
wound healing
Rupture
A: Kaplan Meier curve analysis of heterozygous aE-catenin C-terminal deficient mice (n=9) showed 
significantly lower rupture-free survival post MI (#: p=0.038) compared to their wildtype littermates 
(n=11). B: Macroscopic image of infarct rupture (T=tweezers). The arrow points at the tear in the 
infarct area, showing the blood loss through the ventricular wall. C: Representative images of Im-
munohistochemical analysis of aE-catenin, showing less intense staining of the intercalated disks in 
the heterozygous mice compared to wildtype littermates. D-G: Upper panels: Representative Western 
blot analysis for aE-catenin (D), b-catenin (E), g-catenin (F) and N-cadherin (G) in heterozygous C-
terminal aE-catenin deficient mice and their wildtype littermates, both from septum (non-ischemic) 
and infarct tissue; b-actin was used for normalization of the samples. Lower panels: Quantitative 
analysis of adhesion complex proteins, expressed as protein/b-actin ratio, demonstrating significantly 
lower aE-catenin in mice heterozygously deficient for C-terminally truncated aE-catenin (n=9) com-
pared to their wildtype littermates (n=11). The other cell adhesion proteins were unaffected, although 
N-cadherin showed more degradation under ischemic conditions in the heterozygous mice. #p<0.05, 
*p<0.01, **p<0.001. 
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Figure 6.2   Characterization of target binding of CRIP
Probe targeting was evaluated 3.5 H after intravenous administration of CRIP in 2-week post-MI ani-
mals. The localization of the Cy5.5 fluorescence (red) was clearly observed in the infarct and peri-in-
farct zone in vivo (A, arrowheads). A 30-micron whole mouse slice demonstrates myocardial uptake of 
the probe (B, square); intense uptake is seen in the kidney which serves as the route of excretion. (C), 
Magnification of the area enclosed by the square in (B) demonstrates fluorescent probe localization in 
the subendocardium. (D-E) For further characterization of the probe targets, we correlated the uptake 
of intravenously administered CRIP in 2 week post-MI animals (red, D) with concurrent staining of the 
sections by anti-ASMA antibody (green, E), colocalization is shown by overlay (F) The localization of 
CRIP was observed in spindle shaped myofibroblasts in the infarct area. CRIP and ASMA colocalization 
is seen in transversely sectioned myofibroblasts in (G). For immuno EM, similarly intravenously admin-
istered CRIP was traced by gold labeled anti-cy antibody (black immunogold partikels 10 nm). CRIP 
clearly localized with myofibroblasts (H), containing characteristic abundance of rough endoplasmatic 
reticulum (I). No uptake was seen in mature collagen fibers (J). (K) shows sensograms (Biacore 3000 
instrument) obtained with CRIP and scrambled CRIP exposure to a surface with a immobilized peptide 
sequence H2N-GPP-GKN-GDD-GEA-GKP-GR-COOH, aa221-240 from procollagen-I. In addition, RGD 
imaging peptide without Cy5.5 dye was also used in the experiment (RIP). The higher RU values for 
CRIP than RIP is due to the higher molecular weight of CRIP. 
In vivo microCT, microSPECT and fusion images in frontal projection in 
unmanipulated control and 4-week post-MI animals 3H after radiolabeled 
CRIP administration
No uptake of Tc-CRIP was observed in the unmanipulated animal (top row). On the other hand, intense 
anterior uptake is seen in the infarcted mouse (bottom row). The cardiac localization is confirmed in 
the CT fusion image. 
CT SPECT Fusion
Normal 
control
4 weeks
Post-MI
Figure 6.3
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Ex vivo images of the explanted hearts in control and post-MI 
animals with radiolabeled CRIP and scrambled CRIP
A. Ex Vivo Images. Control heart with RGD probe and 4-week post-MI heart with scrambled sequence 
show no radiotracer uptake. On the other hand, intense CRIP uptake is seen in 2-week post-MI animal. 
The uptake in the infarcted area was highest in mice 2 weeks after MI, followed by 4, and 12 weeks 
after MI. B. Quantitative Tc-CRIP uptake in the infarct (apex), peri-infarct (mid), and remote (base) 
areas.  The %ID/g uptake in the infarct area is highest in mice 2 weeks after MI, followed by 4, and 
12 weeks after MI.  On the other hand, the uptake in peri-infarcted and remote areas shows trends 
towards higher uptake from 2 to 12 weeks after MI.  No uptake of scrambled peptide was seen in the 
infarct zone. Quantitative data confirmed the findings of ex vivo images. 
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Radiolabeled CRIP uptake after anti-angiotensin therapy in post- 
MI animals
A. Ex Vivo Images 4 weeks post-MI. In 4-week post-MI animals, captopril treatment alone and in 
combination with losartan demonstrates significantly lower radiotracer uptake as observed in gamma 
images of the ex vivo explanted hearts. B. Quantitative Tc-CRIP uptake was significantly lower after 
therapeutic intervention in infarcted and nonsignificantly lower in non-infarcted areas. 
A Normal Control No RX
Captopril Captopril + Losartan
Apex Base
Control vs
No RX vs
.0001 .0001 .002
2
U
p
ta
ke
 (
%
ID
/g
)
B
Apex (infarct) Mid Base (remote)
Control No RX Captopril Captopril and Losartan
Captopril vs
.0004 .0001
.003
.007 .03 ns
.049
ns
ns
ns ns ns
ns ns
ns
1
0
3
Figure 6.5
Thesis vd Borne V2.indd   169 20-2-2009   15:02:46
 page 170 |
Figure 6.6  Histological assessment of control heart and 4 weeks post MI
Masson’s trichrome (A,D) and Picro Sirius Red (B,E) staining, and Sirius Red staining with polarized 
light (C, F-H)  in remote (A-C) and infarct center or border regions (D-H) in a heart 4 weeks after MI. 
The remote area is from the base of the heart as indicated by the enclosed mitral valve. The remote 
region shows minimal fibrosis (A) and collagen deposition (B,C). On the other hand, the infarct region 
shows significant wall thinning and fibrosis (D) with evidence of collagen deposition (E,F). The two ar-
eas from (F) are magnified to demonstrate collagen deposition in infarct center (G) and infarct border 
(H). Immunohistochemical characterization with anti-ASMA antibody (brown) of the infarct zone at 2 
(I), 4 (J) and 12 (K) weeks reveal progressive decrease in the number of myofibroblasts over time. 
A D
B E
C F G
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I J K
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Figure 6.7  Collagen fiber analysis in remote and infarct regions
The total collagen content in the infarcted area (A) remains similar with the passage of time, where-
as it increases significantly in the remote region (B). Further characterization of the collagen fibers 
by polarization reveals that the thin or new collagen fibers (green) decreased in the infarct region 
(suggestive of cessation of collagen production and maturation of the collagen fibers) (C) and in-
creased substantially in the remote area (D) (suggesting ongoing production of the new collagen with 
increasing total collagen content). The prevalence of new collagen fibers paralleled the CRIP uptake 
and demonstrated a significant direct correlation, both in infarct and remote zone (E, F). For full color 
illustration, see page 171. 
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Radiolabeled CRIP uptake after neurohumoral antagonist treatment 
in post-MI animals
 A. Disease control (unmanipulated) heart with RGD probe shows no radiotracer uptake in ex vivo im-
age of the heart. On the other hand, intense CRIP uptake is seen in 4-week untreated (no Rx) post-MI 
animals (upper panel, right). The uptake in the infarcted area is reduced after neurohumoral treat-
ment with solitary agents and combination therapy (middle and lower panels). Losartan (L) images are 
displayed twice (middle panel) for the convenience of comparison.  C= captopril, S= spironolactone. 
B. Quantitative Tc-CRIP uptake in the infarct (apex, above) and remote (base, below) areas. The 
%ID/g uptake in the infarct area is highest in untreated mice, followed by treatment with one (1Rx), 
two (2Rx) and three (3Rx) agents, respectively. On the other hand, the uptake in the remote area 
shows no significant differences between treated and untreated animals. Quantitative data confirmed 
the findings of ex vivo images.
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Histopathological characterization of the treated and untreated 
animals
Masson’s trichrome staining was performed for infarct localization in control, untreated and treated ani-
mals (A).  In addition, histological staining was performed with picro sirius red to demonstrate collagen 
deposition, which on polarized light allowed identification of the quality of collagen, in the infarct (B,C) 
and remote regions (D,E). The left column presents control animals, middle column shows untreated 
animals (no Rx) and the right column shows animals treated with 3Rx neurohumoral antagonists (SCL). 
The remote region shows minimal fibrosis and collagen deposition (D). On the other hand, infarct re-
gion shows significant wall thinning (A) and fibrosis with evidence of substantial collagen deposition in 
untreated animals (B, NoRx). 3Rx treated animals show reduced fibrosis (A, SCL) and collagen deposi-
tion (B, SCL) in the infarcted area. The Sirius staining under polarized light provides distinction of thick 
red-orange and thin yellow-green collagen fibers in the infarct region (C). 
Figure 7.3
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Figure 7.4  Collagen fiber deposition in infarct and remote regions
The total collagen content decreases with treatment in the infarcted (A), as well as the remote (B) ar-
eas. Further characterization of the collagen fibers by polarization reveals that the thin or new yellow-
green collagen fibers decreased both in the infarct (C) and remote (D) regions after treatment. This 
indicates cessation of new collagen production and maturation of the collagen fibers after treatment. 
The prevalence of new collagen fibers paralleled the CRIP uptake and demonstrated a significant direct 
correlation, both in infarct (E) and remote (F) regions. For full color images, see page 174.
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Radiolabeled CRIP uptake and the prevalence of ASMA-verified 
myofibroblasts 
Immuohistochemical staining with ASMA antibody allowed quantitative assessment of myofibroblasts 
infiltration in the infarct and remote regions (A). The left column presents control animals, the middle 
column shows untreated animals (no Rx) and the right column shows 3Rx-animals (SCL). There is a 
marked decrease in number of myofibroblasts in the infarct region in 2Rx and 3Rx groups (B). There 
is a significant direct correlation between the extent of myofibroblasts and the CRIP uptake in infarct 
region (C). 
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Cartoon of molecular mechanisms that can lead to infarct rupture 
in humans
In the left part of the cartoon, the wound healing post-MI in patients with normal infarct healing is 
shown whereas the right part of the cartoon focuses on the defective wound healing as proposed in in-
farct rupture patients. In the uninjured cardiomyocytes of normal hearts, aE-catenin is localized in the 
intercalated disks. Ischemia induces death of the cardiomyocytes in the infarct area, as shown by the 
loss of their nuclei. However, apparently the adhering cardiomyocytes still can form an effective barrier 
against inflammatory cells and ventricular blood. In the normal heart, the wound healing will com-
mence and granulation tissue will replace the dead cardiomyocytes, taking over the barrier function 
against the ventricular blood. In the rupture-prone heart, however, aE-catenin is reduced and poorly 
localized in the intercalated disks of the cardiomyocytes. After ischemia, this abnormal cell adhesion 
complex causes the dead cardiomyocytes in the infarct area to loosen up their connections, giving 
access to more inflammatory cells. The MMPs deposited by these inflammatory cells induce extensive 
degradation of the extracellular matrix in the infarct area, causing further deterioration of the integrity 
of the infarct area and subsequently leading to infarct rupture.
Figure 8.1
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DANkWOORD
Eindelijk is het dan zover, het proefschrift is af. Het is een intense periode ge-
weest met vallen en opstaan, met vreugde en frustratie. Een periode waarin ik 
ontzettend veel heb geleerd. En dat had ik niet kunnen doen zonder een heleboel 
mensen die me met raad en daad hebben bijgestaan. Bij deze wil ik iedereen die 
in meer of mindere mate aan dit proefschrift heeft bijgedragen bedanken. Een 
aantal mensen wil ik hier even uitlichten.
Allereerst natuurlijk mijn promotores en copromotor. Professor Daemen; beste 
Mat, het is allemaal begonnen naar aanleiding van een student-assistentschap 
op de vakgroep Pathologie. Uit het onderzoek dat ik daar deed kwamen niet 
zo’n bijzondere resultaten, maar jij gaf me de mogelijkheid om me verder in 
het onderzoek te verdiepen in de vorm van een student-aio plaats. Ik ben je 
ontzettend dankbaar voor die kans en het uiteindelijke resultaat mag er zijn. Je 
positieve houding, interesse en humor, maar vooral ook je capaciteit om “spij-
kers met koppen te slaan” had ik soms heel hard nodig.
Professor Smits; beste Jos, graag wil ik je bedanken voor je vertrouwen en 
positieve houding. Er moeten momenten zijn geweest dat ook jij het somber in 
zag, maar daar heb je nooit iets van laten blijken. Je bleef me motiveren om 
door te gaan. Dank ook voor het kritisch nalezen van de manuscripten en het 
proefschrift. Je kennis van de Nederlandse taal is ongekend. 
Dr. Blankesteijn; beste Matthijs, jij was mijn dagelijkse begeleider en je hebt het 
hele proces vanaf het begin gevolgd. Je hebt de gave om ingewikkelde materie 
heel duidelijk uit te leggen. Dit leidde regelmatig tot goede discussies waar weer 
nieuwe ideeen uit voort kwamen. Bedankt hiervoor. Ook de overige mensen van 
de moleculaire farmacologie mogen hier niet ontbreken. Marielle en Yvonne, 
bedankt voor de introductie in de moleculaire biologie. Jos P, bedankt voor je 
hulp met de weefselverzameling. Peter en Lily voor de oneindige hoeveelheid 
Western blots en QPCR’s, Sanna en Cristel voor de gezelligheid, Hilde voor het 
vele regelwerk en de kletspraatjes en Sander voor alle expertise en gezelligheid 
die je met je meebracht.
Professor Narula; dear Jagat. I am very grateful for the opportunity of working 
with you at your lab at the University of California Irvine, USA. You are a true 
inspiration and a great mentor. Ten minutes of discussion with you leads to an 
explosion of ideas, each of which you approach with great enthusiasm. Thank 
you so much……for everything!
Artiom, Nezam, Han, Youping, Peng, Satoshi, Shin and Ai, thank you for al your 
help in the lab, the nice lunches and great diners.
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Ook een woord van dank aan mijn beoordelingscommissie onder leiding van 
Prof. Crijns en verder bestaande uit Prof. Duncker, Prof. van Engelshoven, Prof. 
Ramaekers en Prof. van Roy voor de tijd die ze inversteerden in het lezen en 
beoordelen van mijn proefschrift.
Agnieszka, ontzettend bedankt voor het inzetten van alle dieren. Behalve dat 
je een fantastische operateur bent, beschik je ook over een goed organizato-
risch talent. Ik kon de planning van de geac en het fokken van de dieren dan 
ook zonder problemen aan je overlaten. Ik heb met ontzettend veel plezier met 
je samengewerkt. Ook een woord van dank aan Peter, Jaques en Helma. Jullie 
waren altijd bereid om bij te springen en hebben menig dierexperiment voor me 
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